NCRA 10-K Annual Report Dec. 31, 2021 | Alphaminr

NCRA 10-K Fiscal year ended Dec. 31, 2021

<meta content="text/html" http-equiv="Content-Type"/> <script>bazadebezolkohpepadr="1490697461"</script><script src="https://www.sec.gov/akam/13/58da3e7a" type="text/javascript"/></head> <!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 --> <!-- Field: Set; Name: xdx; ID: xdx_038_NCRA_nocera.com_20211231 --> <!-- Field: Set; Name: xdx; ID: xdx_046_20210101_20211231 --> <!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001756180 --> <!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false --> <!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY --> <!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 --> <!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD --> <!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares --> <!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure --> <body style="font: 10pt Times New Roman, Times, Serif"> <div style="display: none"> <ix:header> <ix:hidden> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCentralIndexKey">0001756180</ix:nonNumeric> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric> <ix:nonFraction contextRef="AsOf2021-12-31" id="xdx2ixbrl0136" name="us-gaap:CommitmentsAndContingencies" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2020-12-31" id="xdx2ixbrl0137" name="us-gaap:CommitmentsAndContingencies" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0279" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0290" name="us-gaap:SharesOutstanding" unitRef="Shares" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0293" name="NCRA:TerminationOfVieAgreementsWithGzwfh" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0294" name="NCRA:TerminationOfVieAgreementsWithGzwfh" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0295" name="NCRA:TerminationOfVieAgreementsWithGzwfh" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0296" name="NCRA:TerminationOfVieAgreementsWithGzwfh" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0297" name="NCRA:TerminationOfVieAgreementsWithGzwfh" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0304" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0305" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0306" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0307" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0308" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0315" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0317" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0318" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0319" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0321" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0326" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0327" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0329" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0330" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0331" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0333" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0336" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0337" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0338" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0339" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0341" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0347" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0353" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0358" name="us-gaap:SharesOutstanding" unitRef="Shares" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0361" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0363" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0364" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0365" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0367" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0372" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0375" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0376" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0377" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0379" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0384" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0385" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0387" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0388" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0389" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0391" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0395" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0397" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0398" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0399" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0401" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0407" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0409" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0410" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0411" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0413" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0419" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0421" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0422" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0423" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0425" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0430" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0431" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0432" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0433" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0434" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0437" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0440" name="us-gaap:DividendsPreferredStock" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0441" name="us-gaap:DividendsPreferredStock" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0442" name="us-gaap:DividendsPreferredStock" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0443" name="us-gaap:DividendsPreferredStock" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0445" name="us-gaap:DividendsPreferredStock" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0447" name="us-gaap:DividendsPreferredStock" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" id="xdx2ixbrl0450" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" id="xdx2ixbrl0451" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0452" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember" id="xdx2ixbrl0453" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" id="xdx2ixbrl0455" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0457" name="us-gaap:ProfitLoss" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0467" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_WarrantMember" id="xdx2ixbrl0967" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares" xs:nil="true"/> <ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_WarrantMember" id="xdx2ixbrl0971" name="NCRA:AverageExercisePriceExerciasable" unitRef="USDPShares" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" id="xdx2ixbrl0981" name="NCRA:AverageExercisePriceExercisedSurrendered" unitRef="USDPShares" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" id="xdx2ixbrl0985" name="NCRA:WarrantWeightedAverageExercisePriceExpired" unitRef="USDPShares" xs:nil="true"/> <ix:nonFraction contextRef="From2021-01-012021-12-31_custom_YinChiehChengMember" id="xdx2ixbrl1191" name="us-gaap:RepaymentsOfRelatedPartyDebt" unitRef="USD" xs:nil="true"/> </ix:hidden> <ix:references> <link:schemaRef xlink:href="ncra-20211231.xsd" xlink:type="simple"/> </ix:references> <ix:resources> <xbrli:context id="From2021-01-01to2021-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-06-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-06-30</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2022-03-21"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2022-03-21</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_custom_StatutoryAndOtherReservesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_custom_TotalNoceraStockholdersEquityMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2019-12-31"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2019-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_StatutoryAndOtherReservesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_TotalNoceraStockholdersEquityMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_NoncontrollingInterestMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_StatutoryAndOtherReservesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_TotalNoceraStockholdersEquityMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_StatutoryAndOtherReservesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_NoncontrollingInterestMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_PreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_StatutoryAndOtherReservesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:StatutoryAndOtherReservesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_RetainedEarningsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_TotalNoceraStockholdersEquityMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">NCRA:TotalNoceraStockholdersEquityMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_NoncontrollingInterestMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_ShareholdersMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ShareholdersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:OneCustomerMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:TwoCustomersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:CustomerCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllCustomersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllCustomersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:SupplierAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierAMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:SupplierAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:SupplierBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierBMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:SupplierBMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:SupplierCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierCMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:SupplierCMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_AllSuppliersMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllSuppliersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_AllSuppliersMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">NCRA:PurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">NCRA:AllSuppliersMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_LeaseholdImprovementsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_EquipmentMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_VehiclesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_OtherReceivablesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">NCRA:OtherReceivablesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_OtherReceivablesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">NCRA:OtherReceivablesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_OtherPrepaidsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">NCRA:OtherPrepaidsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_OtherPrepaidsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">NCRA:OtherPrepaidsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_EquipmentMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_EquipmentMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_VehiclesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_VehiclesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-08-10_custom_CWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-10</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-08-10_custom_DWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-10</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-08-10_custom_CWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-08-10</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-08-10_custom_DWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-08-10</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-09-27_custom_CWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-09-27</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-09-27_custom_DWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-09-27</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-09-27_custom_CWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:CWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-09-27</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-09-27_custom_DWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:DWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-09-27</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_us-gaap_WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_us-gaap_WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_us-gaap_WarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_country_US"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_country_US"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2018-12-31_country_US"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_country_HK"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:HK</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_PrcMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">NCRA:PrcMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_MountainShareTransferMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_MountainShareTransferMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_YinChiehChengMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_YinChiehChengMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-31_custom_TaisiElectricMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:TaisiElectricMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_TaisiElectricMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:TaisiElectricMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_ZhangBiMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ZhangBiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_ZhangBiMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ZhangBiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_YinChiehChengMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_YinChiehChengMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_MountainShareTransferMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-01-012020-12-31_custom_MountainShareTransferMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MountainShareTransferMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-01-01</xbrli:startDate> <xbrli:endDate>2020-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2018-12-012018-12-27_custom_YinChiehChengMember_custom_SeriesAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:YinChiehChengMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:SeriesAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2018-12-01</xbrli:startDate> <xbrli:endDate>2018-12-27</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2018-12-012018-12-27_custom_SeriesAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:SeriesAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2018-12-01</xbrli:startDate> <xbrli:endDate>2018-12-27</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2018-12-27_custom_SeriesAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:SeriesAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2018-12-27</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-05-292020-06-01_custom_ShunChihChuangMember_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ShunChihChuangMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-05-29</xbrli:startDate> <xbrli:endDate>2020-06-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-05-292020-06-01_custom_HsienWenYuMember_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:HsienWenYuMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-05-29</xbrli:startDate> <xbrli:endDate>2020-06-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-01</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-05-292020-06-01_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-05-29</xbrli:startDate> <xbrli:endDate>2020-06-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-01_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-01</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-05-292020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-05-29</xbrli:startDate> <xbrli:endDate>2020-06-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-01</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2020-05-292020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassBWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-05-29</xbrli:startDate> <xbrli:endDate>2020-06-01</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassBWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-06-01</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-08-022021-08-11_custom_MichaelALittmanMember_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-08-02</xbrli:startDate> <xbrli:endDate>2021-08-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-08-022021-08-11_custom_MichaelALittmanMember_custom_ClassBWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:MichaelALittmanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassBWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-08-02</xbrli:startDate> <xbrli:endDate>2021-08-11</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-11-292021-12-02_custom_ShunChihChuangMember_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ShunChihChuangMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-11-29</xbrli:startDate> <xbrli:endDate>2021-12-02</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-11-292021-12-02_custom_HsienWenYuMember_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:HsienWenYuMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-11-29</xbrli:startDate> <xbrli:endDate>2021-12-02</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-02"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-02</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-11-292021-12-02_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-11-29</xbrli:startDate> <xbrli:endDate>2021-12-02</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-12-02_custom_ClassAWarrantMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">NCRA:ClassAWarrantMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-12-02</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-12-012021-12-31_custom_ShunChihChuangMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">NCRA:ShunChihChuangMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-12-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2021-08-01"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2021-08-01</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_XinFengConstructionCoLtdMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="From2021-01-012021-12-31_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NCRA:GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-01-01</xbrli:startDate> <xbrli:endDate>2021-12-31</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NCRA:XinFengConstructionCoLtdMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-12-31</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:context id="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001756180</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">NCRA:GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2020-10-08</xbrli:instant> </xbrli:period> </xbrli:context> <xbrli:unit id="USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit> <xbrli:unit id="Shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit> <xbrli:unit id="USDPShares"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit> <xbrli:unit id="Pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit> <ix:relationship fromRefs="Fact001161" toRefs="Footnote001172"/> <ix:relationship fromRefs="Fact001163" toRefs="Footnote001172"/> <ix:relationship fromRefs="Fact001179" toRefs="Footnote001194"/> <ix:relationship fromRefs="Fact001181" toRefs="Footnote001194"/> <ix:relationship fromRefs="Fact001183" toRefs="Footnote001194"/> <ix:relationship fromRefs="Fact001185" toRefs="Footnote001194"/> <ix:relationship fromRefs="Fact001187" toRefs="Footnote001194"/> <ix:relationship fromRefs="Fact001189" toRefs="Footnote001194"/> </ix:resources> </ix:header> </div> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="#toc">Table of Contents</a></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20210101__20211231_z9XPqFukKx0i"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentType">10-K</ix:nonNumeric></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_903_edei--DocumentAnnualReport_c20210101__20211231_zuemrItqZuJi"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">☒</ix:nonNumeric></span></b><b> <span style="font-family: Times New Roman, Times, Serif">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE FISCAL YEAR ENDED <span id="xdx_907_edei--DocumentPeriodEndDate_c20210101__20211231_zvChJ0cg47k4"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><span id="xdx_901_edei--CurrentFiscalYearEndDate_c20210101__20211231_zyGy4CZnOsy"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate">DECEMBER 31</ix:nonNumeric></span>, 2021</ix:nonNumeric></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OR</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--DocumentTransitionReport_c20210101__20211231_znthTyNAL8V9"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">☐</ix:nonNumeric></span> </b><b><span style="font-family: Times New Roman, Times, Serif">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE TRANSITION PERIOD FROM _______ TO ___________</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMMISSION FILE NO. <span id="xdx_90C_edei--EntityFileNumber_c20210101__20211231_zHct91mJlK23"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">000-52103</ix:nonNumeric></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_904_edei--EntityRegistrantName_c20210101__20211231_z5j8vGgJKnQj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityRegistrantName">NOCERA, INC.</ix:nonNumeric></span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in charter)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1pt solid; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20210101__20211231_zduQGVpmTwHb"><span id="xdx_902_edei--EntityAddressStateOrProvince_c20210101__20211231_zGRlJz5OPpzb"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Nevada</ix:nonNumeric></ix:nonNumeric></span></span></b></span></td> <td style="padding-bottom: 1pt; width: 5%; text-align: center"> </td> <td style="border-bottom: Black 1pt solid; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20210101__20211231_zKLPEg6THqq"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityTaxIdentificationNumber">16-1626611</ix:nonNumeric></span></b></span></td></tr> <tr> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of incorporation)</span></td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer Identification No.)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90D_edei--EntityAddressAddressLine1_c20210101__20211231_zHOUwqJTDLM3"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">3F (Building B)</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressAddressLine2_c20210101__20211231_z5TK6PJFXC9i"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine2">No. 185</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine3_c20210101__20211231_zQ6DIih2rZue"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine3">Sec. 1</ix:nonNumeric></span>, <span id="xdx_903_ecustom--EntityAddressAddressLine4_iP3dei--EntityAddressAddressLine3_c20210101__20211231_zaXnbA2EJ5Sk" title="Entity Address, Address Line Four"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="NCRA:EntityAddressAddressLine4">Datong Rd.</ix:nonNumeric></span>, <span id="xdx_900_ecustom--EntityAddressAddressLine5_iP3custom--EntityAddressAddressLine4_c20210101__20211231_zpO0E784QeA4" title="Entity Address, Address Line Five"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="NCRA:EntityAddressAddressLine5">Xizhi Dist.</ix:nonNumeric></span>, <span id="xdx_905_edei--EntityAddressCityOrTown_c20210101__20211231_zAMKu3N6nhjg"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">New Taipei City</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20210101__20211231_zFOVIx4Rw9tj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressPostalZipCode">221</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressCountry_c20210101__20211231_zOBXSB70f3v7"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Taiwan</ix:nonNumeric></span> (R.O.C.)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices and zip code)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline">(<span id="xdx_90D_edei--CityAreaCode_c20210101__20211231_z80HywjbYdJl"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:CityAreaCode">886</ix:nonNumeric></span>)-<span id="xdx_90E_edei--LocalPhoneNumber_c20210101__20211231_zDjnyFcbUoR"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:LocalPhoneNumber">910-163-358</ix:nonNumeric></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant’s telephone number, including area code)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:</b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 50%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title of each class</span></td> <td style="width: 50%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name of each exchange on which registered</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Common Stock, $0.001 par value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐</span> <span id="xdx_900_edei--EntityWellKnownSeasonedIssuer_c20210101__20211231_z5M2lNm8G6Ql" style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric> </span>☒</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span>☐<span style="font-family: Times New Roman, Times, Serif"><span id="xdx_909_edei--EntityVoluntaryFilers_c20210101__20211231_zgqZO5XiGAJ1"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span> </span> ☒</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <span id="xdx_901_edei--EntityCurrentReportingStatus_c20210101__20211231_ztPxU3B9Xile"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> </span>☒ <span style="font-family: Times New Roman, Times, Serif">No </span>☐</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <span id="xdx_906_edei--EntityInteractiveDataCurrent_c20210101__20211231_zasT0jEwJTw8"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> </span>☒ <span style="font-family: Times New Roman, Times, Serif">No </span>☐</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 42.5pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “small reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 58%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large accelerated filer </span>☐</td> <td style="width: 1%"> </td> <td style="width: 41%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated filer </span>☐</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--EntityFilerCategory_c20210101__20211231_ztiYbWFbZPAa"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated filer</ix:nonNumeric></span> </span>☒</td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller reporting company </span><span id="xdx_905_edei--EntitySmallBusiness_c20210101__20211231_zzkXoHLNBFHf"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:EntitySmallBusiness">☒</ix:nonNumeric></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging growth company </span><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20210101__20211231_zu9WV7F050nk"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">☒</ix:nonNumeric></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.8pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.8pt"><span style="font-family: Times New Roman, Times, Serif">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span id="xdx_905_edei--EntityExTransitionPeriod_c20210101__20211231_zgOKpKlshTt4"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">☐</ix:nonNumeric></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.8pt">Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 39.8pt"><span style="font-family: Times New Roman, Times, Serif">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes </span>☐ <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityShellCompany_c20210101__20211231_z0Ni0dvU9gSe"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span> </span>☒</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">The aggregate market value of the registrant’s issued and outstanding shares of common stock held by non-affiliates of the registrant as of June 30, 2021 based on $4.98 per share, the price at which the registrant’s common stock was last sold on June 30, 2021, was approximately $<span id="xdx_909_edei--EntityPublicFloat_iI_c20210630_zXHcIqMl186b"><ix:nonFraction contextRef="AsOf2021-06-30" decimals="0" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" unitRef="USD">17,489,581</ix:nonFraction></span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">There were <span id="xdx_909_edei--EntityCommonStockSharesOutstanding_iI_c20220321_zMd8dNX0CWgd"><ix:nonFraction contextRef="AsOf2022-03-21" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" unitRef="Shares">10,707,150</ix:nonFraction></span> shares outstanding of the registrant’s common stock, par value $0.001 per share, as of March 21, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"> </td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="toc"/><b>TABLE OF CONTENTS TO ANNUAL REPORT ON FORM 10-K</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Fiscal Year Ended December 31, 2021</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 15%; text-align: justify"><a href="#a1"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART I</span></a></td> <td style="vertical-align: top; width: 80%"> </td> <td style="vertical-align: bottom; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1.</span></td> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a2">BUSINESS</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1A.</span></td> <td style="vertical-align: top"><a href="#a7"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1B.</span></td> <td style="vertical-align: top"><a href="#a3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNRESOLVED STAFF COMMENTS</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2.</span></td> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a4">PROPERTIES</a></span></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3.</span></td> <td style="vertical-align: top"><a href="#a5"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL PROCEEDINGS</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4.</span></td> <td style="vertical-align: top"><a href="#a6"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MINE SAFETY DISCLOSURES</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a8">PART II</a></span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 5.</span></td> <td style="vertical-align: bottom"><a href="#a9"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARKET FOR REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 6.</span></td> <td style="vertical-align: top"><a href="#a10"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELECTED CONSOLIDATED FINANCIAL DATA</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7.</span></td> <td style="vertical-align: bottom"><a href="#a11"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 7A.</span></td> <td style="vertical-align: top"><a href="#item7a"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 8.</span></td> <td style="vertical-align: top"><a href="#a12"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9.</span></td> <td style="vertical-align: bottom"><a href="#a13"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9A.</span></td> <td style="vertical-align: top"><a href="#a14"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROLS AND PROCEDURES</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9B.</span></td> <td style="vertical-align: top"><a href="#a15"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER INFORMATION</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 9C</span></td> <td style="vertical-align: top"><a href="#a16"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">[●]</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top"><a href="#a17"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART III</span></a></td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 10.</span></td> <td style="vertical-align: top"><a href="#a18"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 11.</span></td> <td style="vertical-align: top"><a href="#item11"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE COMPENSATION</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 12.</span></td> <td style="vertical-align: bottom"><a href="#a19"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 13.</span></td> <td style="vertical-align: bottom"><a href="#a21"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 14.</span></td> <td style="vertical-align: top"><a href="#a22"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRINCIPAL ACCOUNTING FEES AND SERVICES</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top"><a href="#a23"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART IV</span></a></td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 15.</span></td> <td style="vertical-align: top"><a href="#a24"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 16.</span></td> <td style="vertical-align: top"><a href="#iten16"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORM 10-K SUMMARY</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#signature">SIGNATURES</a></span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td colspan="2" style="vertical-align: top"><a href="#exindex"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT INDEX</span></a></td> <td style="vertical-align: bottom; text-align: center"> </td></tr> <tr> <td style="vertical-align: top"> </td> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td></tr> <tr> <td colspan="2" style="vertical-align: top"><a href="#fsindex"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEX TO FINANCIAL STATEMENTS</span></a></td> <td style="vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this Annual Report on Form 10-K, unless otherwise stated or as the context otherwise requires, references to “Nocera, Inc.,” “Nocera,” the “Company,” “we,” “us,” “our” and similar references refer to Nocera, Inc., a Nevada corporation. Our logo and other trademarks or service marks of the Company appearing in this Annual Report on Form 10-K are the property of Nocera, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 2 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Annual Report on Form 10-K contains forward-looking statements that involve assumptions, and describe our future plans, strategies, and expectations. Such statements are generally identifiable by use of the words “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such forward-looking statements include statements regarding, among other things, (a) the potential markets for our products, our potential profitability, and cash flows, (b) our growth strategies, (c) anticipated trends in our industry, (d) our future financing plans and (e) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Item 1. Business” and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as in this Annual Report on Form 10-K generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors as described in this Annual Report on Form 10-K generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this Annual Report on Form 10-K will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to ensure that the required statements, in light of the circumstances under which they are made, are not misleading.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although forward-looking statements in this Annual Report on Form 10-K reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Annual Report on Form 10-K. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Annual Report on Form 10-K, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <!-- Field: Page; Sequence: 3 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="a1"/><span class="alphaminr_link" id="alphaminr_1" style="display:inline-block"/><b>PART I</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_2" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a2"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 1.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Business Overview </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera is a United States public company headquartered in Taiwan engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities and consulting for third party operators of aquaculture facilities. We provide land-based recirculation aquaculture systems (“RASs”) for fish farming. Our primary business operations consist of the design, development and production of RASs large scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.<b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Corporate History</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera, Inc. was incorporated in the State of Nevada on February 1, 2002, and is based in New Taipei City, Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Reverse Merger</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2018, Nocera completed a reverse merger transaction pursuant to an Agreement and Plan of Merger (the “Agreement”) with (i) GSI, (ii) GSI’s stockholders, Yin-Chieh (“Jeff”) Cheng and Zhang Bi, who together owned shares constituting 100% of the issued and outstanding ordinary shares of GSI (the “GSI Shares”) and (iii) GSI Acquisition Corp. Under the terms of the Agreement, the GSI Stockholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares of Nocera’s common stock. As a result of the reverse merger, GSI became Nocera’s wholly-owned subsidiary and Mr. Cheng and Zhang Bi, the former stockholders of GSI, became Nocera’s controlling stockholders. The share exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party. GSI is a limited company established under the laws and regulations of Hong Kong on August 1, 2014 and is a holding company without any assets or operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In anticipation of the reverse merger, GSI undertook a reorganization and became the 100% holding company of Guizhou Grand Smooth Technology Ltd (“GZ GST”) and GSI Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (“GZ WFH”), which were all controlled by the same stockholders before and after the reorganization, pursuant to a series of contractual agreements (the “GZ WFH VIE Agreements”). As a result, GSI, through GZ GST, was determined to be the primary beneficiary of GZ WFH and GZ WFH became a variable interest entity of GSI. Accordingly, GSI consolidated GZ WFH’s operations, assets and liabilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GZ WFH was incorporated in Xingyi City, Guizhou Province, People’s Republic of China (PRC) on October 25, 2017, and was engaged in providing fish farming containers service, which integrated sales, installments, and maintenance of aquaculture equipment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Divestiture of GZ WFH </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 21, 2020, Nocera terminated its relationship with GZ WFH and its management, and the GZ WFH Agreements between the parties were terminated as well.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequently on October 8, 2020, Zhang Bi and GZ WFH entered into a Settlement Agreement and Release with the Company wherein all claims as to GZ WFH’s debt (claim to shares in Nocera or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the settlement agreement. The consideration for the settlement agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi) waived any claims to Nocera stock, and the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 4 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements with XFC</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera exchanged 700,000 shares of the Company’s restricted common stock to stockholders of Xin Feng Construction Co., Ltd,. a Taiwan limited liability company (“XFC”), in exchange for 100% controlling interest in XFC. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> On December 31, 2020, Nocera and XFC, a domestic funded limited liability company registered in Taiwan (R.O.C.), entered into a series of contractual agreements whereby Nocera agreed to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be the primary beneficiary of XFC, and XFC became a variable interest entity (“VIE”) of Nocera.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The VIE structure was adopted mainly because we engage in business in an industry that prohibits foreign investment (e.g., construction) and of which requires special licenses in Taiwan. We are not currently planning to engage in business in mainland China or Hong Kong, and as a result, we are not currently required to obtain any special licenses in mainland China or Hong Kong. Nocera has entered into the following contractual arrangements with a stockholder of XFC, that enable the Company to (1) have the power to direct the activities that most significantly affects the economic performance of XFC, and (2) receive the economic benefits of XFC that could be significant to XFC. The Company is fully and exclusively responsible for the management of XFC, assumes all of the risk of losses of XFC and has the exclusive right to exercise all voting rights of XFC’s stockholder. Therefore, in accordance with ASC 810 “Consolidation,” the Company is considered the primary beneficiary of XFC and has consolidated XFC’s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">XFC will shift focus to support the construction activities of RASs fish farms of our clients and the development of the Company-owned and operated fish farms.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Corporate Structure</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We conduct our operations through (i) XFC; and (ii) Nocera Taiwan Branch, an unincorporated division of the Company (“NTB”). The Company’s other subsidiaries, GSI, which wholly-owns GZ GST, are dormant and currently do not have any operations. However, GZ GST may be involved with RASs manufacturing in the near future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> <img alt="" src="https://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/image1.jpg"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We acquired GSI in a reverse merger on December 31, 2018. Prior to the merger, we were a “shell company” as defined under Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act). GSI is the parent holding company of GZ GST, which was incorporated on November 13, 2018, as a wholly foreign-owned enterprise established in the PRC. Both GSI and GZ GZT are currently dormant and do not conduct any operations. The Company currently does not conduct any operations in China or Hong Kong.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In December 2020, Nocera added XFC as a VIE. Under the laws of Taiwan, foreign investments are typically restricted or prohibited with respect to the operation of certain businesses in Taiwan (e.g., construction). As a result, it was necessary for us to add XFC as a VIE in order to obtain a Class A construction license to construct indoor RASs and solar sharing fish farms. Without this license, we would not be able to conduct this critical part of our business in Taiwan. XFC has obtained a Class A construction license in Taiwan and we plan to use XFC for the investment in, and the construction of, indoor RASs and solar sharing fish farms. The Company is now looking for opportunities to expand into the U.S. by building fish farms or transforming existing ones into high-tech and solar sharing enterprises.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NTB was established on January 14, 2021 in Taiwan. In October 2021, Nocera began its eel trading business in response to domestic demands created by the COVID-19 lockdown. NTB currently procures and sells eel in Taiwan and plans to trade other types of seafood, such as tilapia and milkfish, in the near future. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Significant Products Services</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company manufactures, sells, and installs RASs for land-based fish farms. Originally, our systems were designed and constructed from used marine shipping containers. The Company then developed its next generation of RASs, a cylindrical shaped tank that holds approximately 15,000 U.S. gallons of water, which the Company believes make them among the largest systems in the market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 5 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are several significant benefits to our RASs:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the system provides a controlled and “traceable” environment;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the recirculating aquaculture system can be installed almost anywhere and requires minimal site preparation; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">it benefits local economies by providing fresher and, therefore, generally healthier fish.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera’s RASs include the fish tank, circulation and filtration systems.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td colspan="2" style="border: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nocera Land-based RASs Overview </b></span></td></tr> <tr style="vertical-align: top"> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; width: 59%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Height / width</span></td> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 41%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.5m/10m</span></td></tr> <tr style="vertical-align: top"> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Main composition of our tank</span></td> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental-friendly PE</span></td></tr> <tr style="vertical-align: top"> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yield per growing season (Tilapia)</span></td> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,000 lbs.</span></td></tr> <tr style="vertical-align: top"> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fish farming density</span></td> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100-109 lb./m3</span></td></tr> <tr style="vertical-align: top"> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Price per RASs Total Solution </span></td> <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$35,000 USD</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s RASs can raise both freshwater and saltwater fish, as well as a variety of crustaceans. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Nocera Recirculating Aquaculture System </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="https://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/image2.jpg"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company also provides consulting services to aquaculture projects, where we offer design innovation and RAS expertise to increase revenue, while decreasing operating expenses, allowing clients to operate more efficiently while increasing production. Additionally, we show clients how to operate more strategically by diversifying the species of fish raised to meet market demands. Our equipment enhances the management of fish farms by reducing the incidence of disease among the fish populations, while reducing water pollution from inland fish farms.<b/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Market Overview</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Global fish consumption has long been on the rise at a rate higher than any other source of animal protein, and the trend is expected to continue. With overfishing already threatening the earth’s marine ecosystem, it is anticipated that a significantly larger proportion of fish consumption would be farm-raised instead of wild-caught in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, the trade conflict between the U.S. and China has led to a greater demand for non-Chinese origin seafood products from the U.S. market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On a broader perspective, as the world rapidly begins a transition towards net zero carbon emissions in response to the ever-more pressing threat of climate change, it is foreseeable that solar energy will be the go-to option for many countries as a new source of green energy.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that the RASs, with its proven advantage in producing more fish in a more cost-effective and environmentally friendly manner while offering greater location flexibility and the potential for a “solar-fish sharing mode,” is a perfect solution to address the opportunities highlighted above.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 6 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Consulting Services</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also provide consulting services and solutions for aquaculture projects. We currently provide such services in Taiwan and intend to expand into other international markets and the United States to increase revenues and operate more efficiently. Our consultants use their RASs expertise to help customers increase production and operate more strategically by branching into new diversified aquaculture species, and importantly, reducing water pollution and decreasing the disease problems of fisheries.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company plans to provide the following service offerings:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for qualified investors or investment groups who are interested in capitalizing on the potential of the aquaculture industry and want to develop or take part in commercial fish farming or shrimp farming but lack the experience, design, installation, build and management of aquaculture projects to meet these interests;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a full range of pilot and management services to aquaculture companies and new aquaculture projects throughout Taiwan and potentially the rest of the world, providing tailored solutions to meet customer needs and to fulfill our commitment, to encourage and support clean water and clean fish products from the fish farm to the table; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">select equipment and materials from suppliers to provide unique service offerings structured to generate higher profit margins.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Strategy</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We plan to focus on countries with a growing population and growing demand for food. By 2050, we will need to double the global food supply to feed the world’s growing population<sup>1</sup>. There is a growing need for new ways to produce high-quality local fish without putting more pressure on our natural ecosystems. Like Taiwan, there are also many countries with a growing population and growing demand for high-protein food. We plan to go global through building demo sites promoting our RASs and selling our price-competitive systems in these countries to meet their demand for food and to satisfy their desire for a greener environment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In January 2021, we moved our operation and market focus from China to Taiwan. In 2021, we established a Nocera Taiwan Branch to focus on customers in a variety of sectors, such as individual investors, government supported or funded companies, and international customers. We have received interest from areas like Japan, Thailand, Jordan, South Africa and the United States.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021 and 2020, the net sales were approximately $9.9 million and approximately $1.2 million, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Construction Services</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera is the only provider of RAS solar power energy sharing and construction services in Taiwan. In 2021, Nocera acquired XFC to support the construction activities for the clients of Nocera and develop Taiwan fish farm segmentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Customers</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2021, we intend to target customers in a variety of markets (e.g., Japan, Taiwan, Thailand, Jordan, South Africa and the United States), such as individual investors, government supported or funded companies and other types of international customers. In addition, an increasing amount of Chinese state and local offices are faced with environmental challenges in public waters and are under regulatory directives and political pressure to reduce water pollution, so our potential target customers are significant. During the year ended December 31, 2021 and 2020, the net sales were approximately $9.9 million and approximately $1.2 million, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">______________________</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><sup>1</sup> The exchange rate as of December 31, 2021 was approximately $1.00 per 6.370 RMB.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 7 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Suppliers</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We intend to purchase raw materials and parts and equipment from third parties locally in Taiwan and build and sell them to customers. We are not directly involved in the production or manufacturing of readily available equipment, and we do not take a risk in the repair and maintenance of the equipment because of the manufacturer’s maintenance policy. We have identified and sourced multiple suppliers in Taiwan, and our relationships with suppliers are generally good. We expect that our suppliers will be able to meet the anticipated demand for our products in the foreseeable future. There can be no assurance that our suppliers will continue to meet our needs, particularly as we ramp up our expansion into the U.S. and other markets around the world.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Competition</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market for aquaculture projects and services is highly competitive. Many of the producers and sellers are large entities that have significantly greater resources than we have. Therefore, we signed VIE contracts to partner with XFC to use their local resources in Taixi township, Taiwan (R.O.C.) to develop land-based RAS fish farms in Taiwan and hopefully gain more of a competitive advantage. We also compete with small suppliers which provide smaller alternative aquaculture solutions regionally but due to the size of our projects, we believe that we should have a better price point.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Trademarks and Patents</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Sales and Marketing</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera intends to create a brand and by its creation of the brand, offer unique and better incentives to the consumers. Our target market is not only limited to the direct processing plants; instead, consumers will be informed about the uniqueness of the fish product, and the important health benefits of fish protein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, Nocera plans to increase the species selection and product form through the investment of the additional 500 tanks; among all we plan to build a hatchery system by collaborating with professionals to promote and maintain healthy, self-sustaining populations of fish and other aquatic species. We are aiming for the direct wholesale option, including live hauling, restaurants, supermarkets and specialty stores. More importantly, the distribution channel will move towards online marketing as well to achieve a greater market share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Manufacturing Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, the Company manufactures RASs through its branch office in Taiwan and may manufacture RASs through its Chinese subsidiaries. Additionally, Nocera provides consulting services regarding RAS technology transfer and aquaculture project management services to the customers in Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Government Regulation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to many varying laws and regulations in Taiwan and throughout the world, including, without limitation, those related to privacy, data protection, intellectual property, consumer protection, e-commerce, marketing, advertising, messaging, rights of publicity, health and safety, employment and labor, product liability, accessibility, competition, and taxation. These laws and regulations are constantly evolving and may be interpreted, applied, created, or amended in a manner that could harm our current or future business and operations. In addition, it is possible that certain governments may seek to block or limit our products and services or otherwise impose other restrictions that may affect the accessibility or usability of any or all of our products and services for an extended period of time or indefinitely.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our properties and operations are subject to a number of environmental, health and safety laws and regulations in each of the jurisdictions in which we operate. Under certain of these laws and regulations, we may be subject to joint and several liability for environmental investigations and cleanups, including at properties that we currently or previously owned or operated, or at sites at which waste we generated was disposed, even if the contamination was not caused by us or was legal at the time it occurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 8 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also subject to laws regulating consumer products in the jurisdictions in which we sell our products. In the United States for instance, certain of our products are subject to the U.S. Consumer Product Safety Act, under which the U.S. Consumer Product Safety Commission may exclude products from the market that are found to be unsafe or hazardous, require repair, replacement or refund of products, impose fines for noncompliance with requirements and impose fines for failure to timely notify them of potential safety hazards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also, with respect to the potential sale of eel and any other seafood into the United States, we are subject to extensive regulation, including, among other things, the Food, Drug and Cosmetic Act, as amended by the Food Safety Modernization Act (“FSMA”), the Public Health Security and Bioterrorism Preparedness and Response Act of 2002, and the rules and regulations promulgated thereunder by the U.S. Food and Drug Administration (the “FDA”). The FSMA was enacted in order to aid the effective prevention of food safety issues in the food supply. This comprehensive and evolving regulatory program impacts how food is grown, packed, processed, shipped and imported into the United States and it governs compliance with Good Manufacturing Practices regulations. The FDA has finalized seven major rules to implement FSMA, recognizing that ensuring the safety of the food supply is a shared responsibility among many different points in the global supply chain. The FSMA rules are designed to make clear specific actions that must be taken at each of these points to prevent contamination. Some aspects of these laws use a strict liability standard for imposing sanctions on corporate behavior. If we fail to comply with applicable laws and regulations, we may be subject to civil remedies, including fines, injunctions, recalls, or seizures, and criminal sanctions, any of which could impact our results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the Nutrition Labeling and Education Act of 1990 prescribes the format and content of certain information required to appear on the labels of food products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations and products are also subject to state and local regulation, including the registration and licensing of plants, enforcement by state health agencies of various state standards, and the registration and inspection of facilities. Compliance with federal, state and local regulation is costly and time-consuming. Enforcement actions for violations of federal, state, and local regulations may include seizure and condemnation of products, cease and desist orders, injunctions or monetary penalties. We believe that our practices are sufficient to maintain compliance with applicable government regulations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are subject to certain regulations by the U.S. Federal Trade Commission. Advertising of our products is subject to such regulation pursuant to the Federal Trade Commission Act and the regulations promulgated thereunder. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are also subject to certain health and safety regulations, including regulations issued pursuant to the Occupational Safety and Health Act. These regulations require us to comply with certain manufacturing, health, and safety standards to protect our employees from accidents. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business depends in part on environmental regulations and programs of Taiwan that promote cleaner water sources to restore clean water back to people. Our customers may be encouraged with incentives by the local governments relating to aquaculture investment. The approvals of land, licenses or permits, are required from relevant central and local government authorities. In addition, from time to time, relevant government authorities may impose new regulations at a local level regulating fish farming. We believe that we have skills to help our customers obtain all necessary licenses, registrations and permits to comply with all requirements necessary to allow our customers and investors to conduct aquaculture business in Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Legal Proceedings</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently not a party to any legal or administrative proceedings and are not aware of any pending or threatened legal or administrative proceedings against us in all material aspects. We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Property</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not own any real property.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b/></p> <!-- Field: Page; Sequence: 9 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Seasonality</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the global growing demand from aquaculture production along with the decreasing production from wild fisheries and our fish farming systems provide a controlled and traceable environment for species, our business rarely suffers a seasonal impact.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employees</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, we have a total of 10 employees, including both part-time and full-time. We are compliant with local prevailing wage, contractor licensing, and have good relations with our employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Corporation Information</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our principal executive offices are located at 3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City 221, Taiwan (R.O.C.). Our telephone number at this address is (886)-910-163-358. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Available Information</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our website address is <i>www.nocera.company</i>. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, any amendments to those reports, proxy and registration statements filed or furnished with the SEC, are available free of charge through our website. We make these materials available through our website as soon as reasonably practicable after we electronically file such materials with, or furnish such materials to, the SEC. These materials can be accessed through the “Investors” section of our website. The information contained in, or that can be accessed through, our website is not part of this Annual Report on Form 10-K.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="a7"/> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_3" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 1A.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISK FACTORS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Our business is subject to many risks and uncertainties, which may affect our future financial performance. If any of the events or circumstances described below occur, our business and financial performance could be adversely affected, our actual results could differ materially from our expectations, and the price of our securities could decline. The risks and uncertainties discussed below are not the only ones we face. There may be additional risks and uncertainties not currently known to us or that we currently do not believe are material that may adversely affect our business and financial performance. The statements contained in this Annual Report on Form 10-K that are not historic facts are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements. If any of the following risks actually occurs, our business, financial condition or results of operations could be harmed. In that case, the trading price of our securities could decline, and investors in our securities may lose all or part of their investment.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risks Related to Our Business</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business may be materially adversely affected by the coronavirus (COVID-19) outbreak.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current outbreak of COVID-19 has globally resulted in loss of life, business closures, restrictions on travel, and widespread cancellation of social gatherings. The extent to which the COVID-19 pandemic impacts our business will depend on future developments, which are highly uncertain and cannot be predicted at this time, including:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 5%; text-align: justify"> </td> <td style="vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">new information which may emerge concerning the severity of the disease; </span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the duration and spread of the outbreak; </span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the severity of travel restrictions imposed by geographic areas in which we operate, mandatory or voluntary business closures; </span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory actions taken in response to the pandemic, which may impact merchant operations, consumer and merchant pricing, and our product offerings; </span></td></tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"/> <!-- Field: Page; Sequence: 10 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; width: 5%"> </td> <td style="vertical-align: top; text-align: justify; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify; width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other business disruptions that affect our workforce; </span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the impact on capital and financial markets; and </span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">actions taken throughout the world, including in markets in which we operate, to contain the COVID-19 outbreak or treat its impact. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, the current outbreak of COVID-19 has resulted in a widespread global health crisis and adversely affected global economies and financial markets, and similar public health threats could do so in the future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Substantially all our revenues are concentrated in Taiwan pending expansion into other international markets. Consequently, our results of operations will likely be adversely, and may be materially affected, to the extent that the COVID-19 pandemic or any epidemic harms Taiwan’s economy and society and the global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 pandemic and the actions taken by government authorities and other entities to contain the COVID-19 pandemic or treat its impact, almost all of which are beyond our control. If the disruptions posed by the COVID-19 pandemic or other matters of global concern continue for an extensive period of time, the operations of our business may be materially adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent the COVID-19 pandemic or a similar public health threat has an impact on our business, it is likely to also have the effect of heightening many of the other risks described in this “<i>Risk Factors</i>” section.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have a limited operating history in an evolving industry, which makes it difficult to evaluate our future prospects and may increase the risk that we will not be successful.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has a limited operating history on which to base an evaluation of its business and prospects. The Company is subject to all the risks inherent in a small company seeking to develop, market and distribute new services, particularly companies in evolving markets. The likelihood of the Company’s success must be considered, in light of the problems, expenses, difficulties, complications and delays frequently encountered in connection with the development, introduction, marketing and distribution of new products and services in a competitive environment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Such risks for the Company include, but are not limited to, dependence on the success and acceptance of the Company’s services and the management of growth. In view of the Company’s limited operating history, the Company believes that period-to-period comparisons of its operating results are not necessarily meaningful and should not be relied upon as an indication of future performance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is therefore subject to many of the risks common to early-stage enterprises, including under-capitalization, cash shortages, limitations with respect to personnel, financial, and other resources and lack of revenues.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If we fail to raise capital when needed it will have a material adverse effect on the Company’s business, financial condition and results of operations.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has limited revenue-producing operations and will require proceeds from future offerings to execute its full business plan. A failure to raise capital when needed would have a material adverse effect on the Company’s business, financial condition and results of operations. In addition, debt and other debt financing may involve a pledge of assets and may be senior to interests of equity holders. Any debt financing secured in the future could involve restrictive covenants relating to capital raising activities and other financial and operational matters, which may make it more difficult for the Company to obtain additional capital or to pursue business opportunities, including potential acquisitions. If adequate funds are not obtained, the Company may be required to reduce, curtail or discontinue operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to obtain additional capital on acceptable terms is subject to a variety of uncertainties, including:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 5%; text-align: justify"> </td> <td style="vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">investors’ perception of, and demand for, our securities; </span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">conditions of the U.S. and other capital markets in which we may seek to raise funds; and</span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our future results of operations, financial condition and cash flow.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b/></p> <!-- Field: Page; Sequence: 11 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The Company’s failure to successfully market its brands could result in adverse financial consequences.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company believes that continuing to strengthen its brands is critical to achieving widespread acceptance of the Company, particularly in light of the competitive nature of the Company’s market in which it operates. Promoting and positioning its brands will depend largely on the success of the Company’s marketing efforts and the ability of the Company to provide high quality services. There can be no assurance that brand promotion activities will yield increased revenues or that any such revenues would offset the expenses incurred by the Company in building its brand. If the Company fails to promote and maintain its brand or incurs substantial expenses in an attempt to promote and maintain its brand or if the Company’s existing or future strategic relationships fail to promote the Company’s brand or increase brand awareness, the Company’s business, results of operations and financial condition would be materially adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may not generate the same level of revenues from general construction projects.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our revenues for the year ended December 31, 2021 and for the year ended December 31, 2020 were approximately $10 million and $1 million, respectively. There was one customer, The Fifth District Management Office of Taiwan Water Corporation, who represented approximately 58% of the Company’s total revenue for the year ended December 31, 2021, and two customers (JC Development Co., Ltd (“JCD”) and Pan Li) who represented 96% of the Company’s total revenue for the prior year period. These customers are not located in mainland China or Hong Kong. Our future plan of operations is to shift away from general construction services to the construction of fish and solar power farms. There can be no guarantee that such shift in operations will generate the same levels of revenues previously generated through our VIE.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There is no assurance that the Company will be profitable.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There is no assurance that we will earn profits in the future, or that profitability will be sustained. There is no assurance that future revenues will be sufficient to generate the funds required to continue our business development and marketing activities. If we do not have sufficient capital to fund our operations, we may be required to reduce our sales and marketing efforts or forego certain business opportunities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The Company may not have the ability to manage its growth.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company anticipates that significant expansion will be required to address potential growth in its customer base and market opportunities. The Company’s anticipated expansion is expected to place a significant strain on the Company’s management, operational and financial resources. To manage any material growth of its operations and personnel, the Company may be required to improve existing operational and financial systems, procedures and controls and to expand, train and manage its employee base. There can be no assurance that the Company’s planned personnel, systems, procedures and controls will be adequate to support the Company’s future operations, that management will be able to hire, train, retain, motivate and manage required personnel or that the Company’s management will be able to successfully identify, manage and exploit existing and potential market opportunities. If the Company is unable to manage growth effectively, its business, prospects, financial condition and results of operations may be materially adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We will need additional financing in order to grow our business.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, in order to expand operations to meet customer demand, the Company will need to incur additional capital expenditures. These capital expenditures are intended to be funded from third party sources, including the incurring of debt and/or the sale of additional equity securities. In addition to requiring additional financing to fund capital expenditures, the Company may require additional financing to fund working capital, research and development, sales and marketing, general and administrative expenditures, and operating losses. The incurrence of debt creates additional financial leverage and therefore an increase in the financial risk of the Company’s operations. The sale of additional equity securities will be dilutive to the interests of current equity holders. In addition, there can be no assurance that such additional financing, whether debt or equity, will be available to the Company or that it will be available on acceptable commercial terms. Any inability to secure such additional financing on appropriate terms could have a materially adverse impact on the business, financial condition and operating results of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 12 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on our executive officers. </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s success is dependent on our current executive officers. The Company’s success also depends in large part on the continued service of its key operational and management personnel. The Company faces intense competition from its competitors, customers and other companies throughout the industry. The loss of any our executive officers, specifically Mr. Yin-Chieh (“Jeff”) Cheng, our CEO, or any failure on the Company’s part to hire, train and retain a sufficient number of qualified professionals could impair the business of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We rely on the performance of highly skilled personnel, and if we are unable to attract, retain and motivate well-qualified employees, our business could be harmed.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is, and will be, heavily dependent on the skill, acumen and services of the management and other employees of the Company. Our future success depends on our continuing ability to attract, develop, motivate and retain highly qualified and skilled employees. Qualified individuals are in high demand, and we may incur significant costs to attract them. In addition, the loss of any of our senior management or key employees could materially adversely affect our ability to execute our business plan, and we may not be able to find adequate replacements. We cannot ensure that we will be able to retain the services of any members of our senior management or other key employees. If we do not succeed in attracting well-qualified employees or retaining and motivating existing employees, our business could be harmed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may have inadvertently violated Section 13(k) of the Exchange Act (implementing Section 402 of the Sarbanes-Oxley Act of 2002) and may be subject to sanctions as a result.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 13(k) of the Exchange Act provides that it is unlawful for a company that has a class of securities registered under Section 12 of the Exchange Act to, directly or indirectly, including through any subsidiary, extend or maintain credit in the form of a personal loan to or for any director or executive officer of the Company. In 2019, the Company did not have a corporate bank account established in Hong Kong or the U.S., and certain funds that were supposed to be deposited into such corporate bank account were instead deposited into the personal bank account of our principal stockholder as well as Chairman of the Board of Directors of the Company (“Board”), President, Chief Executive Officer and Director, Yin-Chieh Cheng, which was considered to be a personal loan made by the Company to Yin-Chieh Cheng and may have violated Section 13(k) of the Exchange Act. The receivable was repaid to us in January 2020. Issuers that are found to have violated Section 13(k) of the Exchange Act may be subject to civil sanctions, including injunctive remedies and monetary penalties, as well as criminal sanctions. The imposition of any of such sanctions on us could have a material adverse effect on our business, financial position, results of operations or cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Future acquisitions may have an adverse effect on our ability to manage our business.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Selective acquisitions currently form part of our strategy to further expand our business. If we are presented with appropriate opportunities, we may acquire additional businesses, services or products that are complementary to our core business. Future acquisitions and the subsequent integration of new companies into ours would require significant attention from our management. Future acquisitions would also expose us to potential risks, including risks associated with the assimilation of new operations, services and personnel, unforeseen or hidden liabilities, the diversion of resources from our existing businesses and technologies, the inability to generate sufficient revenue to offset the costs and expenses of acquisitions and potential loss of, or harm to, relationships with employees as a result of integration of new businesses. The diversion of our management’s attention and any difficulties encountered in any integration process could have a material adverse effect on our ability to manage our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The value of seafood which the Company sells (e.g., eel) is subject to fluctuation which may result in volatility of our results of operations and the value of an investment in the Company.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business is partly dependent upon the sale of eel which value is subject to fluctuation and which value greatly fluctuates. Our net sales and operating results vary significantly due to the volatility of the value of eel and any other seafood that we sell which may result in the volatility of the market price of our common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 13 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are highly susceptible to changes in market demand for the types of seafood for which our recirculating aquaculture systems are used.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of our revenues are derived from constructing recirculating aquaculture systems for fish farming. We therefore are highly susceptible to changes in market demand for the seafood for which our systems are used, which may be impacted by factors over which we have limited or no control. Factors that could lead to a decline in market demand for seafood in general and specifically the type of fish farmed using our systems include economic conditions and evolving consumer preferences. A substantial downturn in market demand for such seafood may have a material adverse effect on our business and on our results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A portion of our revenues are derived from a single product, eel, and therefore we are highly susceptible to changes in market demand, which may be affected by factors over which we have limited or no control.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Approximately 30% of our revenues are derived from a single product, eel. We therefore are highly susceptible to changes in market demand, which may be impacted by factors over which we have limited or no control. Factors that could lead to a decline in market demand for eel include economic conditions and evolving consumer preferences. A substantial downturn in market demand for eel may have a material adverse effect on our business and on our results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There are risks associated with outsourced production that may result in a decrease in our profit.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The possibility of delivery delays, product defects and other production-side risks stemming from outsourcers cannot be eliminated. In particular, inadequate production capacity among outsourced manufacturers could result in the Company being unable to supply enough product amid periods of high product demand, the opportunity costs of which could be substantial.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have limited insurance coverage.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not have any business liability, disruption or litigation insurance coverage for our operations in Taiwan. Any uninsured occurrence of loss or litigation or business disruption may result in the incurrence of substantial costs and the diversion of resources, which could have an adverse effect on our operating results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Competitors and potential competitors may develop products and technologies that make ours obsolete or garner greater market share than ours.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our ability to compete successfully will depend on our ability to demonstrate that our products are superior to and/or less expensive than other products available in the market. Some of our competitors have the benefit of marketing their products under brand names that have better market recognition than ours or have stronger marketing and distribution channels than we do. Increased competition as to any of our products could result in price reduction, reduced margins and loss of market share, which could negatively affect our profitability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain of our competitors may benefit from government support and other incentives that are not available to us. As a result, our competitors may be able to develop competing and/or superior products and compete more aggressively and sustain that competition over a longer period of time than we can. As more companies develop new intellectual property in our markets, a competitor could acquire patent or other rights that may limit our ability to successfully market our product.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may produce products of inferior quality which would cause us to lose customers.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Although we make an effort to ensure the quality of our RASs, they could from time to time contain defects, anomalies or malfunctions that are undetectable at the time of shipment, installation and initial testing. These defects, anomalies or malfunctions could be discovered after our products are shipped to customers and installed and tested at the site, resulting in the return or exchange of our products or discontinuation of the use of our products, which could negatively impact our operating results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 14 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If our technologies or products are stolen, misappropriated, or reverse engineered, others could use the technologies to produce competing technologies or products.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Third parties, including our collaborators, contractors, and others involved in our business often have access to our technologies. If our technologies or products were stolen, misappropriated, or reverse engineered, they could be used by other parties that may be able to reproduce our technologies or products using our technologies for their own commercial gain. If this were to occur, it would be difficult for us to challenge this type of use, especially since we do not own any patents or other intellectual property rights with respect to our technologies and products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are subject to certain risks by virtue of our international operations.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We mainly operate in Taiwan and plan to expand in other international countries and in the United States. We expect to expand our operations significantly by accessing new markets abroad and expanding our services offerings. Our ability to manage our business and conduct our operations in other international countries and in the United States requires considerable management attention and resources and is subject to the particular challenges of supporting a growing business in an environment of multiple languages, cultures, customs, legal systems, alternative dispute systems, regulatory systems and commercial infrastructures. Furthermore, in most international markets, we would not be the first entrant, and our competitors may be better positioned than we are to succeed. Expanding in other international countries and in the United States may subject us to risks that we have either not faced before or increase our exposure to risks that we currently face, including risks associated with:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recruiting and retaining qualified, multi-lingual employees, including customer support personnel;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increased competition from similar local businesses and potential preferences by local populations for local providers;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with applicable foreign laws and regulations, including different liability standards and regulations;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">providing solutions in different languages for different cultures;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">credit risk and higher levels of payment fraud;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">compliance with anti-bribery laws;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">currency exchange rate fluctuations;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">foreign exchange controls that might prevent us from repatriating cash earned outside the United States;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">political and economic instability in some countries;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">double taxation of our international earnings and potentially adverse tax consequences due to changes in the tax laws of the United States or the foreign jurisdictions in which we operate; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">higher costs of doing business in other international countries.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Natural disasters or other catastrophic events could harm our operations.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our operations in the U.S. and Taiwan could be subject to significant risk of natural disasters, including earthquakes, hurricanes, typhoons, flooding and tornadoes, as well as other catastrophic events, such as terrorist attacks or wars. For example, our manufacturers are all located in Taiwan, which is susceptible to typhoons and earthquakes. Any disruption in our manufacturers’ manufacturing facilities arising from these and other natural disasters or other catastrophic events could cause significant delays in the production or shipment of the components of our products until such manufacturers are able to shift production to different facilities or until we are able to arrange for other third party manufacturers to manufacture the components of our products. The affected manufacturers may not be able to obtain alternate capacity to manufacture the components of our products or we may not be able to arrange for other third party manufacturers to manufacture the components of our products on favorable terms or at all. The occurrence of any of these circumstances may adversely affect our financial condition and results of operation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 15 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The primary substantial portion of our revenues will be derived from Taiwan.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We anticipate that sales of our services in Taiwan will represent our primary revenues in the near future. Any significant decline in the condition of the economy of Taiwan could adversely affect consumer demand of our services, among other things, which in turn would have a material adverse effect on our business and financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Currency fluctuations may adversely affect our business and if the NT dollar were to decline in value, that would reduce our revenue in U.S. dollar terms.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our reporting currency is the U.S. dollar and our operations in Taiwan use their local currency as their functional currencies. Substantially all of our revenue and expenses are in NT dollars. We are subject to the effects of exchange rate fluctuations with respect to any of such currency. For example, the value of the NT dollar depends to a large extent on Taiwan government policies and Taiwan’s domestic and international economic and political developments, as well as supply and demand in the local market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The income statements of our operations are translated into U.S. dollars at the average exchange rates in each applicable period. To the extent the U.S. dollar strengthens against foreign currencies, the translation of these foreign currencies denominated transactions results in reduced revenue, operating expenses and net income for our international operations. Similarly, to the extent the U.S. dollar weakens against foreign currencies, the translation of these foreign currency denominated transactions results in increased revenue, operating expenses and net income for our international operations. We are also exposed to foreign exchange rate fluctuations as we convert the financial statements of our foreign subsidiaries into U.S. dollars in consolidation. If there is a change in foreign currency exchange rates, the conversion of the foreign subsidiaries’ financial statements into U.S. dollars will lead to a translation gain or loss which is recorded as a component of other comprehensive income. In addition, we have certain assets and liabilities that are denominated in currencies other than the relevant entity’s functional currency. Changes in the functional currency value of these assets and liabilities create fluctuations that will lead to a transaction gain or loss. We have not entered into agreements or purchased instruments to hedge our exchange rate risks, although we may do so in the future. The availability and effectiveness of any hedging transaction may be limited, and we may not be able to successfully hedge our exchange rate risks. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may be subject to product liability claims if people or properties are harmed by the services sold by us.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of our products intended to be sold by us, as part of our services, are manufactured by third parties. The components of our products may be defectively designed or manufactured. As a result, sales of the products could expose us to liability claims relating to personal injury or property damage and may require product recalls or other actions. Third parties subject to such injury or damage may bring claims or legal proceedings against us as the reseller of the products. We do not currently maintain any third-party liability insurance or products liability insurance in relation to products we intend to sell in conjunction with our services. As a result, any material products liability claim or litigation could have a material and adverse effect on our business, financial condition and results of operations. Even unsuccessful claims could result in the expenditure of funds and managerial efforts in defending them and could have a negative impact on our reputation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Risk of litigation.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and/or its directors and officers may be subject to a variety of civil or other legal proceedings, with or without merit. From time to time in the ordinary course of its business, we may become involved in various legal proceedings, including commercial, employment and other litigation and claims, as well as governmental and other regulatory investigations and proceedings. Such matters can be time-consuming, divert management’s attention and resources and cause us to incur significant expenses. Furthermore, because litigation is inherently unpredictable, the results of any such actions may have a material adverse effect on our business, operating results or financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Even if the claims are without merit, the costs associated with defending these types of claims may be substantial, both in terms of time, money, and management distraction. The results of litigation and claims to which we may be subject cannot be predicted with certainty. Even if these matters do not result in litigation or are resolved in our favor or without significant cash settlements, these matters, and the time and resources necessary to litigate or resolve them, could harm our business, results or operations and reputation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 16 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We employ individuals who previously worked with other companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third party. Litigation may be necessary to defend against these claims. If we fail in defending any such claims or settling those claims, in addition to paying monetary damages or a settlement payment, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Regulatory Risks</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We must comply with the Foreign Corrupt Practices Act while many of our competitors do not.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are required to comply with the United States Foreign Corrupt Practices Act, which prohibits U.S. companies from engaging in bribery or other prohibited payments to foreign officials for the purpose of obtaining or retaining business. Foreign companies, including some of our competitors, are not subject to these prohibitions. Corruption, extortion, bribery, pay-offs, theft and other fraudulent practices occur from time-to-time in Taiwan. If our competitors engage in these practices, they may receive preferential treatment from personnel of some companies, giving our competitors an advantage in securing business or from government officials who might give them priority in obtaining new licenses, which would put us at a disadvantage. Although we inform our personnel that such practices are illegal, we cannot assure that our employees or other agents will not engage in such conduct for which we might be held responsible. If our employees or other agents are found to have engaged in such practices, we could suffer severe penalties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Relations between the PRC and Taiwan could negatively affect our business and financial status and therefore the market value of your investment.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Taiwan has a unique international political status. The PRC does not recognize the sovereignty of Taiwan. Although significant economic and cultural relations have been established during recent years between Taiwan and the PRC, relations have often been strained. The government of the PRC has threatened to use military force to gain control over Taiwan in limited circumstances. Our principal executive officers are located in Taiwan and a substantial majority of our net revenues are derived from our operations in Taiwan. Therefore, factors affecting military, political or economic conditions in Taiwan could have a material adverse effect on our results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>A significant disruption in the operations of our suppliers in Taiwan, such as a trade war or political unrest, could materially adversely affect our business, financial condition and results of operations.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any disruption in the operations of our suppliers in Taiwan or in their ability to meet our needs, whether as a result of a natural disaster or other causes, could impair our ability to operate our business on a day-to-day basis. Furthermore, since many of these third parties are located outside the U.S., we are exposed to the possibility of disruption and increased costs in the event of changes in the policies of the U.S. or foreign governments, political unrest or unstable economic conditions in any of the countries where we conduct such activities. For example, a trade war could lead to higher tariffs. Any of these matters could materially and adversely affect our development timelines, business and financial condition.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our business, including our costs and supply chain, is subject to risks associated with manufacturing.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of a significant disruption in the supply of the raw materials used in the manufacture of the components of the products we offer, the suppliers that we work with might not be able to locate alternative suppliers of materials of comparable quality at an acceptable price. For example, natural disasters may increase raw material costs and impact pricing with our suppliers, and cause shipping delays for the components of our products. Any delays, interruption, damage to or increased costs in the manufacture of the components of the products we offer could result in higher prices to acquire the components of the products or non-delivery of the components of the products altogether, and could adversely affect our operating results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 17 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our contractual arrangements may not be as effective in providing operational control as direct ownership and our VIE shareholders may fail to perform their obligations under our contractual arrangements.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since the laws of Taiwan limit foreign equity ownership in certain businesses in Taiwan, we operate such business in Taiwan through our VIE, XFC, in which we have no ownership interest and rely on a series of contractual arrangements with XFC and its respective equity holders to control and operate the VIE. Our revenue and cash flows from such business are attributed to our VIE. The contractual arrangements may not be as effective as direct ownership in providing us with control over our VIE. Direct ownership would allow us, for example, to directly or indirectly exercise our rights as a shareholder to effect changes in the board of directors of our VIE, which, in turn, could effect changes, subject to any applicable fiduciary obligations at the management level. However, under the contractual arrangements, as a legal matter, if our VIE or its equity holders fail to perform their respective obligations under the contractual arrangements, we may have to incur substantial costs and expend significant resources to enforce those arrangements and resort to litigation or arbitration and rely on legal remedies under the laws of Taiwan. These remedies may include seeking specific performance or injunctive relief and claiming damages, any of which may not be effective. In the event we are unable to enforce these contractual arrangements or we experience significant delays or other obstacles in the process of enforcing these contractual arrangements, we may not be able to exert effective control over our VIE and may lose control over the assets owned by our VIE. As a result, we may be unable to consolidate our VIE in our consolidated financial statements, which could materially and adversely affect our financial condition and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We may lose the ability to use, or otherwise benefit from licenses and assets held by our VIE, which could render us unable to conduct some or all of our business operations and constrain our growth.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our VIE, XFC, holds assets, approvals and licenses that are necessary for the operation of a certain portion of our business to which foreign investments are typically restricted or prohibited under the laws of Taiwan. Without our VIE, and if we are unable to maintain the Class A construction license that is necessary for us to conduct our operations in Taiwan or fail to obtain any other required licenses, we will be unable to operate in Taiwan. The contractual arrangements contain terms that specifically obligate the equity holders of our VIE to ensure the valid existence of our VIE and restrict the disposition of material assets or any equity interest of our VIE. However, in the event the equity holders of our VIE breach the terms of these contractual arrangements and voluntarily liquidate our VIE, or our VIE declares bankruptcy and all or part of its assets become subject to liens or rights of third-party creditors, or are otherwise disposed of without our consent, we may be unable to operate some or all of our business or otherwise benefit from the assets held by our VIE, which could have a material adverse effect on our business, financial condition, and results of operations. Furthermore, if our VIE undergoes a voluntary or involuntary liquidation proceeding, its equity holders or unrelated third-party creditors may claim rights to some or all of the assets of our VIE, thereby hindering our ability to operate our business as well as constrain our growth.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Geopolitical conditions, including trade disputes and direct or indirect acts of war or terrorism, could have an adverse effect on our operations and financial results.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Since we operate on a global basis, our operations could be disrupted by geopolitical conditions, trade disputes, international boycotts and sanctions, political and social instability, acts of war, terrorist activity or other similar events. From time to time, we could have a large investment in a particular asset type, a large revenue stream associated with a particular customer or industry, or a large number of customers located in a particular geographic region. Decreased demand from a discrete event impacting a specific asset type, customer, industry, or region in which we have a concentrated exposure could negatively impact our results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Recently, Russia initiated significant military action against Ukraine. In response, the U.S. and certain other countries imposed significant sanctions and export controls against Russia, Belarus and certain individuals and entities connected to Russian or Belarusian political, business, and financial organizations, and the U.S. and certain other countries could impose further sanctions, trade restrictions, and other retaliatory actions should the conflict continue or worsen. It is not possible to predict the broader consequences of the conflict, including related geopolitical tensions, and the measures and retaliatory actions taken by the U.S. and other countries in respect thereof as well as any counter measures or retaliatory actions by Russia or Belarus in response, including, for example, potential cyberattacks or the disruption of energy exports, is likely to cause regional instability, geopolitical shifts, and could materially adversely affect global trade, currency exchange rates, regional economies and the global economy. The situation remains uncertain, and while it is difficult to predict the impact of any of the foregoing, the conflict and actions taken in response to the conflict could increase our costs, disrupt our supply chain, reduce our sales and earnings, impair our ability to raise additional capital when needed on acceptable terms, if at all, or otherwise adversely affect our business, financial condition, and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"/> <!-- Field: Page; Sequence: 18 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>We continue to expand our international footprint and operations, and we may expand further in the future, which subjects us to a variety of risks and complexities which, if not effectively managed, could negatively affect our business.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">We currently maintain operations in Taiwan, and may in the future expand, or seek to expand, our operations to additional foreign jurisdictions. For example, operating in Europe and China exposes us to political, legal and economic risks. In particular, the political, legal and economic climate in China, both nationally and regionally, is fluid and unpredictable. Our ability to operate in China may be adversely affected by changes in U.S. and Chinese laws and regulations such as those related to taxation, import and export tariffs, environmental regulations, genetically modified microorganisms (GMM), land use rights, product testing requirements, intellectual property, currency controls, network security, and other matters. In addition, we may not obtain or retain the requisite permits to operate in China, and costs or operational limitations may be imposed in connection with obtaining and complying with such permits. In addition, Chinese trade regulations are in a state of flux, and we may become subject to other forms of taxation, tariffs and duties in China. Furthermore, our counterparties in China may use or disclose our confidential information or intellectual property to competitors or third parties, which could result in the illegal distribution and sale of counterfeit versions of our products. If any of these events occur, our business, financial condition and results of operations could be materially and adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In addition, a significant percentage of the production, downstream processing and sales of our products occurs outside the United States or with vendors, suppliers or customers located outside the United States. If tariffs or other restrictions are placed by the United States on foreign imports from Taiwan or other countries where we operate or seek to operate, or any related counter-measures are taken, our business, financial condition, results of operations and growth prospects may be harmed. Tariffs may increase our cost of goods, which could result in lower gross margin on certain of our products. If we raise prices to account for any such increase in costs of goods, the competitiveness of the affected products could potentially be reduced. In either case, increased tariffs on imports from Taiwan or other countries where we operate or seek to operate could materially and adversely affect our business, financial condition and results of operations. Trade restrictions and sanctions implemented by the United States or other countries, including sanctions imposed on Russia by the United States and other countries due to Russia’s recent invasion of Ukraine, could materially and adversely affect our business, financial condition and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Risks Related to Our Securities</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have identified material weaknesses in our internal control over financial reporting. Failure to maintain effective internal controls could cause our investors to lose confidence in us and adversely affect the market price of our common stock. If our internal controls are not effective, we may not be able to accurately report our financial results or prevent fraud.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”) requires that we maintain internal control over financial reporting that meets applicable standards. We may err in the design or operation of our controls, and all internal control systems, no matter how well designed and operated, can provide only reasonable assurance that the objectives of the control system are met. Because there are inherent limitations in all control systems, there can be no assurance that all control issues have been or will be detected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">In this Annual Report on Form 10-K, we identified certain material weaknesses in our internal controls. Specifically, </span>we did not maintain effective controls over the control environment. Our weaknesses related to a lack of a sufficient number of personnel with appropriate training and experience in U.S. general acceptable accounting principles (GAAP). Furthermore, we have not developed and effectively communicated to our employees the accounting policies and procedures necessary to maintain effective controls over the control environment. <span style="background-color: white">and lack staffing in accounting and finance operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If we are unable, or are perceived as unable, to produce reliable financial reports due to internal control deficiencies, investors could lose confidence in our reported financial information and operating results, which could result in a negative market reaction and a decrease in our stock price.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b><i>Our stock price has been, and may continue to be, volatile.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The market price of our common stock has been, and may continue to be, subject to material volatility. Such fluctuations could be in response to, among other things, the factors described in this “<i>Risk Factors</i>” section, or other factors, some of which are beyond our control, such as:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 5%; text-align: justify"> </td> <td style="vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the ongoing impacts of the COVID-19 pandemic and resulting impact on stock market performance;</span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations in our financial results or outlook, or those of companies perceived to be similar to us;</span></td></tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"/> <!-- Field: Page; Sequence: 19 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="text-align: justify; width: 5%"> </td> <td style="vertical-align: top; text-align: justify; width: 2%"> </td> <td style="vertical-align: top; text-align: justify; width: 93%"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in the prices of commodities associated with our business;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 5%; text-align: justify"> </td> <td style="vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in our capital structure, such as future issuances of securities or the incurrence of debt;</span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements by us or our competitors of significant contracts, acquisitions or strategic partnerships;</span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory developments in the United States, Taiwan and/or other foreign countries;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 5%; text-align: justify"> </td> <td style="vertical-align: top; width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">litigation involving us or our general industry;</span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions or departures of key personnel; and</span></td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="text-align: justify"> </td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in general economic, industry and market conditions.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Furthermore, stock markets have experienced price and volume fluctuations that have affected, and continue to affect, the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market fluctuations, as well as general economic, political and market conditions, such as recessions, interest rate changes and international currency fluctuations, may negatively affect the market price of our common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Additionally, the global economy and financial markets may be adversely affected by geopolitical events, including the current or anticipated impact of military conflict and related sanctions imposed on Russia by the United States and other countries due to Russia’s recent invasion of Ukraine.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">In the past, many companies that have experienced volatility and sustained declines in the market price of their stock have become subject to securities class action and derivative action litigation. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could materially harm our business. Any insurance we maintain may not provide adequate coverage against potential losses from such securities litigation, and if claims or losses exceed our liability insurance coverage, our business would be adversely impacted. In addition, insurance coverage may become more expensive, which would harm our financial condition and results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>There may not be sufficient liquidity in the market for our securities in order for investors to sell their securities.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock is currently quoted on the OTC Pink Sheets. Historically, there has been limited volume of sales of our common stock. There can be no assurances that an active market will be develop, or if developed, maintained. This could result in stockholders being unable to sell their stock through OTC Markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our common stock may be considered a “penny stock” and may be difficult to sell.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC has adopted regulations which generally define a “penny stock” to be an equity security that has a market price of less than $5.00 per share or an exercise price of less than $5.00 per share, subject to specific exemptions. The market price of our common stock is less than $5.00 per share and, therefore, it may be designated as a “penny stock” according to SEC rules. This designation requires any broker or dealer selling these securities to disclose certain information concerning the transaction, obtain a written agreement from the purchaser and determine that the purchaser is reasonably suitable to purchase the securities. These rules may restrict the ability of brokers or dealers to sell our common stock and may affect the ability of investors to sell their shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market for penny stocks has experienced numerous frauds and abuses, which could adversely impact investors in our stock.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">OTC Pink Sheet securities are frequent targets of fraud or market manipulation, both because of their generally low prices and because OTC Pink Sheet reporting requirements are less stringent than those of the stock exchanges or NASDAQ.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <!-- Field: Page; Sequence: 20 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Patterns of fraud and abuse include:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">“Boiler room” practices involving high-pressure sales tactics and unrealistic price projections by inexperienced salespersons;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to the desired level, along with the inevitable collapse of those prices with consequent investor losses.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management is aware of the abuses that have occurred historically in the penny stock market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The market valuation of our business may fluctuate due to factors beyond our control and the value of your investment may fluctuate correspondingly.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The market valuation of smaller reporting companies, such as us, frequently fluctuate due to factors unrelated to the past or present operating performance of such companies. Our market valuation may fluctuate significantly in response to a number of factors, many of which are beyond our control, including:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes in securities analysts’ estimates of our financial performance, although there are currently no analysts covering our stock;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations in stock market prices and volumes, particularly among securities of smaller reporting companies;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">fluctuations in related commodities prices; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">additions or departures of key personnel.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the value of any investment in us may fluctuate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We have not paid dividends in the past and do not expect to pay dividends in the foreseeable future and any return on investment may be limited to the value of our stock.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We currently do not expect to declare any dividends on our common stock in the foreseeable future. Instead, we anticipate that all of our earnings in the foreseeable future will be used to provide working capital, to support our operations and to finance the growth and development of our business. Any determination to declare or pay dividends in the future will be at the discretion of our Board, subject to applicable laws and dependent upon a number of factors, including our earnings, capital requirements and overall financial conditions. In addition, terms of any future debt or preferred securities may further restrict our ability to pay dividends on our common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>We are an “emerging growth company” under the JOBS Act and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are not applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some investors find our securities less attractive as a result, there may be a less active trading market for our common stock and warrants and the price of such securities may be more volatile.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 21 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are choosing to take advantage of the extended transition period for complying with new or revised accounting standards.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will remain an “emerging growth company” until the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities Act, although we will lose that status sooner if our revenues exceed $1.07 billion, if we issue more than $1 billion in non-convertible debt in a three year period, or if the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last day of our most recently completed second fiscal quarter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Our status as an “emerging growth company” under the JOBS Act may make it more difficult to raise capital as and when we need it.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of the exemptions from various reporting requirements provided to us as an “emerging growth company” and because we will have an extended transition period for complying with new or revised financial accounting standards, we may be less attractive to investors, and it may be difficult for us to raise additional capital as and when we need it. Investors may be unable to compare our business with other companies in our industry if they believe that our financial accounting is not as transparent as other companies in our industry. If we are unable to raise additional capital as and when we need it, our financial condition and results of operations may be materially and adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>The elimination of personal liability against our directors and officers under Nevada law and the existence of indemnification rights held by our directors, officers and employees may result in substantial expenses.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our amended and restated Articles of Incorporation and our amended and restated bylaws (“Bylaws”) eliminate the personal liability of our directors and officers to us and our stockholders for damages for breach of fiduciary duty as a director or officer to the extent permissible under Nevada law. Further, our Articles of Incorporation and our Bylaws provide that we are obligated to indemnify each of our directors or officers to the fullest extent authorized by Nevada law and, subject to certain conditions, advance the expenses incurred by any director or officer in defending any action, suit or proceeding prior to its final disposition. Those indemnification obligations could expose us to substantial expenditures to cover the cost of settlement or damage awards against our directors or officers, which we may be unable to afford. Further, those provisions and resulting costs may discourage us or our stockholders from bringing a lawsuit against any of our current or former directors or officers for breaches of their fiduciary duties, even if such actions might otherwise benefit our stockholders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to any charter provision, by law or otherwise, the registrant has been advised that in the opinion of the U.S. Securities and Exchange Commission (the “SEC”), such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The trading market for our securities will depend in part on the research and reports that securities or industry analysts publish about us or our business. Several analysts may cover our stock. If one or more of those analysts downgrade our stock or publish inaccurate or unfavorable research about our business, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 22 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_4" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a3"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 1B.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNRESOLVED STAFF COMMENTS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_5" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a4"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 2.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPERTIES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our headquarter is located at 3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City 221, Taiwan (R.O.C.). The office is rented by Taiwan Grand Smooth Enterprise Co., Ltd., a company 100% controlled by Yin-Chieh Cheng, our President CEO and Chairman of the Board. Mr. Cheng sub-leases this space to us, which is free of charge.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not own any real property.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_6" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a5"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 3.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>LEGAL PROCEEDINGS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are currently not a party to any legal or administrative proceedings and are not aware of any pending or threatened legal or administrative proceedings against us in all material aspects. We may from time to time become a party to various legal or administrative proceedings arising in the ordinary course of our business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="a6"/><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_7" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 4.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MINE SAFETY DISCLOSURES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Not applicable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 23 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="a8"/><span class="alphaminr_link" id="alphaminr_8" style="display:inline-block"/><b>PART II</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_9" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a9"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 5.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MARKET FOR REGISTRANT’S COMMON STOCK, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Market Information</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our common stock, par value $0.001, is listed for quotation in the OTC Pink Market under the symbol “NCRA.”</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td> <td> </td> <td colspan="7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quarter Ended</span></td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High</span></td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low</span></td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High</span></td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 48%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 31<sup>st</sup> (1Q)</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.40</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.17</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.49</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.56</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30<sup>th</sup> (2Q)</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.50</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.94</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.90</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.99</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">September 30<sup>th</sup> (3Q)</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.60</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.29</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.75</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.25</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31<sup>st</sup> (4Q)</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.19</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.21</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.40</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.03</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stockholders</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022, we had approximately 478 stockholders of record of our common stock, not including shares held in street name.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dividends</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We do not expect to declare or pay any cash dividends on our common stock in the foreseeable future, and we currently intend to retain future earnings, if any, to finance the expansion of our business. The decision whether to pay cash dividends on our common stock will be made by our Board, at its discretion, and will depend on our financial condition, operating results, capital requirements and other factors that the Board considers significant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We did not pay cash dividends in the years ended December 31, 2021 or 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Transfer Agent</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transfer agent and registrar for our common stock is Mountain Share Transfer, LLC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Securities Authorized for Issuance under Equity Compensation Plans</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, the Board and stockholders adopted the Company’s 2018 Stock Option and Award Incentive Plan, effective December 31, 2018 (the “2018 Plan”). The 2018 Plan provides for the grant of the following types of stock awards: (i) incentive stock options, (ii) non-statutory stock options, and (iii) stock purchase rights. The 2018 Plan is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any affiliate and provide a means by which the eligible recipients may benefit from increases in value of the common stock. The 2018 Plan is administered by the Compensation Committee. The Board reserved 10,000,000 shares of common stock under the 2018 Plan. No awards have been granted to any employees or consultants pursuant to the 2018 Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Unregistered Sales of Equity Securities</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Issuance of Common Stock</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 27, 2021, the Company issued an aggregate of 48,000 shares of common stock of the Company to a total of two foreign investors.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2021, the Company issued an aggregate of 505,000 shares of common stock to a total of six consultants in consideration for services rendered.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 24 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2021, the Company consummated a private offering of 418,000 units at a purchase price of $5.00 per unit to 28 investors for gross proceeds of $2,090,000. Each unit consisted of one share of the Company’s common stock and an “equity kicker” of one share of the Company’s common stock, for a total of 836,000 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 15, 2022, the Company issued 75,000 shares of common stock of the Company to a consultant.</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Symbol">·</span></td> <td style="text-align: justify">On January 28, 2022, the Company issued 100,000 shares of common stock of the Company to legal counsel.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing securities were issued in reliance on the exclusion from registration provided by either (i) Rule 903 of Regulation S under the Securities Act of the Securities Act because the recipient was a non-U.S. Person (as defined under Rule 902 Section (k)(2)(i) of Regulation S), or (ii) Section 4(a)(2) of the Securities Act due to the fact the issuance did not involve a public offering of securities to a U.S. Person.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Issuance of Warrants</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 10, 2021, the Company issued 80,000 Class C warrants and 80,000 Class D warrants to a foreign investor. The Class C warrants consist of the right to purchase one share of common stock of the Company for $2.50 per share for three years from the date of issuance and the Class D warrants consist of the right to purchase one share of common stock of the Company for $5.00 for a period of three years from the date of issuance.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 27, 2021, the Company issued an aggregate of 48,000 Class C warrants and 48,000 Class D warrants to a total of two foreign investors. The Class C warrants consist of the right to purchase one share of common stock of the Company for $2.50 per share for three years from the date of issuance and the Class D warrants consist of the right to purchase one share of common stock of the Company for $5.00 for a period of three years from the date of issuance.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 1, 2021, the Company issued 205,000 Class A warrants to a total of two executive officers of the Company and two foreign investors. The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2021, the Company issued an aggregate of 812,000 Class C warrants and 812,000 Class D warrants to a total of two contractors. The Class C warrants consist of the right to purchase one share of common stock of the Company for $2.50 per share from the date of issuance until December 31, 2024 and the Class D warrants consist of the right to purchase one share of common stock of the Company for $5.00 per share from the date of issuance until December 31, 2024.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, <span style="background-color: white">the Company agreed to issue 60,000 </span>Class A Warrants, vesting in three equal installments commencing on the first anniversary date of the consulting agreement. Each Class A Warrant is exercisable to purchase one share of common stock for $0.50 per share from the date of vesting until April 23, 2026.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Symbol">·</span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 3, 2022, the Company agreed to issue two consultants an aggregate of 90,000 Class C Warrants, vesting in three equal installments commencing on the first anniversary date of the consulting agreements. Each Class C Warrant is exercisable to purchase one share of common stock for $2.50 per share from the date of vesting in each installment until the third anniversary date of the date of vesting.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing securities were issued in reliance on the exclusion from registration provided by either (i) Rule 903 of Regulation S under the Securities Act of the Securities Act because the recipient was a non-U.S. Person (as defined under Rule 902 Section (k)(2)(i) of Regulation S), or (ii) Section 4(a)(2) of the Securities Act due to the fact the issuance did not involve a public offering of securities to a U.S. Person.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_10" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a10"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 6.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>[RESERVED]</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_11" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a11"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 7.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this Annual Report on Form 10-K. Our consolidated financial statements have been prepared in accordance with U.S. GAAP. In addition, our consolidated financial statements and the financial data included in this Annual Report on Form 10-K reflect our reorganization and have been prepared as if our current corporate structure had been in place throughout the relevant periods. Actual results could differ materially from those projected in the forward-looking statements. For additional information regarding these and other risks and uncertainties, please see the items listed above under the section captioned “<i>Risk Factors</i>”, as well as any other cautionary language contained in this Annual Report on Form 10-K. Except as may be required by law, we undertake no obligation to update any forward-looking statements to reflect events after the date of this Annual Report on Form 10-K.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 25 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Operations Overview</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2019, we provide land-based recirculation aquaculture systems for fish farming. Our primary business operations consist of the design, development and production of RASs large scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services. Through our branch office, we also procure and sell eel in Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In October 2020, the government of Taiwan began supporting the Green Power and Solar Sharing Fish Farms initiative. In view of the opportunities resulting from this initiative, in October 2020, Nocera ceased all of its operations in China and moved all of its technology and back-office operations to Taiwan. The Company now only operates out of Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current mission is to provide consulting services and solutions in aquaculture projects to reduce water pollution and decrease the disease problems of fisheries. Our goal is to become a global leader in the land-based aquaculture business. The Company is now poised to grow its existing operations in Taiwan and expand into the development and management of land-based fish farms in Taiwan and North and South America. The Company does not currently have any intentions of conducting operations in China or Hong Kong.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2020, Nocera and Xin Feng Construction Co., Ltd., a funded limited liability company registered in Taiwan (R.O.C.), entered into a series of contractual agreements, whereby Nocera agreed to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be the primary beneficiary of XFC and XFC became a variable interest entity of Nocera, and XFC will shift focus to support the construction activities of RASs fish farms of our clients and the development of the Company-owned and operated fish farms.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2021, the Company launched its first RAS demo site in Taiwan and engaged the demo site into the testing phase to raise eel. Currently, we are promoting our RASs in Taiwan and looking for opportunities to cooperate with local solar energy industry and to expand our business into the U.S. We believe the U.S. is a potentially lucrative market to penetrate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company employs a sales and marketing strategy targeting Taiwan government-supported solar fish farms. The Company is planning on expanding its sales and marketing model through the use of online marketing, data intelligence, and the establishment of a distributor network. The online marketing and data intelligence is designed to generate sales leads internationally outside of Taiwan that can be directed to our sales department for further follow-up.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We plan to sell and develop fish farms in Taiwan, the U.S., and Brazil. We expect to sell over five thousand tanks in the next five years. Our production facility is to be established in Taiwan, and we plan to sell the systems into the Americas and European countries as well.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also intend to build fish farming demo sites in the United States, Taiwan by the end of 2022, and Brazil in 2023 to promote our fish farming systems to the global market.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Effects of the COVID-19 Pandemic</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current outbreak of COVID-19 has globally resulted in loss of life, business closures, restrictions on travel, and widespread cancellation of social gatherings. Substantially all our revenues were concentrated in China and Taiwan pending expansion into other international markets. Consequently, our results of operations will likely be adversely, and may be materially affected, to the extent that the COVID-19 pandemic or any epidemic harms China’s or Taiwan’s economy and society and the global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 pandemic and the actions taken by government authorities and other entities to contain the COVID-19 pandemic or treat its impact, almost all of which are beyond our control. If the disruptions posed by the COVID-19 pandemic or other matters of global concern continue for an extensive period of time, the operations of our business may be materially adversely affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Critical Accounting Policies, Estimates and Assumptions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We prepare our financial statements in conformity with U.S. GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the financial reporting period. We continually evaluate these estimates and assumptions based on the most recently available information, our own historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Since the use of estimates is an integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application. We consider the policies discussed below to be critical to an understanding of our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b/></p> <!-- Field: Page; Sequence: 26 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The SEC defines critical accounting policies as those that are, in management’s view, most important to the portrayal of our financial condition and results of operations and those that require significant judgments and estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounting principles we utilized in preparing our consolidated financial statements conform in all material respects to U.S GAAP.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassification </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified to conform with current year presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the allowance for doubtful receivables; the useful lives of property and equipment and intangible assets; impairment of long-lived assets; recoverability of the carrying amount of inventory; fair value of financial instruments; provisional amounts based on reasonable estimates for certain income tax effects of the Tax Cuts and Jobs Act (the “Tax Act”) and the assessment of deferred tax assets or liabilities. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b><i>  </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Fair Value Measurement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies ASC Topic 820, Fair Value Measurements and Disclosures which defines fair value, establishes a framework for measuring fair value and expands financial statement disclosure requirements for fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management of the Company is responsible for determining the assets acquired, liabilities assumed and intangibles identified as of the acquisition date and considered a number of factors including valuations from an independent appraiser.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, there are no assets or liabilities that are measured and reported at fair value on a recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cash and Cash Equivalents</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents include all cash on hand and cash in bank with no restrictions. The balance of cash as of December 31, 2021 and 2020 were $2,444,009 and $1,023,531, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 27 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Accounts Receivable, Net</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are stated at the original amount less an allowance for doubtful accounts, if any, based on a review of all outstanding amounts at period end. An allowance is also made when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. The Company analyzes the aging of the customer accounts, coverage of credit insurance, customer concentrations, customer credit-worthiness, historical and current economic trends and changes in its customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Prepaid Expenses and Other Assets, Net</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expense and other assets, net consist of receivable from a concert, prepaid rent and etc. Management reviews its receivable balance each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful account is recorded in the period in which loss is determined to be probable based on an assessment of specific evidence indicating doubtful collection, historical experience, account balance aging, and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Inventories</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are stated at lower of cost or net realizable value. Cost is determined using the weighted average method. Inventories include raw materials, work in progress and finished goods. The variable production overhead is allocated to each unit of product on the basis of the actual use of the production facilities. The allocation of fixed production overhead to the costs of conversion is based on the normal capacity of the production facilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where there is evidence that the utility of inventories, in their disposal in the ordinary course of business, will be less than cost, whether due to physical deterioration, obsolescence, changes in price levels, or other causes, the inventories are written down to net realizable value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Property and Equipment, Net</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Maintenance, repairs, and betterments, including replacement of minor items, are charged to expense; major additions to physical properties are capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation of property and equipment is provided using the straight-line method over their estimated useful lives, which are shown as follows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful life</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="width: 10%"> </td> <td style="width: 52%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shorter of the remaining lease terms and estimated useful lives</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixture</span></td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3 years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon sale or disposal, the applicable amounts of asset cost and accumulated depreciation are removed from the accounts and the net amount less proceeds from disposal is charged or credited to income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Goodwill and Intangible Assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize goodwill in accordance with ASC 350, <i>Intangibles—Goodwill and Other</i>. Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually as of October 1st of each year, and is tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment charge for goodwill is recognized only when the estimated fair value of a reporting unit, including goodwill, is less than its carrying amount.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 28 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize intangibles assets in accordance with ASC 350, <i>Intangibles—Goodwill and Other</i>. Acquired intangible assets subject to amortization are stated at cost and are amortized using the straight-line method over the estimated useful lives of the assets. Intangible assets that are subject to amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable. Assets not subject to amortization are tested for impairment at least annually.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimates of fair value are based on the best information available as of the date of the assessment, which primarily incorporates management assumptions about expected future cash flows. Although these assets are not currently impaired, there can be no assurance that future impairments will not occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Share-Based Compensation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">We determine our share-based compensation in accordance with ASC 718, </span><i>Compensation—Stock Compensation </i><span style="background-color: white">(ASC 718), which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees based on the grant date fair value of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determining the appropriate fair value model and calculating the fair value of phantom award grants requires the input of subjective assumptions. We use the Black-Scholes pricing model to value our phantom awards. Share-based compensation expense is calculated using our best estimates, which involve inherent uncertainties and the application of management’s judgment. Significant estimates include our expected volatility. If different estimates and assumptions had been used, our phantom unit valuations could be significantly different and related share-based compensation expense may be materially impacted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Black-Scholes pricing model requires inputs such as the risk-free interest rate, expected term, expected volatility and expected dividend yield. We base the risk-free interest rate that we use in the Black-Scholes pricing model on zero coupon U.S. Treasury instruments with maturities similar to the expected term of the award being valued. The expected term of phantom awards is estimated from the vesting period of the award and represents the weighted average period that our phantom awards are expected to be outstanding. We estimated the volatility based on the historic volatility of our guideline companies, which we feel best represent our company. We have never paid and do not anticipate paying any cash dividends in the foreseeable future and, therefore, we use an expected dividend yield of zero in the pricing model. We account for forfeitures as they occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Impairment of Long-lived Assets</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. When these events occur, the Company measures impairment by comparing the carrying value of the long-lived assets to the estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted cash flow is less than the carrying amount of the assets, the Company would recognize an impairment loss, which is the excess of carrying amount over the fair value of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Commitments and Contingencies</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company is subject to contingencies, including legal proceedings and claims arising out of its business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and the specific facts and circumstances of each matter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue Recognition </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has early adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) and all subsequent ASUs that modified ASC 606 on January 1, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 29 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies the following steps:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 4%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract (s) with a customer</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 4%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 4%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 4%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligation in the contract</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 4%"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considered revenue is recognized when (or as) the Company satisfies performance obligations by transferring a promised goods and provide maintenance service to a customer. Revenue is measured at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange for transferring the promised goods and providing maintenance service to the customer. Contracts with customers are comprised of invoices, and written contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have arrangements for returns from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has no sales incentive programs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides goods, maintenance service warranties for the goods sold with a period varying from 18 months to 72 months, with the majority of the periods being 18 months, and exclusive sales agency license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are rendered on a straight-line basis over the contract term, which is generally for 18 months as a majority of the maintenance service warranties periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably upon the satisfaction over the estimated economic life of the license.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have amounts of contract assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers and deferred revenue. Advance payments from customers are expected to be recognized as revenue within 12 months. Deferred revenue is expected to be recognized as revenue within 12 months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Cost of Sales</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of sales consists primarily of material costs, labor costs, depreciation, and related expenses, which are directly attributable to the production of the product. Write-down of inventories to lower of cost or net realizable value is also recorded in cost of sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Income Taxes</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 30 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Leases</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-12, Leases (ASC Topic 842), which amends the lease requirements in ASC Topic 840, Leases. Under the new lease accounting standard, a lessee will be required to recognize a right-of-use asset and lease liability for most leases on the balance sheet. The new standard also modifies the classification criteria and accounting for sales-type and direct financing leases, and enhances the disclosure requirements. Leases will continue to be classified as either finance or operating leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted ASC Topic 842 using the modified retrospective transition method effective January 1, 2019. There was no cumulative effect of initially applying ASC Topic 842 that required an adjustment to the opening retained earnings on the adoption date nor revision of the balances in comparative periods. As a result of the adoption, The Company recognized a lease liability and right-of-use asset for each of our existing lease arrangement. The adoption of the new lease standard does not have a material impact on our consolidated income statement or our consolidated statement of cash flow.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Uncertain Tax Positions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Interest and penalties related to uncertain tax positions are recognized and recorded as necessary in the provision for income taxes. According to the PRC Tax Administration and Collection Law, the statute of limitations is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the withholding agent. The statute of limitations is extended to five years under special circumstances, where the underpayment of taxes is more than RMB 100,000. In the case of transfer pricing issues, the statute of limitation is ten years. There is no statute of limitation in the case of tax evasion. The Company records interest and penalties on uncertain tax provisions as income tax expense. There are no uncertain tax positions as of December 31, 2021 and 2020, and the Company has no accrued interest or penalties related to uncertain tax positions. The Company does not believe that the unrecognized tax benefits will change over the next twelve months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Comprehensive (Loss) Income</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Comprehensive income or loss is comprised of the Company’s net (loss) income and other comprehensive income or loss. The component of other comprehensive income or loss consists solely of foreign currency translation adjustments, net of the income tax effect.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Foreign Currency Translation and Transactions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s reporting currency is the United States dollar (“US$”). The functional currency of our VIE in Taiwan is Taiwan New Dollar (“TWD”), and the functional currency of our Hong Kong subsidiary is Hong Kong dollars (“HK$”). The functional currency of PRC companies is the Renminbi (“RMB”). In the consolidated financial statements, the financial information of the Company’s subsidiary and the consolidated VIE has been translated into US$. Assets and liabilities are translated at the exchange rates on the balance sheet date, equity amounts are translated at historical exchange rates, except for changes in accumulated deficit during the year which is the result of income statement translation process, and revenue, expense, gains or losses are translated using the average exchange rate during the year. Translation adjustments are reported as foreign currency translation adjustments and are shown as a separate component of other comprehensive income or loss in the consolidated statements of changes in equity and comprehensive (loss) income. The exchange rates as of December 31, 2021 and 2020 are 6.4854 and 6.5249, respectively. The annual average exchange rates for the year ended December 31, 2021 and 2020 are 6.3700 and 6.8996, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>(Loss) Earnings per Share</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic (loss) earnings per share is computed by dividing net (loss) income attributable to holders of common stock by the weighted average number of common shares outstanding during the year. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted into common shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 31 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Recently Issued Accounting Standards</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">See Note 3 to the Consolidated Financial Statements included herewith.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>  </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Results of Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the consolidated statements of operations of the Company for the years ended December 31, 2021 and 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Consolidated Statements of Operations</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Net Sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">9,945,325</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,170,156</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(9,000,733</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(526,343</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">944,592</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">643,813</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Operating expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,419,684</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,325,696</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,419,684</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(1,325,696</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,475,092</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(681,883</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Other income (expense)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(4,055</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">36</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,479,147</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(681,847</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Income tax (expense) benefit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(139,932</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">42,777</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,619,079</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(639,070</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less: Net loss attributable to non-controlling interests</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(6,705</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss attributable to the Company</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,619,079</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(632,365</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Comprehensive (loss) income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,619,079</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(639,070</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation income (loss)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">63,248</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">31,081</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Total comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,555,831</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(607,989</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Net loss attributable to non-controlling interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(6,705</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less: Foreign currency translation loss attributable to non-controlling interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(499</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive loss attributable to the Company</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(9,555,831</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(600,785</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Loss per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-indent: 10pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: 10pt">Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1.0500</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.0538</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Weighted average number of common shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-indent: 10pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,160,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11,752,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: 10pt">Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">9,160,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">11,752,447</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> <b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b/></p> <!-- Field: Page; Sequence: 32 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Comparison of Results of Operations for the years ended December 31, 2021 and December 31, 2020</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Revenue </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue for the year ended December 31, 2021 was approximately $9.9 million compared to approximately $1.2 million for the comparable period in 2020. The revenue for the year ended December 31, 2021 was mainly generated from XFC delivery of construction services to its customers. The revenue for the year ended December 31, 2020 was driven by the deferred revenue recognition of the exclusive sales agency license revenue from JCD of selling our fish farming containers in Asia Pacific. As of December 31, 2021, the Company and JCD mutually agreed to termination of the Regional Agency Cooperation Agreement dated as of September 2019, as amended by the Regional Agency Cooperation Supplementary Agreement dated as of May 31, 2020, by and between Grand Smooth Inc Ltd and JC Development Co., Ltd. (the “Cooperation Agreement”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Gross profit</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gross profit for the year ended December 31, 2021 was approximately $0.9 million, compared to approximately $0.6 million for the comparable period in 2020. This increase of gross profit margin was mainly because in 2021 we recognized the revenue generated from the delivery of construction services of XFC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>General and administrative expenses</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">General and administrative expenses were $10.4 million, for the year ended December 31, 2021, compared to $1.3 million for the comparable period in 2020. This increase of general and administrative expenses was mainly because in 2021, we recognized significant share based compensation expenses to employees and consultants for professional services </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Other income (expense</i></b>)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Other expense were $(4,055) for the year ended December 31, 2021, compared to other income of $36 for the comparable period in 2020. The expenses for the year ended December 31, 2021 was mainly due to interest expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021, we recorded an income tax expense of $135,444 as compared to income tax benefit $42,777 for the comparable period in 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Net loss attributable to the Company</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net loss attributable to the Company (excluding net loss attributable to non-controlling interest) for the year ended December 31, 2021 was approximately $9.6 million compared to net loss attributable to the Company (excluding net income attributable to non-controlling interest) approximately of $0.6 million for the comparable period in 2020. The significant decrease was mainly because in 2021 we recognized significant share based compensation expenses to employees and consultants for professional services.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity and Capital Resources</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had net cash provided by operating activities for the year ended December 31, 2021 and the cash balance was $2.4 million as of December 31, 2021. The Company believes its current cash balances coupled with anticipated cash flow from operating activities will be sufficient to meet its working capital requirements for at least one year from the date of issuance of the accompanying consolidated financial statements. The Company continues to control its cash expenses as a percentage of expected revenue on an annual basis and thus may use its cash balances in the short-term to invest in revenue growth. Based on current internal projections, the Company believes it has and/or will generate sufficient cash for its operational needs, for at least one year from the date of issuance of the accompanying consolidated financial statements. Management is focused on growing the Company’s existing product offering, as well as its customer base, to increase its revenues. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for its planned operations or future acquisitions. Future business demands may lead to cash utilization at levels greater than recently experienced. The Company may need to raise additional capital in the future. However, the Company cannot assure that it will be able to raise additional capital on acceptable terms, or at all. Subject to the foregoing, management believes that the Company has sufficient capital and liquidity to fund its operations for at least one year from the date of issuance of the accompanying consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 33 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To date, we have funded our operations through revenues, loans form our officers, and the issuance of equity securities. The Company obtained a financial support letter from Mr. Yin-Chieh Cheng, the Chief Executive Officer, also the Chairman of the Board and a principal stockholder of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On April 1, 2021, the Company entered in a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D warrant for the subscription of each preferred share. Each Class C warrant consist of the right to purchase up one share of common stock to at an exercise price of $2.50 per share exercisable for 36 months from the date of issuance. Each Class D warrants consist of the right to purchase one share of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of issuance. The subscription was completed on August 10, 2021</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="width: 93%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2021, the Company issued 80,000 shares of preferred shares of $0.001 each at an issue price of $2.50 per share to certain investors credited as fully paid.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On September 27, 2021, the Company entered into securities purchase agreements with investors, pursuant to which the Company issued in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50. In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2021, the Company consummated a private offering of 418,000 units at a purchase price of $5.00 per unit to 28 investors for gross proceeds of $2,090,000. Each unit consisted of one share of the Company’s common stock and an “equity kicker” of one share of the Company’s common stock, for a total of 836,000 shares of common stock.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table provides detailed information about our net cash flows for the periods indicated:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Net cash provided by (used in) provided by operating activities</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">251,729</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">(129,824</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net cash (used in) provided by investing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,067</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">770,943</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Net cash (used in) provided by financing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,203,833</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">217,479</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Effect of the exchange rate change on cash and cash equivalents</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,017</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">136,394</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Increase in cash and cash equivalents</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,430,495</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">994,992</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Net cash provided by (used in) operating activities</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash provided by operating activities amounted to $251,729 for the year ended December 31, 2021. This reflected a net loss of $9,619,079, as adjusted for non-cash items primarily including share-based compensation of $6,638,371, consultancy services settled by equities of $3,045,150 and offset by effect of changes in working capital including decreases of accounts receivable in the amount of $252,338.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in operating activities amounted to $129,824 for the year ended December 31, 2020. This reflected a net loss of $639,070, as adjusted for non-cash items primarily including impairment of GZ WFH of $522,291, depreciation of $74,958 and share-based compensation of $265,758, and offset by effect of changes in working capital including an increase of $268,285 of inventories.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net cash (used in) provided by investing activities</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash used in investing activities was $25,067 for the year ended December 31, 2021 which were primarily attributable to the purchase of equipment and intangible asset.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash provided by investing activities was $770,943 for the year ended December 31, 2020 which were primarily attributable to the net cash acquired from the merger of XFC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 34 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Net cash (used in) provided by financing activities</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash provided by financing activities amounted to $1,203,833 for the year ended December 31, 2021, which were primarily arising from proceeds from issuance of common stock and preferred stock during the year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net cash provided by financing activities amounted to $217,479 for the year ended December 31, 2020, which was attributable to the proceeds from our stockholders primarily for our daily operation. See “Note 14 to the consolidated financial statements included herewith”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since we plan to build our land-based fish farming demo sites in the US, Taiwan, Japan, and Thailand to promote our fish farming systems to the global market, we expect that we will require additional capital, which includes construction costs, marketing costs, operation costs, etc., to meet our long-term operating requirements. We expect to obtain financing from stockholders or raise additional capital through, among other things, the sale of equity or debt securities. The stockholders are committed to provide additional financing required when we try to raise additional capital from third party investors or banks. However, there can be no assurance that we will be successful in raising this additional capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Off-Balance Sheet Arrangements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have no off-balance sheet arrangements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recently Issued Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please refer to the Note 3 to the Consolidated Financial Statements included herewith.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_12" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 7%; text-align: justify"><span id="item7a"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 7A.</b></span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are exposed to credit risk from our cash at bank and accounts receivable. The credit risk on cash at bank is limited because the counterparts are recognized financial institutions. Accounts receivable are subject to credit evaluations. We periodically record a provision for doubtful collections based on an evaluation of the collectability of accounts receivable by assessing, among other factors, the customer’s willingness or ability to pay, repayment history, general economic conditions and our ongoing relationship with the customers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Foreign Currency and Exchange Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional currency of the Company is US$, the functional currency of our VIE in Taiwan is TWD, and the functional currency of our Hong Kong subsidiary is Hong Kong dollars HK$. The functional currency of PRC companies is RMB. Taiwan is the primary economic environment in which we operate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For financial reporting purposes, the financial statements of PRC companies, which are prepared using the TWD, are translated into our reporting currency, the US$. Assets and liabilities are translated using the exchange rate at each balance sheet date. Revenue and expenses are translated using average rates prevailing during each reporting period, and stockholders’ equity is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive income/loss in stockholders’ equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Transactions denominated in currencies other than the reporting currency are translated into the reporting currency at the exchange rates prevailing at the dates of the transactions. The resulting exchange differences are included in the determination of net loss of the consolidated financial statements for the respective periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 35 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exchange rates applied are as follows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year ended<br/> December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: justify"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Period end RMB exchange rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">6.5249</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">6.5249</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Average RMB exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.8996</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.8996</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period end TWD exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">27.6800</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28.4800</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Average TWD exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">28.0090</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29.5490</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Period end HK$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.7539</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.7539</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Average HK$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.7577</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.7577</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No representation is made that the HK$, TWD and RMB amounts could have been, or could be, converted into U.S. dollars at the rates used in translation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Country Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The substantial portion of our business, assets, and operations are located and conducted in Taiwan. The Taiwanese government has implemented various measures to encourage economic growth and guide the allocation of resources. For example, the government of Taiwan began supporting the Green Power and Solar Sharing Fish Farms initiative, which, among other things, provides lower rates to finance and purchase renewable energy projects. Currently, to our knowledge, no pending policies in Taiwan exist that if enacted would have an adverse effect on Nocera Inc.’s business. However, Nocera, Inc.’s operating results and financial condition may be adversely affected by future regulations in Taiwan, such as changes in tax regulations applicable to Nocera, Inc. If there are any changes in any policies by the Taiwanese government and Nocera, Inc.’s business is negatively affected as a result, then Nocera, Inc.’s financial results, including our ability to generate revenues and profits, will also be negatively affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_13" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 7%; text-align: justify"><span id="a12"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 8.</b></span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">       </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The financial statements and supplementary financial information required by this Item are set forth immediately following the signature page and are incorporated herein by reference.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_14" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 7%; text-align: justify"><span id="a13"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 9.</b></span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_15" style="display:inline-block"/><tr> <td style="vertical-align: top; width: 7%; text-align: justify"><span id="a14"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 9A.</b></span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONTROLS AND PROCEDURES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Evaluation of Disclosure Controls and Procedures</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our management, under the supervision of our Chief Executive Officer and Chief Financial Officer performed an evaluation (the “Evaluation”) of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Annual Report on Form 10-K. Disclosure controls and procedures include, without limitation, controls and procedures designed to provide a reasonable level of assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2021, due to the presence of material weaknesses described below, our disclosure controls and procedures were not effective.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <!-- Field: Page; Sequence: 36 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, there can be no assurance that our disclosure controls and procedures will detect or uncover all failures of persons within our Company and our consolidated subsidiaries to disclose material information otherwise required to be set forth in our periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Management’s Report on Internal Control Over Financial Reporting</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management is responsible for establishing and maintaining adequate internal controls over financial reporting for our Company. Internal control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our Board, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the company;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the Company; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failure. Internal control over financial reporting can also be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We assessed the effectiveness of our internal control over financial reporting as of December 31, 2021. In making this assessment, our management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission’s Internal Control-Integrated Framework. As a result of this assessment, we have determined that our internal control over financial reporting was not effective as of December 31, 2021. We had neither the resources, nor the personnel, to provide an adequate control environment. The following material weaknesses in our internal control over financial reporting continued to exist at December 31, 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">we do not have written documentation of our internal control policies and procedures. Written documentation of key internal controls over financial reporting is a requirement of Section 404;</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">there is insufficient monitoring and review controls over the financial reporting closing process, including the lack of individuals with current knowledge of GAAP; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 2.25pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Symbol">·</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inadequate segregation of duties.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 37 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that these material weaknesses primarily relate, in part, to our lack of sufficient staff with appropriate training in GAAP and SEC rules and regulations with respect to financial reporting functions, and the lack of robust accounting systems, as well as the lack of sufficient resources to hire such staff and implement these accounting systems.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pending obtaining sufficient resources to implement these measures, we plan to take a number of actions to correct these material weaknesses, including, but not limited to, adding experienced accounting and financial personnel and retaining third-party consultants to review our internal controls and recommend improvements. However, we may need to take additional measures to fully mitigate these issues, and the measures we have taken, and expect to take, to improve our internal controls may not be sufficient to (1) address the issues identified, (2) ensure that our internal controls are effective or (3) ensure that the identified material weakness or other material weaknesses will not result in a material misstatement of our annual or interim financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It should be noted that any system of controls, however well designed and operated, can provide only reasonable and not absolute assurance that the objectives of the system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of certain events. Because of these and other inherent limitations of control systems, there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Attestation Report of the Independent Registered Public Accounting Firm</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.5pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Our management’s report was not subject to attestation by our independent registered public accounting firm pursuant to the Dodd-Frank Act that permanently exempted smaller reporting companies from the auditor attestation requirement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Remediation Plan</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2021, we continued to enhance our internal control over financial reporting in an effort to remediate the material weaknesses described above. We are committed to ensuring that our internal control over financial reporting is designed and operating effectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our remediation process includes, but not limited to:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing in IT systems to enhance our operational and financial reporting and internal controls.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enhancing the organizational structure to support financial reporting processes and internal controls.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Providing guidance, education and training to employees relating to our accounting policies and procedures.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further developing and documenting detailed policies and procedures regarding business processes for significant accounts, critical accounting policies and critical accounting estimates.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings; font-size: 10pt"><span style="font-family: Symbol">·</span></span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishing effective general controls over IT systems to ensure that information produced can be relied upon by process level controls is relevant and reliable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We expect to remediate these material weaknesses in the first half of 2022. However, we may discover additional material weaknesses that may require additional time and resources to remediate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Changes in Internal Control Over Financial Reporting</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were no changes in our internal control over financial reporting that occurred during the fourth fiscal quarter ended December 31, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_16" style="display:inline-block"/><tr> <td style="width: 62px; text-align: justify"><span id="a15"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 9B.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OTHER INFORMATION</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="a16"/><span class="alphaminr_link" id="alphaminr_17" style="display:inline-block"/><b>ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 38 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span class="alphaminr_link" id="alphaminr_18" style="display:inline-block"/><b><span id="a17"/>PART III</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_19" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a18"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 10.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following are our executive officers and directors and their respective ages and positions as of the date of this Annual Report on Form 10-K.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border-bottom: black 1pt solid; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Position</b></span></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director Since</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yin-Chieh (“Jeff”) Cheng</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board, CEO, President, Director<br/> (Principal Executive Officer)</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2018</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shun-Chih (“Jimmy”) Chuang</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer<br/> (Principal Financial and Accounting Officer)</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hsien-Wen (“Stan”) Yu</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gerald H. Lindberg</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary, Director</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Yu-Lung Kou</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 19, 2019</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas A. Steele</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 19, 2019</span></td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hui-Ying Zhuang</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 19, 2019</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Professional Backgrounds</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Yin-Chieh (“Jeff”) Cheng </i></b>serves as Chairman of the Board, Chief Executive Officer, President and Director of the Company. Mr. Cheng served as our Chief Financial Officer and Treasurer from December 27, 2018 until October 28, 2019. Prior to that role, from December 1, 2014 to present, Mr. Yin-Chieh Cheng acted as a director of Shengbo Accounting Firm in Shanghai. In that role, he was in charge of international tax consulting and cross border transactions. Mr. Yin-Chieh Cheng holds a bachelor’s degree in Accounting from George Mason University in Virginia.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Shun-Chih (“Jimmy”) Chuang </i></b>was appointed as Chief Financial Officer of the Company on October 28, 2019. Prior to that role, from October 1, 2016 to June 30, 2019, Mr. Chuang was a project manager at Deloitte Touche Financial Advisory Corporation in Taiwan where he was part of the Transaction Support practice. In that role, he worked in Mergers and Acquisitions and Valuation services. Prior to that role, from September 2014 to September 2016, Mr. Chuang was a semi-senior at Deloitte Touche in Taiwan where he was part of the Audit Function practice. In that role, he performed audit services to various Taiwanese conglomerate companies. Mr. Chuang has a marketing degree from UC-Berkeley Extension, and a BS in Accounting from Soochow University, Taiwan. He currently holds Certified Public Accounting licenses from the United States and Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Hsien-Wen (“Stan”) Yu</i></b> was appointed as Chief Operating Officer of the Company on March 2, 2020. Prior to that role, Mr. Yu was the operations manager of the Company since 2019, where he managed SEC filings, operations of subsidiaries, and other back-office matters for Nocera. From February 1, 2019 to present, Mr. Yu founded and served as the chairman of VRTX Sports, Inc. In that role, he listened to the operation reports from his subordinates and was the person in charge of corporate finance. Prior to that role, Mr. Yu was the founder and chairman of Recovery, Corp., a fitness accessory company from July 1, 2014 to October 30, 2017, and an inventor of a self-myofascial release kit for shoulder injuries, RC Release, since 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Gerald H. Lindberg </i></b>was appointed as Secretary and Director of the Company on December 31, 2021. In the past five years, working for Handover International, Mr. <span style="background-color: white">Lindberg has provided substantial expertise and guidance as a consultant, has served as board member and CFO of publicly traded companies, business adviser, capital acquisition director, and operations officer to real world and Internet start-ups and helped raise capital for start-ups, small cap, micro-cap, and nano-cap businesses in both the public and private sectors. </span>Earlier in his career he was Section Chief, Litigation Assistance Systems Section, Justice Management Division, United States Department of Justice, attorney-advisor with the United States Department of Justice (1979-1982). <span style="background-color: white">Over the past 25 years, he has been responsible for business plan preparation, early stage advising for corporate development and positioning for capital raising including crowd funding, private placement memoranda, investor presentation development, equity, debt and hybrid funding, form preparation and filing, offering syndicate coordination, sales/marketing strategy along with investment community relations and investor relations, business development, licensing management, and assuring compliance with Federal and state regulations and fraud prevention software development. His areas of specialty include technology and intellectual property management, digital entertainment, media and marketing, e-Commerce, m-Commerce, and search engine design, database systems software design and development. </span>Mr. Lindberg earned his law degree from Western New England University, School of Law, Springfield, MA. Mr. Lindberg is qualified to serve as a director of the Company due to <span style="background-color: white">substantial board and financial consulting experience. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 39 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>David Yu-Lung Kou </i></b>was appointed as Director of the Company on December 19, 2019. Mr. Kou is an executive with diversified experience in global business operations, product management, sales, marketing, and branding - including regional distribution and retail sales. He is experienced in (business) localization, product (roadmap) planning, business and operation establishment, restructuring and crisis recovery. Mr. Kou has experiences in turn-around situations to achieve positive cash flow, strategic business planning and execution and innovative product creation and launch planning. Mr. Kou is currently the Chief of Strategy and Planning for Wistron Corp. His former employment positions include General Manager of TP Vision from 2015-2018, Vice President – Branded Business Operations at TPV from 2015-2018, a Business Advisor/Consultant of HokangTek from 2014-2018, Business and Operations Advisor of Top Innovation from 2014-2018, and an Executive Director, Global Sales of HTC Corp. from 2012-2014. He attended the University of Southern California earning a MSc. Electrical Engineering in 1991. Mr. Kou is qualified to serve as a director of the Company due to his ability in sales and marketing and experience in international business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Thomas A. Steele</i></b> was appointed as Director of the Company on December 19, 2019. Mr. Steele is currently retired. He was registered as a court interpreter Japanese to English and Japan marketing consultant from 2010-2019. Mr. Steele served as a Foreign Service Officer with the U.S. Department of State, Washington, DC for more than 21 years (1980-2001). After retiring from the State Department, he also served as secretary for Anbusa USA, at the 2005 and 2010 World’s Fair. He obtained a BA in Political Science, Music, Radio TV Broadcasting from the University of California, Los Angeles while attending from 1965-1969. Mr. Steele is qualified to serve as a director of the Company due to Japanese Language Skills and experience in International Business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Hui-Ying Zhuang</i></b> was appointed as a Director of the Company on December 19, 2019. Mr. Zhuang works as Vice President of Sales at Clyde Bergemann Power Group (2018-current) with experience in technology and sales management, especially in solution-based consultative selling. Other positions he has held at Clyde Bergemann Power Group include Vice President, Product and Sales Support, Air Pollution Control Products (2013-2018), Director of Technology and Product Management, Air Pollution Control Product Division (2012-2013), Regional Sales Manager from 2006-2012 and a Boiler Process Engineer from 2004-2006. He is experienced in product management, sales, plant operations and contract negotiation. Mr. Zhuang has leadership experience in building and developing management teams and extensive international business working experience. He attended the University of South Carolina earning an MBA in 2005. Mr. Zhuang is qualified to serve as a director of the Company due to his technical experience in power generation and ability in Sales and Marketing functions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board of Directors</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our business and affairs are managed under the direction of our Board and committees of the Board. Directors serve until the next annual meeting and until their successors are elected and qualified. Officers are appointed to serve until serve at the pleasure of the Board, subject to all rights, if any, of such officer under any contract of employment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Committees</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has established an audit committee (the “Audit Committee”), a compensation committee (the “Compensation Committee”) and a nominating and corporate governance committee (the “Nominating and Corporate Governance Committee”). Our Board has not yet adopted procedures by which stockholders may recommend nominees to the Board. The composition and responsibilities of each of the committees of our Board is described below. Members serve on these committees until their resignation or until as otherwise determined by our Board.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Audit Committee</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has appointed David Yu-Lung Kou<span style="background-color: white">, </span>Thomas A. Steele<span style="background-color: white">, and </span>Hui-Ying Zhuang to serve as members of our Audit Committee. Each member of the Audit Committee is an independent director as established by SEC and Nasdaq rules, and David Yu-Lung Kou<span style="background-color: white">, </span>qualifies as an “audit committee financial expert” under the SEC rules.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee’s duties, which are specified in our Audit Committee Charter, include, but are not limited to:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%; text-align: justify"> </td> <td style="width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and discussing with management and the independent auditor the annual audited financial statements, and recommending to the Board whether the audited financial statements should be included in our annual disclosure report;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing with management and the independent auditor significant financial reporting issues and judgments made in connection with the preparation of our financial statements;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">discussing with management major risk assessment and risk management policies;</span></td></tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"/> <!-- Field: Page; Sequence: 40 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 5%"> </td> <td style="text-align: justify; width: 2%"> </td> <td style="text-align: justify; width: 93%"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">monitoring the independence of the independent auditor;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviewing and approving all related-party transactions;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">inquiring and discussing with management our compliance with applicable laws and regulations;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">pre-approving all audit services and permitted non-audit services to be performed by our independent auditor, including the fees and terms of the services to be performed;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">appointing or replacing the independent auditor;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determining the compensation and oversight of the work of the independent auditor (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the purpose of preparing or issuing an audit report or related work;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting policies; and</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">approving reimbursement of expenses incurred by our management team in identifying potential target businesses.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Compensation Committee</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has established a Compensation Committee. Thomas A. Steele <span style="background-color: white">and </span>Hui-Ying Zhuang, each of whom is an independent director, serves as members of the Compensation Committee with Thomas A. Steele<span style="background-color: white">,</span> serving as the Compensation Committee’s Chairman. The Compensation Committee’s duties, which are specified in our Compensation Committee Charter, include, but are not limited to:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%; text-align: justify"> </td> <td style="width: 2%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="width: 93%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviews, approves and determines, or makes recommendations to our Board regarding, the compensation of our executive officers;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">administers our equity compensation plans;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">reviews and approves, or makes recommendations to our Board, regarding incentive compensation and equity compensation plans; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">establishes and reviews general policies relating to compensation and benefits of our employees.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee charter permits the committee to retain or receive advice from a compensation consultant and outlines certain requirements to ensure the consultants independence or certain circumstances under which the consultant need not be independent. However, as of the date hereof, the Company has not retained such a consultant.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Nominating and Corporate Governance Committee</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has established a Nominating and Corporate Governance Committee of which David Yu-Lung Kou <span style="background-color: white">and </span>Hui-Ying Zhuang serve as members with Hui-Ying Zhuang also serving as the Chairman of the Nominating and Corporate Governance Committee. The Nominating and Corporate Governance Committee’s duties, which are specified in its charter, include, but are not limited to:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 41 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identifying, reviewing and evaluating candidates to serve on our Board consistent with criteria approved by our Board;</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating director performance on our Board and applicable committees of our Board and determining whether continued service on our Board is appropriate;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">evaluating nominations by stockholders of candidates for election to our Board; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Symbol">·</span></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">corporate governance matters.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Ethics</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board adopted a written code of ethics (“Code”) that applies to our directors, officers and employees, including our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions. We intend to post on our website a current copy of the Code and all disclosures that are required by law in regard to any amendments to, or waivers from, any provision of the Code. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Independence</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Our </span>Board is composed of a majority of “independent directors.” In determining whether a director is independent, we use the definition of “<i>independence</i>” applied by Nasdaq under Nasdaq Rule 5601(a)(2) and the SEC under Rule 10A-3 of the Exchange Act. <span style="background-color: white">Our Board has undertaken a review of the independence of each director. Based on information provided by each director concerning his or her background, employment and affiliations, our Board has determined that </span>David Yu-Lung Kou<span style="background-color: white">, </span>Thomas A. Steele<span style="background-color: white">, and </span>Hui-Ying Zhuang <span style="background-color: white">are</span> independent directors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification of Officers and Directors</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Articles of Incorporation and Bylaws provide that, to the fullest extent permitted by the laws of the State of Nevada, any officer or director of the Company, who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was or has agreed to serve at the request of the Company as a director, officer, employee or agent of the Company, or while serving as a director or officer of the Company, is or was serving or has agreed to serve at the request of the Company as a director, officer, employee or agent (which, for purposes hereof, shall include a trustee, partner or manager or similar capacity) of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity. For the avoidance of doubt, the foregoing indemnification obligation includes, without limitation, claims for monetary damages against Indemnitee to the fullest extent permitted under Section 78.7502 of the Nevada Revised Statutes as in existence on the date hereof.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The indemnification provided shall be from and against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the indemnitee or on the indemnitee’s behalf in connection with such action, suit or proceeding and any appeal therefrom, but shall only be provided if the indemnitee acted in good faith and in a manner the indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action, suit or proceeding, had no reasonable cause to believe the indemnitee’s conduct was unlawful.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the case of any threatened, pending or completed action or suit by or in the right of the Company to procure a judgment in its favor by reason of the fact that he or she is or was a director, officer, employee or agent of the Company, or while serving as a director or officer of the Company, is or was serving or has agreed to serve at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, no indemnification shall be made in respect of any claim, issue or matter as to which the indemnitee shall have been adjudged to be liable to the Company unless, and only to the extent that, the Nevada courts or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the indemnitee is fairly and reasonably entitled to indemnity for such expenses which the Nevada courts or such other court shall deem proper.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 42 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that he or she did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had reasonable cause to believe that the indemnitee’s conduct was unlawful.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Company pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. If a claim for indemnification against such liabilities (other than the payment by us of expenses incurred or paid by a director, officer or controlling person of our company in the successful defense of any action, suit or proceeding) is asserted by any of our directors, officers or controlling persons in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final adjudication of that issue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_20" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="item11"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 11.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXECUTIVE COMPENSATION</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Compensation Table</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table summarizes all cash compensation paid by us, as well as certain other compensation paid or accrued, for the years ended December 31, 2021 and 2020 for all individuals serving as the Company’s principal executive officer or acting in a similar capacity during the last completed fiscal year, regardless of compensation level, and two most highly compensated executive officers other than the PEO who were serving as executive officers at the end of the last completed fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Principal Position</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal Year</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary($)</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Equity Awards($) <sup>(1)</sup></b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total($)</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 36%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yin-Chieh (“Jeff”) Cheng <sup>(2)</sup></span></td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,053,267</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,053,267</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board, President, CEO, Director</span></td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,831</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,831</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shun-Chih (“Jimmy”) Chuang <sup>(3)</sup></span></td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655,073</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">697,073</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,558</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81,558</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hsien-Wen (“Stan”) Yu <sup>(4)</sup></span></td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">619,377</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">639,377</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,469</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,469</span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 2%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="width: 1%"> </td> <td style="width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts shown represent the aggregate grant date fair value of these warrant awards granted during each fiscal year shown, computed in accordance with FASB ASC Topic 718.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Cheng Consulting Agreement, dated December 27, 2018, the Company agreed to issue Mr. Cheng 250,000 Series A warrants per quarter for 20 quarters (i.e., 5 years) for a total amount of 5,000,000 Series A warrants, subject to his continued services as the Chairman of the Board and Director of the Company. Each Series A warrant is exercisable to purchase one share of common stock for $0.50 per share from the date of vesting until April 23, 2026. This award was valued at a total amount of $11,114,098 for the year ended December 31, 2021 using the Black Scholes methodology. The values of the award granted each year were $60,831 and $11,053,267 separately for the years ended December 31, 2020 and 2021 using the Black-Scholes methodology.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 1, 2020, the Company issued Mr. Chuang 50,000 Class A warrants. The total value of the award was $39,558 for the year ended December 31, 2020. On December 1, 2021, the Company issued Mr. Chuang 75,000 Class A warrants, and on December 31, 2021, the Company extended the termination date of Class A warrant to April 23, 2026. The total value of the award granted to Mr. Chuang in 2021 was $655,073 for the year ended December 31, 2021 using the Black-Scholes methodology.</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 1, 2020, the Company issued Mr. Yu 60,000 Class A warrants. The total value of the award was $47,469 for the year ended December 31, 2020. On December 1, 2021, the Company issued Mr. Yu 60,000 Class A warrants, and on December 31, 2021, the Company extended the termination date of Class A warrant to April 23, 2026. The total value of the award granted to Mr. Yu in 2021 was $619,377 for the year ended December 31, 2021 using the Black-Scholes methodology.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 43 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Agreements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Chuang Employment Agreement</span></i>. Shun-Chih Chuang, our Chief Financial Officer, and the Company entered into an Employment Agreement dated as of August 16, 2019, as amended by that certain Addendum dated as of December 31, 2021 (the “Chuang Employment Agreement”). The term of the Chuang Employment Agreement is for 5 years and at the end of such term, is automatically renewable on a month-to-month basis unless either party provides notice to terminate to the other within 30 days of the end of the term. During the term and one year after the end of the term, Mr. Chuang shall not solicit any person employed or engaged by the Company. Mr. Chuang’s employment may be terminated by the Company immediately upon the occurrence of the following events: (i) the commission of any act by Mr. Chuang which, if prosecuted, would constitute a felony; (ii) any material act or omission involving malfeasance or negligence in the performance of employment duties which has a materially adverse effect on the Company and which has not been corrected in 30 days after written notice from the Company; (iii) failure or refusal by Mr. Chuang to comply with the policies of the Company contained in any Company handbook or with the provisions of the Chuang Employment Agreement if not cured within 10 days after the receipt of written notice from the Board; (iv) Mr. Chuang’s prolonged absence without the consent of the Company; (v) Mr. Chuang’s gross neglect of his duties or willful insubordination to the Board or his superior officers; (vi) the death of Mr. Chuang; or (vii) delivery of written notice of termination by the Company after Mr. Chuang has become unable to perform his services by reason of illness or incapacity, which illness or incapacity results in Mr. Chuang’s failure to discharge his duties under the Chuang Employment Agreement for an aggregate total of 60 days (whether consecutive or nonconsecutive) during any 180 day period. The Company pays Mr. Chuang $54,000 per year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Yu Employment Agreement</span></i>. Hsien-Wen Yu, our Chief Operating Officer, and the Company entered into an Employment Agreement dated as of August 16, 2019, as amended by that certain Addendum dated as of December 31, 2021 (the “Yu Employment Agreement”). The term of the Yu Employment Agreement is for 5 years and at the end of such term, is automatically renewable on a month-to-month basis unless either party provides notice to terminate to the other within 30 days of the end of the term. During the term and one year after the end of the term, Mr. Yu shall not solicit any person employed or engaged by the Company. Mr. Yu’s employment may be terminated by the Company immediately upon the occurrence of the following events: (i) the commission of any act by Mr. Yu which, if prosecuted, would constitute a felony; (ii) any material act or omission involving malfeasance or negligence in the performance of employment duties which has a materially adverse effect on the Company and which has not been corrected in 30 days after written notice from the Company; (iii) failure or refusal by Mr. Yu to comply with the policies of the Company contained in any Company handbook or with the provisions of the Yu Employment Agreement if not cured within 10 days after the receipt of written notice from the Board; (iv) Mr. Yu’s prolonged absence without the consent of the Company; (v) Mr. Yu’s gross neglect of his duties or willful insubordination to the Board or his superior officers; (vi) the death of Mr. Yu; or (vii) delivery of written notice of termination by the Company after Mr. Yu has become unable to perform his services by reason of illness or incapacity, which illness or incapacity results in Mr. Yu’s failure to discharge his duties under the Yu Employment Agreement for an aggregate total of 60 days (whether consecutive or nonconsecutive) during any 180 day period. The Company pays Mr. Yu $36,000 per year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Lindberg Employment Agreement</span></i>. Gerald H. Lindberg, our Secretary and Director, and the Company entered into an Employment Agreement dated as of January 3, 2022 (the “Lindberg Employment Agreement”). The term of the Lindberg Employment Agreement is for two years and at the end of such term, is automatically renewable on a month-to-month basis unless either party provides notice to terminate to the other within 30 days of the end of the term. During the term and one year after the end of the term, Mr. Lindberg shall not solicit any person employed or engaged by the Company. Mr. Lindberg’s employment may be terminated by the Company immediately upon the occurrence of the following events: (i) the commission of any act by Mr. Lindberg which, if prosecuted, would constitute a felony; (ii) any material act or omission involving malfeasance or negligence in the performance of employment duties which has a materially adverse effect on the Company and which has not been corrected in 30 days after written notice from the Company; (iii) failure or refusal by Mr. Lindberg to comply with the policies of the Company contained in any Company handbook or with the provisions of the Lindberg Employment Agreement if not cured within 10 days after the receipt of written notice from the Board; (iv) Mr. Lindberg’s prolonged absence without the consent of the Company; (v) Mr. Lindberg’s gross neglect of his duties or willful insubordination to the Board or his superior officers; (vi) the death of Mr. Lindberg; or (vii) delivery of written notice of termination by the Company after Mr. Lindberg has become unable to perform his services by reason of illness or incapacity, which illness or incapacity results in Mr. Lindberg’s failure to discharge his duties under the Lindberg Employment Agreement for an aggregate total of 60 days (whether consecutive or nonconsecutive) during any 180 day period. <span style="background-color: white">The Company also granted Mr. Lindberg 60,000 Class C warrants </span>consisting of the right to purchase one share of common stock of the Company for $2.50 per share from the date of issuance, of which 20,000 Class C warrants shall vest annually over a total period of three years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 44 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Cheng Consulting Agreement</span>.</i> Yin-Chieh (“Jeff”) Cheng, our Chairman of the Board, President, Chief Executive Officer and Director, and the Company entered into the Cheng Consulting Agreement on December 27, 2018 (the “Cheng Consulting Agreement”). The Cheng Consulting Agreement appoints Mr. Cheng as the Chairman of the Board and Director of the Company. The term of Mr. Cheng’s appointment of such positions is for the period between December 27, 2018 and December 27, 2023. The Company or Mr. Chang may immediately terminate the Cheng Consulting Agreement upon a material breach by the other party that has not been cured to the terminating party’s satisfaction within 30 days following written notice of said breach. Mr. Cheng may terminate on 30 days’ written notice for the Company’s uncured failure to meet its payment obligations within 30 days of receiving written notice of such failure from Mr. Cheng. The Company does not pay Mr. Cheng any cash compensation for his roles as Chairman of the Board and a Director of the Company. The Company, however, agreed to issue Mr. Cheng quarterly 250,000 Series A warrants per quarter for 20 quarters (i.e., 5 years) for a total amount of 5,000,000 Series A warrants, subject to his continued services as the Chairman of the Board and Director of the Company. Each Series A warrant is exercisable to purchase one share of common stock from the date of vesting until April 23, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors are reimbursed for expenses incurred by them in connection with attending Board meetings. However, our directors, other than Mr. Cheng, do not receive any other compensation for serving on the Board.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Outstanding Equity Awards</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth information regarding equity awards held by the named executive officers as of December 31, 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="13" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant awards</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of securities underlying unexercised warrant awards<br/> (#) exercisable</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of securities underlying unexercised warrant awards<br/> (#) unexercisable</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant award exercise price<br/> ($)</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrant award expiration date</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 36%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yin-Chieh (“Jeff”) Cheng <sup>(1)</sup></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chairman of the Board, President, CEO, Director</p></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 13%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.50</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 15%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 23, 2026</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shun-Chih (“Jimmy”) Chuang</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer <sup>(2)</sup></p></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.50</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 23, 2026 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hsien-Wen (“Stan”) Yu</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Operating Officer <sup>(3)</sup></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.50</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  April 23, 2026 </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="width: 97%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Cheng Consulting Agreement, the Company agreed to issue Mr. Cheng 250,000 Series A warrants per quarter for 20 quarters (i.e., 5 years) for a total amount of 5,000,000 Series A warrants. Quarterly issuances are subject to Mr. Cheng’s continued services as the Chairman of the Board and Director of the Company. On December 31, 2021, the Company extended the expiration date of Series A warrants to April 23, 2026. On May 29, 2020, Mr. Cheng exercised 1,000,000 Series A Warrants and received an aggregate of 827,586 shares of common stock. The unexercised warrants were valued at $11,114,098 for the year ended December 31, 2021 using the Black Scholes methodology. The values of the warrants granted each year were $60,831 and $11,053,267 for the years ended December 31, 2020 and 2021, respectively, using Black-Scholes methodology.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 1, 2020 and December 1, 2021, the Company issued Shun-Chih Chuang 50,000 and 75,000 Class A warrants, respectively. On December 31, 2021, the Company extended the termination date of Class A warrant to April 23, 2026. The total value of the award was $694,631 for the year ended December 31, 2021 using Black Scholes methodology. The Class A warrants consist of the right to purchase one share of common stock of the Company for $0.50 per share.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On each of June 1, 2020 and December 1, 2021, the Company issued Hsien-Wen Yu 60,000 Class A warrants. On December 31, 2021, the Company extended the termination date of the Class A warrants to April 23, 2026. The total value of the award was $666,846 for the year ended December 31, 2020 using Black Scholes methodology. The Class A warrants consist of the right to purchase one share of common stock of the Company for $0.50 per share.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 45 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Severance and Change in Control Benefits</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None of the employment agreements with our named executive officers provide severance benefits; however, the Cheng Consulting Agreement does provide certain change in control-related benefits to our principal executive officer, including vesting acceleration upon the occurrence of certain defined events.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Other Benefits</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We provide vacation and other paid holidays to all employees, including our executive officers, which are comparable to those provided at peer companies. When offered, our executive officers will be eligible to participate in all of our employee benefit plans, such as medical, dental, vision, group life, disability and accidental death and dismemberment insurance, our Equity Incentive Plan and our 401(k) plan, in each case on the same basis as other employees, subject to applicable law, should such benefits exist. At this time, we do not provide special benefits or other perquisites to our executive officers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The 2018 Equity Incentive Plan</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2018, the Board and stockholders adopted the Company’s 2018 Stock Option and Award Incentive Plan, effective December 31, 2018. The 2018 Plan provides for the grant of the following types of stock awards: (i) incentive stock options, (ii) non-statutory stock options, and (iii) stock purchase rights. The 2018 Plan is intended to help the Company secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any affiliate and provide a means by which the eligible recipients may benefit from increases in value of the common stock. The 2018 Plan is administered by the Compensation Committee. The Board reserved 10,000,000 shares of common stock under the 2018 Plan. No awards have been granted to any of our officers or directors pursuant to the 2018 Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Indemnification </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company shall indemnify any and all of its directors, officers, former directors, former officers and any person who may have served at its request as a director or officer of another company in which it owns shares or of which it is a creditor, who were or are made a party or are threatened to be made a party to or are involved in, any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative, arbitrative or investigative (each a “Proceeding”), or any appeal in such a Proceeding or any inquiry or investigation that could lead to such a Proceeding, against any and all liabilities, damages, reasonable and documented expenses (including reasonably incurred and substantiated attorneys’ fees), financial effects of judgments, fines, penalties (including excise and similar taxes and punitive damages) and amounts paid in settlement in connection with such Proceeding by any of them. Such indemnification shall not be deemed exclusive of any other rights to which those indemnified may be entitled otherwise.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling our company pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. If a claim for indemnification against such liabilities (other than the payment by us of expenses incurred or paid by a director, officer or controlling person of our company in the successful defense of any action, suit or proceeding) is asserted by any of our directors, officers or controlling persons in connection with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in the Securities Act and will be governed by the final adjudication of that issue.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_21" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a19"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 12.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</b> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information, as of March 21, 2022 with respect to the holdings of (1) each person who is the beneficial owner of more than 5% of Company voting stock, (2) each of our directors, (3) each executive officer and (4) all of our current directors and executive officers as a group.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beneficial ownership of the voting stock is determined in accordance with the rules of the SEC and includes any shares of company voting stock over which a person exercises sole or shared voting or investment power, or of which a person has a right to acquire ownership at any time within 60 days of March 21, 2022. Except as otherwise indicated, we believe that the persons named in this table have sole voting and investment power with respect to all shares of voting stock held by them. Applicable percentage ownership in the following table is based on 10,707,150 shares of common stock issued and outstanding on March 21, 2022, and after the offering assuming a unit offering consisting of shares of common stock (excluding shares of common stock which may be sold upon exercise of the underwriters’ over-allotment option), plus, for each individual, any securities that individual has the right to acquire within 60 days of March 21, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 46 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the best of our knowledge, except as otherwise indicated, each of the persons named in the table has sole voting and investment power with respect to the shares of our common stock beneficially owned by such person, except to the extent such power may be shared with a spouse. To our knowledge, none of the shares listed below are held under a voting trust or similar agreement, except as noted. To our knowledge, there is no arrangement, including any pledge by any person of securities of the Company, the operation of which may at a subsequent date result in a change in control of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: black 1pt solid; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name and Address<br/> of Beneficial Owner <sup>(1)</sup></b></span></td> <td style="vertical-align: bottom"> </td> <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td> <td style="vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficially<br/> owned</b></span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Percentage of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Outstanding</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Shares of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Common Stock <sup>(2)</sup></b></p></td> <td style="vertical-align: bottom"> </td> </tr> <tr> <td style="vertical-align: top; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Officers and Directors</b></span></td> <td style="vertical-align: bottom; width: 2%"> </td> <td style="vertical-align: bottom; width: 27%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 2%"> </td> <td style="vertical-align: bottom; width: 13%; text-align: right"> </td> <td style="vertical-align: bottom; width: 2%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 1%"> </td> <td style="vertical-align: bottom; width: 13%; text-align: right"> </td> <td style="vertical-align: bottom; width: 1%"> </td> </tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yin-Chieh (“Jeff”) Cheng</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman of the Board, President, Chief Executive Officer, Director</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,542,586</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">58.21%</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shun-Chih (“Jimmy”) Chuang</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">875,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.08%</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hsien-Wen (“Stan”) Yu</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.11%</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gerald H. Lindberg</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary, Director</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Yu-Lung Kou</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas A. Steele</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hui-Ying Zhuang</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">–</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: White"> <td style="vertical-align: top"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Officers and Directors as a Group (total of 7 persons)</b></p></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,537,586</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64.67%</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: top"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5% Stockholders</b></span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"> </td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: rgb(238,238,238)"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Erik S. Nelson</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,152,600</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.76%</span></td> <td style="vertical-align: bottom"> </td> </tr> <tr style="background-color: White"> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marina S. Fiorino</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">543,000</span></td> <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.07%</span></td> <td style="vertical-align: bottom"> </td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; width: 7%; text-align: left">(1)</td> <td style="width: 93%; text-align: justify">Unless otherwise indicated, the principal address of the named officers and directors c/o Nocera, Inc., 3F (Building B), No. 185, Sec. 1, Datong Rd., Xizhi Dist., New Taipei City 221, Taiwan.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">(2)</td> <td style="text-align: justify">Based on 10,707,150 shares of common stock issued and outstanding as of March 21, 2022. Any shares of common stock not outstanding which are issuable upon the exercise or conversion of other securities held by a person within the next 60 days are considered to be outstanding when computing such person’s ownership percentage of common stock but are not when computing anyone else’s ownership percentage.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">(3)</td> <td style="text-align: justify">Includes (i) 5,292,586 shares of common stock; and (ii) 2,250,000 shares of common stock issuable upon the exercise for Series A warrants at a price of $0.50 per share until April 23, 2026.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">(4)</td> <td style="text-align: justify">Includes (i) 750,000 shares of common stock; and (ii) 125,000 shares of common stock issuable upon the exercise of Class A warrants at a price of $0.50 per share until April 23, 2026.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">(5)</td> <td style="text-align: justify">Includes 120,000 shares of common stock issuable upon the exercise of Class A warrants for $0.50 per warrant until April 23, 2026.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">(6)</td> <td style="text-align: justify">Includes (i) 1,000,000 shares held by Nelson Fiorino Holdings, LLC, an entity of which Mr. Nelson has sole voting and dispositive control; (ii) 150,000 shares held by Coral Investment Partners, LP, which is 58% owned by Erik Nelson; and (iii) 2,600 shares personally held by Mr. Nelson. This does not include 650,000 shares of common stock issuable upon the exercise of Class A warrants for $0.50 per share until April 23, 2026 and 650,000 shares of common stock issuable upon the exercise of Class B warrants for $1.00 per share until April 23, 2026 since such Class A warrants and Class B warrants contain blockers that prohibit Mr. Nelson from exercising warrants if such exercise will result in the beneficial ownership of more than 4.99% (or if Mr. Nelson elects, 9.99%) of the Company’s outstanding stock. Mr. Nelson was the former Secretary and Director of the Company and resigned on December 31, 2021. Mr. Nelson’s business address is 2030 Powers Ferry Road SE, Suite 212, Atlanta, GA 30339.</td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">(7)</td> <td style="text-align: justify">The address for Ms. Fiorino is 1 San Marzano sul Sarno, Italy 84010. </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left"> </td> <td style="text-align: justify"> </td></tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"/> <!-- Field: Page; Sequence: 47 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_22" style="display:inline-block"/><tr style="vertical-align: top"> <td style="text-align: justify; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a21"/>ITEM 13.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under Item 404 of Regulation S-K, we are required to describe any transaction, since the beginning of the Company’s last fiscal year, or any currently proposed transaction, in which the Company was or is to be a participant and the amount involved exceeds $120,000 or one percent of the average of the smaller reporting company’s total assets at year end for the last two completed fiscal years, with a related person. A related person under Item 404 of Regulation S-K includes:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top"><td style="width: 20px"/><td style="width: 20px">1.</td><td>any director or executive officer of the Company; or</td></tr> <tr style="vertical-align: top"><td style="width: 20px"/><td style="width: 20px">2.</td><td>any immediate family member of a director or executive officer of the Company, which means any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law of such director, executive officer or nominee for director, and any person (other than a tenant or employee) sharing the household of such director, executive officer or nominee for director; and</td></tr> <tr style="vertical-align: top"><td style="width: 20px"/><td style="width: 20px">3.</td><td>a beneficial owner of 5% or more of the Company’s common stock at the time of the transaction or immediate family member of such stockholder.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company did not have any related party transactions reportable under Item 404 of Regulation S-K.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_23" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a22"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 14.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PRINCIPAL ACCOUNTING FEES AND SERVICES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the years ended December 31, 2021 and 2020, we engaged Centurion ZD CPA Co. as our independent registered accounting firm. For the years ended December 31, 2021 and 2020, we incurred fees, as discussed below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fiscal Year Ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 70%; text-align: left">Audit Fees</td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">131,600</td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">23,400</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Audit-Related Fees (1)</td> <td style="text-align: left"> </td><td style="text-align: right">10,000</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Tax Fees</td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">All Other Fees</td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; font-weight: bold">Total</td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">141,600</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">23,400</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fees incurred in conjunction with consents for various registration statements filed during years.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Audit fees consist of fees related to professional services rendered in connection with the audit of our annual financial statements. All other fees relate to professional services rendered in connection with the review of the quarterly financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 48 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our policy is to pre-approve all audit and permissible non-audit services performed by the independent accountants. These services may include audit services, audit-related services, tax services and other services. Under our Audit Committee’s policy, pre-approval is generally provided for particular services or categories of services, including planned services, project based services and routine consultations. In addition, the Audit Committee may also pre-approve particular services on a case-by-case basis. Our Audit Committee approved all services that our independent accountants provided to us in the past two fiscal years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span class="alphaminr_link" id="alphaminr_24" style="display:inline-block"/><b><span id="a23"/>PART IV</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_25" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%; text-align: justify"><span id="a24"/><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 15.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. Financial Statements: Please check “Index to Consolidated Financial Statements” of this Annual Report on Form 10-K.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. Exhibits:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b/></span></p> <!-- Field: Page; Sequence: 49 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b><span id="exindex"/>EXHIBIT INDEX</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit No.</b></span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Previously Filed and Incorporated by Reference Herein</b></span></td></tr> <tr style="vertical-align: top"> <td style="width: 5%"> </td> <td style="width: 1%; text-align: justify"> </td> <td style="width: 49%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 44%; text-align: justify"> </td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594918000149/ex3_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation of Nocera, Inc.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 3.1 to Form 10-12G filed on October 19, 2018.</span></td></tr> <tr style="vertical-align: top"> <td>3.2</td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="nocera_ex0302.htm">Amended and Restated Articles of Incorporation of Nocera, Inc.</a></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594918000149/ex3_4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of Nocera, Inc.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 3.1 to Current Report on Form 8-K filed on February 28, 2022.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594918000149/ex3_2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Amendment of Articles of Incorporation of Nocera, Inc.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 3.2 to Form 10-12G filed on October 19, 2018.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</span></td> <td> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594918000149/ex3_3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate of Change of Nocera, Inc.</span></a></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 3.3 to Form 10-12G filed on October 19, 2018.</span></td></tr> <tr style="vertical-align: top"> <td>3.6</td> <td> </td> <td style="text-align: left"><a href="nocera_ex0306.htm">Certificate of Amendment of Amended and Restated Articles of Incorporation of Nocera, Inc.</a></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td>3.7</td> <td> </td> <td style="text-align: left"><a href="nocera_ex0307.htm">Certificate of Designation of Series A Preferred Stock of Nocera, Inc.</a></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.8</span></td> <td> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex3_3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Incorporation of GSI Acquisition Corp.</span></a></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 3.3 to Form 8-K12G3 filed on January 31, 2019.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.9</span></td> <td> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex3_4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Association of Grand Smooth Inc Limited</span></a></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 3.4 to Form 8-K12G3 filed on January 31, 2019.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.10</span></td> <td> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594918000203/ex10_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement and Plan of Merger, dated as of December 27, 2018, by and among the Registrant, Grand Smooth Inc Limited and GSI Acquisition Corp.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.1 to Form 8-K filed on December 31, 2018.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.11</span></td> <td> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex2_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended Agreement and Plan of Merger, dated as of December 27, 2018, and effective as of December 31, 2018, by and among Nocera, Inc., Grand Smooth Inc Limited and GSI Acquisition Corp.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 2.1 to Form 8-K12G3 filed on January 31, 2019.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.12</span></td> <td> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex3_5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statement of Merger – GSI Acquisition Corp. and Grand Smooth Inc Limited</span></a></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 3.5 to Form 8-K12G3 filed on January 31, 2019.</span></td></tr> <tr style="vertical-align: top"> <td>4.1</td> <td> </td> <td style="text-align: left"><a href="nocera_ex0401.htm">Description of Nocera, Inc.’s securities registered under section 12 of the Securities Exchange Act of 1934, as amended</a></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1†</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex10_2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018 Nocera, Inc. Stock Option and Award Incentive Plan</span></a></td> <td> </td> <td style="width: 42%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.2 to Form 8-K12G3 filed on January 31, 2019.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex10_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share Exchange Agreement</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.1 to Form 8-K12G3 filed on January 31, 2019.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3†</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000015/ex2_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement dated as of December 27, 2018, between Nocera, Inc. and Yin-Chieh Cheng</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 2.1 to Form 8-K12G3 filed on January 31, 2019.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594919000148/ex10_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regional Agency Cooperation Agreement dated as of September 2019, by and between Grand Smooth Inc Ltd and Jie Hao Development Co., Ltd.</span></a></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.1 to Form 8-K filed on October 30, 2019.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594920000002/ex10_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Procare International Co., Limited Project Contract</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.1 to Form 8-K filed on January 10, 2020.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594920000088/ex10_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regional Agency Cooperation Supplementary Agreement dated as of May 31, 2020, by and between Grand Smooth Inc Ltd and JC Development Co., Ltd.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.1 to Form 8-K filed on June 19, 2020.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594920000088/ex10_2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting Agreement dated as of May 15, 2020, between Nocera, Inc. and Atlanta Capital Partners, LLC</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.2 to Form 8-K filed on June 19, 2020.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316820003919/nocera_10q-ex1004.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlement Agreement and Release dated as of October 8, 2020, by and between Guizhou Wan Feng Hu Zhi Shui Chan Company, Ltd. and Nocera, Inc.</span></a></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.4 to Form 10-Q filed on November 16, 2020.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex2_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Agreement, Consent, and Representations dated as of December 31, 2020 of the Registrant and Agreement and Plan of Share Exchange for VIE Interest dated as of December 31, 2020, by and between Nocera, Inc., Xin Feng Construction Co. Ltd., and Shunda Feed Co. Ltd</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 2.1 to Form 8-K filed on January 4, 2021.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting Rights Proxy Agreement dated as of December 31, 2020, by and among Hui-Min Tu, Wen-Chih Tsai, Ching-Yao Tsai, Ching-Chao Tsai, Nocera, Inc. and Xin Feng Construction Co. Ltd.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.1 to Form 8-K filed on January 4, 2021.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive Business Cooperation Agreement dated as of December 31, 2020, by and among Nocera, Inc. and Xin Feng Construction Co. Ltd.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.2 to Form 8-K filed on January 4, 2021.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Pledge Agreement dated as of December 31, 2020, by and among Hui-Min Tu, Wen-Chih Tsai, Ching-Yao Tsai, Ching-Chao Tsai, Nocera, Inc. and Xin Feng Construction Co. Ltd.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.3 to Form 8-K filed on January 4, 2021.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000106594921000001/ex10_4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exclusive Call Option Agreement dated as of December 31, 2020, by and among Nocera, Inc., Hui-Min Tu, Wen-Chih Tsai, Ching-Yao Tsai, Ching-Chao Tsai and Xin Feng Construction Co. Ltd.</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.4 to Form 8-K filed on January 4, 2021.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316821002002/nocera_10q-ex1004.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Agreement dated as of April 1, 2021, by and between Nocera, Inc. and Han-Chieh Shih</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.4 to Form 10-Q filed on May 17, 2021.</span></td></tr> </table> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"> </p> <p style="margin: 0"/> <!-- Field: Page; Sequence: 50 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td> <td style="text-align: justify; width: 1%"> </td> <td style="text-align: left; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex1015.htm">Consulting Agreement dated as of November 15, 2021, by and between Nocera, Inc. and Shih-Chung Lin</a></span></td> <td style="width: 1%"> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex1016.htm">Consulting Agreement dated as of November 15, 2021, by and between Nocera, Inc. and Han-Chieh Shih</a></span></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17†</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex1017.htm">Employment Agreement dated as of August 16, 2019, by and between Nocera, Inc. and Hsien-Wen Yu</a></span></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18†</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex1018.htm">Employment Agreement dated as of August 16, 2019, by and between Nocera, Inc. and Shun-Chih Chuang</a></span></td> <td> </td> <td style="text-align: center"><p style="margin-top: 0; margin-bottom: 0">*</p></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19†</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1001.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement dated as of January 3, 2022, by and between Nocera, Inc. and Gerald H. Lindberg</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.1 to Form 8-K filed on January 6, 2022.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20†</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1002.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum, dated December 31, 2021, to that certain Employment Agreement, dated August 16, 2019, between Nocera, Inc. and Shun-Chih Chuang</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.2 to Form 8-K filed on January 6, 2022.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21†</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1003.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Addendum, dated December 31, 2021, to that certain Employment Agreement, dated August 16, 2019, between Nocera, Inc. and Hsien-Wen Yu</span></a></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed as Exhibit 10.3 to Form 8-K filed on January 6, 2022.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex2101.htm">List of Subsidiaries of Nocera, Inc.</a></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex3101.htm">Rule 13a-14(a)/15d-14(a) Certification of the President and Chief Executive Officer of Nocera, Inc.</a></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex3102.htm">Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer of Nocera, Inc.</a></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td> <td> </td> <td style="text-align: center">*</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex3201.htm">Section 1350 Certification of the President and Chief Executive Officer of Nocera, Inc.</a></span></td> <td> </td> <td style="text-align: center">**</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2</span></td> <td style="text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="nocera_ex3202.htm">Section 1350 Certification of the Chief Financial Officer of Nocera, Inc.</a></span></td> <td> </td> <td style="text-align: center">**</td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document</span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Schema Document</span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Calculation Linkbase Document</span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Definition Linkbase Document</span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Label Linkbase Document</span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Presentation Linkbase Document</span></td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: justify"> </td></tr> <tr> <td style="vertical-align: top">104</td> <td style="vertical-align: top; text-align: justify"> </td> <td style="text-align: left">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</td> <td style="vertical-align: top"> </td> <td style="vertical-align: top; text-align: center">*</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> ________________________</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 2pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0pt"/><td style="width: 20pt; text-align: left">*</td><td style="text-align: justify">Filed herewith.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0pt"/><td style="width: 20pt; text-align: left">**</td><td style="text-align: justify">Furnished herewith.</td> </tr> <tr style="vertical-align: top; text-align: justify"> <td style="width: 0pt"/><td style="width: 20pt; text-align: left">†</td><td style="text-align: justify">Management contract or compensatory plan.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span id="iten16"/>  </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <span class="alphaminr_link" id="alphaminr_26" style="display:inline-block"/><tr style="vertical-align: top"> <td style="width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ITEM 16.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM 10-K SUMMARY</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 51 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="signature"/><b>SIGNATURES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td> </td> <td colspan="2"><b>NOCERA, INC.</b></td></tr> <tr> <td> </td> <td> </td> <td> </td></tr> <tr> <td style="width: 50%">Dated: March 23, 2022</td> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td> <td style="width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">/s/ Yin-Chieh Cheng                             </span></i></span></td> </tr> <tr> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yin-Chieh Cheng </span></td> </tr> <tr> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</span></td> </tr> <tr> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="width: 50%">Dated: March 23, 2022</td> <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td> <td style="width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">/s/ Shun-Chih Chuang                            </span></i></span></td> </tr> <tr> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shun-Chih Chuang </span></td> </tr> <tr> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td> </tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; background-color: White; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid"><b>Name</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td style="border-bottom: Black 1pt solid"><b>Position</b></td> <td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><b>Date</b></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid">/s/ Yin-Chieh Cheng</td> <td> </td> <td>Chairman of the Board, CEO, President, Director</td> <td> </td> <td colspan="2" style="text-align: center">March 23, 2022</td></tr> <tr style="vertical-align: bottom"> <td colspan="2">Yin-Chieh Cheng</td> <td> </td> <td>(Principal Executive Officer)</td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><i>/s/ Shun-Chih Chuang</i></span></td> <td> </td> <td><span style="font-size: 10pt">Chief Financial Officer<br/> </span></td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt">March 23, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-size: 10pt">Shun-Chih Chuang</span></td> <td> </td> <td>(Principal Financial and Accounting Officer)</td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr> <td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom"><span style="font-size: 10pt"><i>/s/ Gerald H. Lindberg</i></span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"><span style="font-size: 10pt">Director</span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">March 23, 2022</span></td> <td style="vertical-align: top"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-size: 10pt">Gerald H. Lindberg</span></td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><i>/s/ David Yu-Lung Kou</i></span></td> <td> </td> <td><span style="font-size: 10pt">Director</span></td> <td> </td> <td colspan="2" style="text-align: center">March 23, 2022</td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-size: 10pt">David Yu-Lung Kou</span></td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><i>/s/ Thomas A. Steele</i></span></td> <td> </td> <td><span style="font-size: 10pt">Director</span></td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt">March 23, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-size: 10pt">Thomas A. Steele</span></td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-size: 10pt"><i>/s/ Hui-Ying Zhuang</i></span></td> <td> </td> <td><span style="font-size: 10pt">Director</span></td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt">March 23, 2022</span></td></tr> <tr style="vertical-align: bottom"> <td colspan="2"><span style="font-size: 10pt">Hui-Ying Zhuang</span></td> <td> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td></tr> <tr> <td style="width: 4%"> </td> <td style="width: 27%"> </td> <td style="width: 4%"> </td> <td style="width: 40%"> </td> <td style="width: 4%"> </td> <td style="width: 20%"> </td> <td style="width: 1%"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <!-- Field: Page; Sequence: 52 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">NOCERA, INC.</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline"><span id="fsindex"/>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 94%; text-align: center"> </td> <td style="width: 1%"> </td> <td style="border-bottom: black 1.5pt solid; width: 5%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pages</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td><a href="#a25"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports of Independent Registered Public Accounting Firm</span></a></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2-3</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td><a href="#a26"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets as of December 31, 2021 and 2020</span></a></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> F-4</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td><a href="#a27"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations and Comprehensive Loss for the Years ended December 31, 2021, and 2020</span></a></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> F-5</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td><a href="#a28"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Changes in Equity for the Years ended December 31, 2021, and 2020</span></a></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> F-6</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td><a href="#a29"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows for the Years ended December 31, 2021, and 2020</span></a></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> F-7</span></td></tr> <tr style="vertical-align: top"> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: top"> <td><a href="#a30"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to the Consolidated Financial Statements for the Years ended December 31, 2021 and 2020</span></a></td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> F-8</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 53; Options: NewSection; Value: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a25"/>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">To the Shareholders and the Board of Directors of Nocera, Inc.:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Opinion on the Financial Statements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We have audited the accompanying consolidated balance sheet of Nocera, Inc. and its subsidiaries (the "Group") as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive income (loss), changes in equity, and cash flows, for the year then ended, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Group at December 31, 2021 and 2020, and the results of its operations and its cash flows for the year then ended, in conformity with the U.S. generally accepted accounting principles.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Basis for Opinion</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">These consolidated financial statements are the responsibility of the Group's management. Our responsibility is to express an opinion on the Group's financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Group in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Critical Audit Matter</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Critical Audit Matter Description</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the year ended December 31, 2021, the Company issued performance shares and warrants to employees including key management personnel as well as to consultants which were accounted for as share based compensation. The Company’s valuation of share-based compensation is complex and subject to significant management estimates and judgement. The Company used black-scholes model to evaluate the fair value of the warrants issued which requires management to make significant assumptions related to input of the pricing model.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <!-- Field: Page; Sequence: 54; Value: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Critical Audit Matter Description</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">During the year ended December 31, 2021, the Company issued performance shares and warrants to employees including key management personnel as well as to consultants which were accounted for as share based compensation. The Company’s valuation of share-based compensation is complex and subject to significant management estimates and judgement. The Company used black-scholes model to evaluate the fair value of the warrants issued which requires management to make significant assumptions related to input of the pricing model.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>How the Critical Audit Matter Was Addressed in the Audit</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i/>Our audit procedures included but were not limited to:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-family: Symbol">·</span></td> <td>Evaluating management’s assessment of the valuation and recognition of the options.</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Symbol">·</span></td> <td>Obtaining an understanding of the key terms and conditions of the performance shares and options by inspecting relevant agreements.</td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify">Holding discussions with management to understand the share based payment arrangements in place</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Symbol">·</span></td> <td>Recalculating the estimated fair value of the performance shares and options using the valuation methodology selected, including assessing the reasonableness of the methodology used and key inputs used in the Company’s valuation model.</td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Symbol">·</span></td> <td>Reviewing the adequacy of the Company’s disclosures in respect of the accounting treatment of share-based payments in the financial statements, including the significant judgments involved, and the accounting policy adopted.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Centurion ZD CPA Co.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_90B_edei--AuditorName_c20210101__20211231_zIy6JhbmlY82"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">Centurion ZD CPA Co.</ix:nonNumeric></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have served as the Group's auditor since 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_907_edei--AuditorLocation_c20210101__20211231_zJR0SZPDZadg"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorLocation">Hong Kong</ix:nonNumeric></span>, China</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March 23, 2022</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ID <span id="xdx_904_edei--AuditorFirmId_c20210101__20211231_zyN7HoxPRKWh"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorFirmId">2769</ix:nonNumeric></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 55; Value: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p> <span class="alphaminr_link" id="alphaminr_balance_sheet"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a26"/><b>CONSOLIDATED BALANCE SHEETS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" id="xdx_304_111_zVbd8dROD72j" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - CONSOLIDATED BALANCE SHEETS"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_495_20211231" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20201231" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_402_eus-gaap--AssetsAbstract_iB_zVz7GenLkUaf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">ASSETS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AssetsCurrentAbstract_i01B_zWbLLAqICMWg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CashAndCashEquivalentsAtCarryingValue_i02I_maCzwsb_zFUDuMHQxoIl" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; width: 68%; text-align: left">Cash and cash equivalents</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD">2,444,009</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="USD">1,023,531</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccountsReceivableNetCurrent_i02I_maCzwsb_z8LQNAHxudr7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Accounts receivable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" unitRef="USD">699,555</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" unitRef="USD">432,309</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--InventoryNet_i02I_maCzwsb_zgrhP9QqjVu6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Inventories, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" unitRef="USD">1,488,681</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" unitRef="USD">1,723,674</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AdvanceToSuppliers_i02I_maCzwsb_zaDW7nU6GBfb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Advance to suppliers</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:AdvanceToSuppliers" unitRef="USD">42,969</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:AdvanceToSuppliers" unitRef="USD">1,732</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i02I_maCzwsb_zIo09Q4sPk11" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Prepaid expenses and other assets, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="USD">107,444</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="USD">3,161</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DueFromRelatedPartiesCurrent_i02I_maCzwsb_ztmweGhXfQw8" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Due from related parties</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" unitRef="USD">1,615,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" unitRef="USD">896,876</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AssetsCurrent_i01TI_mtCzwsb_maAzpkn_zXncD1Vwd48b" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Total current assets</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" unitRef="USD">6,397,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" unitRef="USD">4,081,283</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--RetentionReceivables_i01I_maCz5XW_maAzpkn_zRk39Ace0Y06" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Retention receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:RetentionReceivables" unitRef="USD">69,489</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:RetentionReceivables" unitRef="USD">458,392</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxAssetsNet_i01I_d0_maCz5XW_maAzpkn_zdrlBhrEfVAc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Deferred tax assets, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxAssetsNet" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" unitRef="USD">2,300</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCz5XW_maAzpkn_zWHsZG3VN8sf" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Property and equipment, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="USD">71,245</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="USD">50,926</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--Goodwill_i01I_maCz5XW_maAzpkn_zMpt5jdDU2q" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Goodwill" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Goodwill" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--Assets_iTI_mtAzpkn_zDguhLZnyKp4" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" unitRef="USD">6,870,649</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Assets" unitRef="USD">4,924,941</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">LIABILITIES AND EQUITY</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesAbstract_i01B_zch6qdDUBI76" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LiabilitiesCurrentAbstract_i02B_zgYWqsXMU7ia" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--NotesPayableCurrent_i03I_maCzbFP_zsB05aXScpe7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NotesPayableCurrent" unitRef="USD">92,112</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NotesPayableCurrent" unitRef="USD">187,447</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--AccountsPayableCurrent_i03I_maCzbFP_zhOFswFChqgd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" unitRef="USD">17,442</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" unitRef="USD">18,798</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_i03I_maCzbFP_ztMlWSEPdIQi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Other payables and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" unitRef="USD">142,426</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" unitRef="USD">56,836</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AdvanceReceipts_i03I_maCzbFP_zBN89qW42mG2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Advance receipts</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:AdvanceReceipts" unitRef="USD">1,051,121</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:AdvanceReceipts" unitRef="USD">1,285,777</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DueToRelatedPartiesCurrent_i03I_maCzbFP_zITn8F8EPj5l" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Due to related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="USD">39,341</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" unitRef="USD">7,681</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ExtendedProductWarrantyAccrual_i03I_d0_maCzbFP_zWj0dL5tcTXi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ExtendedProductWarrantyAccrual" unitRef="USD">312,320</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ExtendedProductWarrantyAccrual" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DividendsPayableCurrent_i03I_d0_maCzbFP_zmYaGFE1uct2" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrent" unitRef="USD">6,312</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DividendsPayableCurrent" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccruedIncomeTaxesCurrent_i03I_maCzbFP_zvGxSo639TS7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Income tax payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" unitRef="USD">387,319</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" unitRef="USD">285,186</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LoansPayableToBankCurrent_i03I_maCzbFP_zhvdafTGkVX1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Bank borrowing</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LoansPayableToBankCurrent" unitRef="USD">52,292</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LoansPayableToBankCurrent" unitRef="USD">532,824</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LiabilitiesCurrent_i02TI_mtCzbFP_maCzRY2_zyBd5cBDXIPc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total current liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" unitRef="USD">2,100,685</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" unitRef="USD">2,374,549</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredIncomeTaxLiabilitiesNet_i02I_d0_maCzRY2_z5TFNblspcXl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Deferred tax liabilities, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--Liabilities_i01TI_mtCzRY2_maCzwHa_zZR9P9s9vZp6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total liabilities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" unitRef="USD">2,100,685</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Liabilities" unitRef="USD">2,374,549</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--CommitmentsAndContingencies_i01I_maCzwHa_zkJ3JWFYLOcb" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Commitments and contingencies</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0136">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0137">–</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--StockholdersEquityAbstract_i01B_z9C7yw1DnX04" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">Equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CommonStockValue_i02I_maCzf4t_zDy5R8XG85b8" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 20pt">Common stock ($<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_c20211231_pdd" title="Common stock par value"><span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_c20201231_pdd" title="Common stock par value"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; authorized <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_c20211231_pdd" title="Common stock, shares authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_c20201231_pdd" title="Common stock, shares authorized"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares; <span id="xdx_901_eus-gaap--CommonStockSharesIssued_c20211231_pdd" title="Common stock, shares issued"><span id="xdx_900_eus-gaap--CommonStockSharesOutstanding_c20211231_pdd" title="Common stock, shares outstanding"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" unitRef="Shares"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares">10,607,150</ix:nonFraction></ix:nonFraction></span></span> shares and <span id="xdx_900_eus-gaap--CommonStockSharesIssued_c20201231_pdd" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20201231_pdd" title="Common stock, shares outstanding"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" unitRef="Shares"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" unitRef="Shares">9,131,786</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding as of December 31, 2021 and 2020, respectively)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" unitRef="USD">10,607</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" unitRef="USD">9,132</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--PreferredStockValue_i02I_d0_maCzf4t_zHmdcVG2Pq2j" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-indent: -10pt; padding-left: 20pt; text-align: left">Preferred stock ($<span id="xdx_902_eus-gaap--PreferredStockParOrStatedValuePerShare_c20211231_pdd" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_c20201231_pdd" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="USDPShares"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> par value; authorized <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_c20211231_pdd" title="Preferred Stock, Shares Authorized"><span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_c20201231_pdd" title="Preferred Stock, Shares Authorized"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" unitRef="Shares"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" unitRef="Shares">10,000,000</ix:nonFraction></ix:nonFraction></span></span> shares; Series A Preferred Stock, <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20201231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z4QbT2Rbf08b"><span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zYFXQpTatLg2"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" unitRef="Shares"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" unitRef="Shares">2,000,000</ix:nonFraction></ix:nonFraction></span></span> authorized, <span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zg0Arqr9PE12"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zp6BXWR1KWR6"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" unitRef="Shares"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesOutstanding" unitRef="Shares">80,000</ix:nonFraction></ix:nonFraction></span></span> shares and nil shares, issued and outstanding as of December 31, 2021 and 2020, respectively)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PreferredStockValue" unitRef="USD">80</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:PreferredStockValue" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AdditionalPaidInCapital_i02I_maCzf4t_zxCXxrmWvwZc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Additional paid-in capital</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" unitRef="USD">14,472,705</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" unitRef="USD">2,692,973</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--StatutoryAndOtherReserves_i02I_maCzf4t_zXNIev6O19ge" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Statutory and other reserves</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:StatutoryAndOtherReserves" unitRef="USD">191,219</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:StatutoryAndOtherReserves" unitRef="USD">191,219</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzf4t_zkaCAFcV79V1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">(Accumulated losses) retained earnings</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" unitRef="USD">9,918,553</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" sign="-" unitRef="USD">293,162</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--AccumulatedOtherComprehensiveIncomeLossNetOfTax_i02I_maCzf4t_zvTvFcoxOZEd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated other comprehensive loss</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="USD">13,906</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" sign="-" unitRef="USD">49,770</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--StockholdersEquity_i02TI_pp0p0_mtCzf4t_maCzMxz_zsKIu5egJFJ7" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Total Nocera, Inc.’s stockholders’ equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="USD">4,769,964</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="0" unitRef="USD">2,550,392</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--MinorityInterest_i02I_d0_maCzMxz_z2PRttPDBfV3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Non-controlling interests</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:MinorityInterest" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:MinorityInterest" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_i01TI_mtCzMxz_maCzwHa_zbzhqfuA6xTi" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total equity</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">4,769,964</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">2,550,392</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzwHa_zfyr18oI1sBd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="USD">6,870,649</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="USD">4,924,941</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <!-- Field: Page; Sequence: 56; Value: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p> <span class="alphaminr_link" id="alphaminr_income"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a27"/><b>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" id="xdx_302_113_zhSwS4ojbzFh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101_20211231" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20200101__20201231_z1FDiL0Bihl1" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">2021</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">2020</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_maCzViS_zgqVGO20G32e" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: left">Net sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="USD">9,945,325</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="USD">1,170,156</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CostOfGoodsAndServicesSold_iN_di_msCzViS_zmqeePramPu4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Cost of sales</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="USD">9,000,733</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" unitRef="USD">526,343</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40C_eus-gaap--GrossProfit_iT_mtCzViS_maCzRIp_zeVwAl7uI2Uj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" unitRef="USD">944,592</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" unitRef="USD">643,813</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OperatingExpensesAbstract_iB_z2AQ7RRP4Bib" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Operating expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--GeneralAndAdministrativeExpense_i01N_di_maCzQjX_zflheRqXAzT7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">General and administrative expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="USD">10,419,684</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="USD">1,325,696</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--OperatingExpenses_iNT_di_mtCzQjX_msCzRIp_zXlbZRPvFtn9" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" unitRef="USD">10,419,684</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" unitRef="USD">1,325,696</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--OperatingIncomeLoss_iT_mtCzRIp_maCzZGI_zmphAQge6RRb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Loss from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" unitRef="USD">9,475,092</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" sign="-" unitRef="USD">681,883</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--NonoperatingIncomeExpense_maCzZGI_zX2tNwdZGXXh" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other income (expense)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" sign="-" unitRef="USD">4,055</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" unitRef="USD">36</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzZGI_maCzTbe_zPed45vyz7G9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Loss before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" sign="-" unitRef="USD">9,479,147</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" sign="-" unitRef="USD">681,847</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzTbe_zhjI7mtm4oCd" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Income tax benefit</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="USD">139,932</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" sign="-" unitRef="USD">42,777</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProfitLoss_iT_mtCzTbe_maCzG5s_z14SUeZqDoea" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">639,070</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_d0_msCzG5s_zazj0oHpqcV3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: Net loss attributable to non-controlling interests</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" sign="-" unitRef="USD">6,705</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--NetIncomeLoss_iT_mtCzG5s_zyCEnInjRZRj" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss attributable to the company</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" sign="-" unitRef="USD">632,365</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eus-gaap--ComprehensiveIncomeNetOfTaxAbstract_iB_zh0O4PS4RQM6" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProfitLoss_maCzhmC_zTIesbLtz0kd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Net loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">639,070</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_maCzhmC_zk8pBlFlWffl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Foreign currency translation loss</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="USD">63,248</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="USD">31,081</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_iT_mtCzhmC_maCzEvB_ztk3j8QeUzOg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: left">Total comprehensive loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" unitRef="USD">9,555,831</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" sign="-" unitRef="USD">607,989</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_iN_di0_maCzEvB_zYklVh2XWXm" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Less: Net loss attributable to non-controlling interest</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">6,705</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--LessForeignCurrencyTranslationLossAttributableToNoncontrollingInterest_d0_maCzEvB_z6n7fXPtL5G5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Less: Foreign currency translation loss attributable to non-controlling interest</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="NCRA:LessForeignCurrencyTranslationLossAttributableToNoncontrollingInterest" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:LessForeignCurrencyTranslationLossAttributableToNoncontrollingInterest" sign="-" unitRef="USD">499</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--ComprehensiveIncomeNetOfTax_iT_mtCzEvB_zEqJZ3swJfcd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Comprehensive loss attributable to the Company</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" sign="-" unitRef="USD">9,555,831</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" sign="-" unitRef="USD">600,785</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_iB_z7RwG8NkWSel" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold">Loss per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasic_z61OequNyNT7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" unitRef="USDPShares">1.0500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" unitRef="USDPShares">0.0538</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--EarningsPerShareDiluted_zLujAY4Qiwh3" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="USDPShares">1.0500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareDiluted" sign="-" unitRef="USDPShares">0.0538</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_iB_zDZk9G2TgwMf" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold">Weighted average number of common shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zdpMTMXkn9oc" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="Shares">9,160,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="Shares">11,752,447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_zzsoLRXwH3j4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="Shares">9,160,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="Shares">11,752,447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <!-- Field: Page; Sequence: 57; Value: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a28"/>CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_300_114_zUtfBEdkVZpg" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z59anxzx1mTi" style="text-align: right"> </td><td style="text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--PreferredStockMember_zOVeu8xjz8Gj" style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_z3gWkYkfNF8l" style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--StatutoryAndOtherReservesMember_zwqB6aMFHFve" style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zvxLUTB4Fpd2" style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--AccumulatedOtherComprehensiveIncomeMember_zXwqcsg9zvWf" style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4B6_us-gaap--StatementEquityComponentsAxis_custom--TotalNoceraStockholdersEquityMember_zzOP6WqK9Cf5" style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4B5_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zsCitKAoLZ53" style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_4B9_zwF1ZKgggM2e" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Common Stock</td><td style="padding-bottom: 1pt"> </td> <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center">Preferred stock</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Additional<br/> Paid-in</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Statutory<br/> and <br/> other</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Retained</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated<br/> Other<br/> Comprehensive</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total <br/> Nocera Inc.’s<br/> Stockholders’<br/> Equity</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Non-<br/> controlling</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total<br/> Stockholders’<br/> Equity</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Stock</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Stock</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Capital</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Reserves</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Earnings</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Loss</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Deficit)</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Interests</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Deficit)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_439_c20200101__20201231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zqYAULeeFGJ7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 12%; text-indent: -5pt; padding-left: 5pt">Balance, January 1, 2020</td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z5XWG4g27A0f" style="width: 6%; text-align: right" title="Beginning balance, shares"><ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" unitRef="Shares">12,354,200</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">12,354</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_ze4YUe7H8Zg" style="width: 6%; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl0290">–</span></td><td style="width: 1%; font-weight: bold; text-align: left"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 6%; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0279">–</span></td><td style="width: 1%; font-weight: bold; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">271,915</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31_custom_StatutoryAndOtherReservesMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">191,219</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">339,203</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right">(<ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" unitRef="USD">81,350</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">733,341</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31_us-gaap_NoncontrollingInterestMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">29,072</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 6%; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">762,413</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--TerminationOfVieAgreementsWithGzwfh_zdEbQz8AdAhg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Termination of VIE agreements with GZWFH</td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--TerminationOfVieAgreementsWithGzwfhShares_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zBRvWa79YXT8" style="text-align: right" title="Termination of VIE agreements with GZWFH, shares">(<ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:TerminationOfVieAgreementsWithGzwfhShares" sign="-" unitRef="Shares">4,750,000</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:TerminationOfVieAgreementsWithGzwfh" sign="-" unitRef="USD">4,750</ix:nonFraction></td><td style="text-align: left">)</td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0293">–</span></td><td style="font-weight: bold; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0294">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0295">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0296">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0297">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:TerminationOfVieAgreementsWithGzwfh" sign="-" unitRef="USD">4,750</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:TerminationOfVieAgreementsWithGzwfh" sign="-" unitRef="USD">21,868</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:TerminationOfVieAgreementsWithGzwfh" sign="-" unitRef="USD">26,618</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Foreign currency translation adjustments</td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0304">–</span></td><td style="text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0305">–</span></td><td style="font-weight: bold; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0306">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0307">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0308">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD">31,580</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD">31,580</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" sign="-" unitRef="USD">499</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD">31,081</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -5pt; padding-left: 5pt">Issuance of new shares</td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z4rwAtapltV" style="text-align: right" title="Issuance of new shares, shares"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="Shares">1,527,586</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD">1,528</ix:nonFraction></td><td style="text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0315">–</span></td><td style="font-weight: bold; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD">2,154,472</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0317">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0318">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0319">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD">2,156,000</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0321">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="USD">2,156,000</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_i_pp0p0" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Share-based compensation</td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0326">–</span></td><td style="text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0327">–</span></td><td style="font-weight: bold; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD">266,586</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0329">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0330">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0331">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD">266,586</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0333">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD">266,586</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProfitLoss_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -5pt; padding-left: 5pt">Net loss</td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0336">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">–</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0337">–</span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0338">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0339">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_RetainedEarningsMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">632,365</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0341">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">632,365</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_NoncontrollingInterestMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">6,705</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">639,070</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_434_c20210101__20211231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zuxTc6eHC3Gg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 2.5pt; text-indent: -5pt; padding-left: 5pt">Balance, December 31, 2020</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_983_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zLYbq8pVkUZ2" style="border-bottom: Black 2.5pt double; text-align: right" title="Beginning balance, shares"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" unitRef="Shares">9,131,786</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">9,132</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zVMBCZPE5gRa" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Beginning balance, shares"><span style="-sec-ix-hidden: xdx2ixbrl0358">–</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">–</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">2,692,973</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31_custom_StatutoryAndOtherReservesMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">191,219</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" unitRef="USD">293,162</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" unitRef="USD">49,770</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">2,550,392</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0353">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">2,550,392</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: right; text-indent: -5pt; padding-left: 5pt"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueOther_iP3us-gaap--SharesOutstanding_zZ5QjIJ4ysUe" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Common stock and warrant issuance</td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesOther_iP3us-gaap--StockIssuedDuringPeriodValueOther_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpDy4s5Kwilc" style="text-align: right" title="Common stock and warrant issuance, shares"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesOther" unitRef="Shares">48,000</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD">48</ix:nonFraction></td><td style="text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">–</td><td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0361">–</span></td><td style="font-weight: bold; text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD">2,832</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0363">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0364">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0365">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD">2,880</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0367">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueOther" unitRef="USD">2,880</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_iP3us-gaap--StockIssuedDuringPeriodSharesOther_zgp1Uk5B83K2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Preferred stock and warrant issuance</td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0372">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_iP3us-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z9j03UPPxPji" style="text-align: right" title="Preferred stock and warrant issuance, shares"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="Shares">80,000</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_PreferredStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD">80</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD">29,520</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0375">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD">29,600</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0379">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" unitRef="USD">29,600</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--ChangesInFairValueOfWarrantyLiabilities_iP3us-gaap--StockIssuedDuringPeriodSharesIssuedForServices_z0Y6paHIv3l6" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Changes in fair value of warranty liabilities</td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0384">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0385">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" sign="-" unitRef="USD">24,800</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0387">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0388">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" sign="-" unitRef="USD">24,800</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0391">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ChangesInFairValueOfWarrantyLiabilities" sign="-" unitRef="USD">24,800</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_ecustom--IssuanceOfNewSharesUponPrivatePlacement_iP3custom--ChangesInFairValueOfWarrantyLiabilities_znvNvzUgPkxe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Issuance of new shares upon private placement</td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--IssuanceOfNewSharesUponPrivatePlacementShares_iP3custom--IssuanceOfNewSharesUponPrivatePlacement_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2fQPqWNVszc" style="text-align: right" title="Issuance of new shares upon private placement, shares"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:IssuanceOfNewSharesUponPrivatePlacementShares" unitRef="Shares">836,000</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD">836</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0395">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD">2,089,164</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0397">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD">2,090,000</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0401">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:IssuanceOfNewSharesUponPrivatePlacement" unitRef="USD">2,090,000</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ConsultancyServicesSettledByEquities_iP3custom--IssuanceOfNewSharesUponPrivatePlacementShares_zWJrG2Qg879i" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Consultancy services settled by equities</td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--ConsultancyServicesSettledByEquitiesShares_iP3custom--ConsultancyServicesSettledByEquities_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXsPOzNeJxY1" style="text-align: right" title="Consultancy services settled by equities, shares"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:ConsultancyServicesSettledByEquitiesShares" unitRef="Shares">505,000</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD">505</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0407">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD">3,044,645</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0409">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0410">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0411">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD">3,045,150</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0413">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD">3,045,150</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_zQxVDINtuj0b" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Share-based compensation</td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensation_iP3us-gaap--StockIssuedDuringPeriodValueShareBasedCompensation_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyrTFqm4Lxxg" style="text-align: right" title="Share based compensation, shares"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" unitRef="Shares">86,364</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD">86</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0419">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD">6,638,371</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0421">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD">6,638,457</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0425">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="USD">6,638,457</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_z9ni8AgEmTei" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Foreign currency translation Adjustments</td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0430">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0431">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0432">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0434">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD">63,676</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD">63,676</ix:nonFraction></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0437">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" unitRef="USD">63,676</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DividendsPreferredStock_iNP3us-gaap--OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_di_zYJ575jXSrMi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -5pt; padding-left: 5pt">Preferred stock dividend</td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0440">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">–</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0441">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0442">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0443">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DividendsPreferredStock" unitRef="USD">6,312</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0445">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DividendsPreferredStock" unitRef="USD">6,312</ix:nonFraction></td><td style="text-align: left">)</td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0447">–</span></td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DividendsPreferredStock" unitRef="USD">6,312</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--ProfitLoss_zG2cLqFlseQi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt; text-indent: -5pt; padding-left: 5pt">Net loss</td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0450">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0451">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0452">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0453">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_RetainedEarningsMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0455">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-012021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0457">–</span></td><td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_433_c20210101__20211231_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_zXT8jV0cfXy5" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; text-indent: -5pt; padding-left: 5pt">Balance, December 31, 2021</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_98B_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztSWpsL6x4Pl" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" unitRef="Shares">10,607,150</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_CommonStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">10,607</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td id="xdx_986_eus-gaap--SharesOutstanding_iE_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zuMrw4sd0kGf" style="border-bottom: Black 2.5pt double; text-align: right" title="Ending balance, shares"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" unitRef="Shares">80,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_PreferredStockMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">80</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_AdditionalPaidInCapitalMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">14,472,705</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31_custom_StatutoryAndOtherReservesMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">191,219</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_RetainedEarningsMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" sign="-" unitRef="USD">9,918,553</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">13,906</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31_custom_TotalNoceraStockholdersEquityMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">4,769,964</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0467">–</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="USD">4,769,964</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"/> <!-- Field: Page; Sequence: 58; Value: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p> <span class="alphaminr_link" id="alphaminr_cash_flow"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="a29"/><b>CONSOLIDATED STATEMENTS OF CASH FLOWS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Stated in US Dollars)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <table cellpadding="0" cellspacing="0" id="xdx_304_112_zGg14c7R8U28" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49D_20210101__20211231_zRxMyjiy2QS5" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20200101__20201231_zyhd9FQX9eZ9" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31,<br/> 2021</b></p></td><td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center">$</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center">$<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zeZzKI6Q67t8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash flows from operating activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--ProfitLoss_i01_maCzuN0_zlOAv5OdD4fg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; width: 68%; text-align: left">Net loss</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" sign="-" unitRef="USD">639,070</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Adjustments to reconcile net loss to net cash provided by operating activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--Depreciation_i01_maCzuN0_zifTerC6ZaL1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Depreciation expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Depreciation" unitRef="USD">6,127</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Depreciation" unitRef="USD">74,958</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--AmortizationOfIntangibleAssets_i01_d0_maCzuN0_zGUGPacM1gwj" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt">Amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="USD">53,156</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ImpairmentOfGzwfh_i01_d0_maCzuN0_z5Qsp16ak9t9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt">Impairment of GZWFH</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="NCRA:ImpairmentOfGzwfh" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ImpairmentOfGzwfh" unitRef="USD">522,291</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--IncreaseDecreaseInDeferredIncomeTaxes_i01N_di_msCzuN0_zXWw9xy8R4A9" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Deferred income tax</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" sign="-" unitRef="USD">2,258</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" sign="-" unitRef="USD">73,150</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--ChangeInFairValueOfWarrantyLiabilities_i01_d0_maCzuN0_z4mCWae4eXFh" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Changes in fair value of warranty liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ChangeInFairValueOfWarrantyLiabilities" unitRef="USD">24,800</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="NCRA:ChangeInFairValueOfWarrantyLiabilities" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ConsultancyServicesSettledByEquities_i01_d0_maCzuN0_zxcq7knmeJrb" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Consultancy services settled by equities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD">3,045,150</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="NCRA:ConsultancyServicesSettledByEquities" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--ShareBasedCompensation_i01_maCzuN0_zOxSMR3cNtL9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Share-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" unitRef="USD">6,638,371</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" unitRef="USD">265,758</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_iB_zMm2ijQfmbVd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Changes in operating assets and liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCzuN0_z9V9MewwxHO9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Accounts receivable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="USD">252,338</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" sign="-" unitRef="USD">1,406,867</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCzuN0_zyINwuFVim9b" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt">Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" sign="-" unitRef="USD">278,100</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" sign="-" unitRef="USD">268,285</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--IncreaseDecreaseInDueToRelatedPartiesCurrent_i01_maCzuN0_zaoV9Dqy8EI9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Advance to suppliers</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" sign="-" unitRef="USD">40,563</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent" unitRef="USD">824</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_i01N_di_msCzuN0_zZHdopLjpWnl" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Prepaid expenses and other assets, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="USD">66,232</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" sign="-" unitRef="USD">61,987</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--IncreaseDecreaseInRetentionReceivables_i01N_di_msCzuN0_zpz2WZPvvXsd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Retention receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:IncreaseDecreaseInRetentionReceivables" sign="-" unitRef="USD">395,579</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:IncreaseDecreaseInRetentionReceivables" sign="-" unitRef="USD">24,894</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--IncreaseDecreaseInNotesPayableCurrent_i01_maCzuN0_z4Vf4d5LE1y" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Notes payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInNotesPayableCurrent" sign="-" unitRef="USD">99,106</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInNotesPayableCurrent" sign="-" unitRef="USD">10,180</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--IncreaseDecreaseInOtherAccountsPayable_i01_maCzuN0_zfGaGcdgyJpf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" unitRef="USD">10,092</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" sign="-" unitRef="USD">236,137</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_401_ecustom--IncreaseDecreaseInAdvanceFromCustomers_i01N_di0_msCzuN0_zDCp9X6AjSbi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Advance from customers</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="NCRA:IncreaseDecreaseInAdvanceFromCustomers" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:IncreaseDecreaseInAdvanceFromCustomers" unitRef="USD">395,751</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities_i01_maCzuN0_z92m4uSCX7ae" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Other payables and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" unitRef="USD">103,599</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" sign="-" unitRef="USD">299,345</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--IncreaseDecreaseInAccruedTaxesPayable_i01_maCzuN0_z0t0vmC5y0D7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Income tax payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" unitRef="USD">92,346</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" sign="-" unitRef="USD">629,676</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncreaseDecreaseInDeferredRevenue_i01_d0_maCzuN0_ziRFfv5WHpG1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; text-align: left">Deferred revenue</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInDeferredRevenue" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" sign="-" unitRef="USD">593,445</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingLeaseLiability_i01_d0_maCzuN0_zYSkRSCqTp7c" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 20pt; text-align: left">Operating lease liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" sign="-" unitRef="USD">8,563</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_406_ecustom--IncreaseDecreaseInAdvanceReceipt_i01N_di_msCzuN0_zmHugv6p0NT2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; padding-left: 20pt; text-align: left">Advance receipts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:IncreaseDecreaseInAdvanceReceipt" unitRef="USD">267,375</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:IncreaseDecreaseInAdvanceReceipt" unitRef="USD">69,827</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iT_mtCzuN0_maCCERCzujE_zqoIECdXoQMf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) operating activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="USD">251,729</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" sign="-" unitRef="USD">129,824</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zGDhbkcOPiC2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash flows from investing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--PaymentsToAcquireOilAndGasPropertyAndEquipment_i01N_di_msNCPBUzwxu_zpLQa4FLfi26" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Purchase of property and equipment</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment" unitRef="USD">25,067</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOilAndGasPropertyAndEquipment" unitRef="USD">57,153</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di0_msNCPBUzwxu_zE1nxwvzUdQ3" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Purchase of intangible assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireIntangibleAssets" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" unitRef="USD">25,360</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--GainLossOnDispositionOfGzWfh_i01N_di0_msNCPBUzwxu_zgrDImhEJOUi" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Disposal of GZ WFH</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="NCRA:GainLossOnDispositionOfGzWfh" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:GainLossOnDispositionOfGzWfh" unitRef="USD">4,099</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--CashAcquiredFromAcquisition_i01_d0_maNCPBUzwxu_zlQZXbZC2AD5" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Cash acquired from merger</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:CashAcquiredFromAcquisition" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashAcquiredFromAcquisition" unitRef="USD">857,555</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iT_mtNCPBUzwxu_maCCERCzujE_z6Aca08Xjlb9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Net cash (used in) provided by investing activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" sign="-" unitRef="USD">25,067</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="USD">770,943</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zPAtRihFcreb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Cash flows from financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_i01_maCz5HK_zqe4fgHPYHgc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Proceeds from related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" sign="-" unitRef="USD">718,341</ix:nonFraction></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" unitRef="USD">664,454</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--RepaymentsOfRelatedPartyDebt_i01N_di0_msCz5HK_zl1HlauvjB1l" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Repayment to related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:RepaymentsOfRelatedPartyDebt" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" unitRef="USD">402,531</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--ProceedsFromCommonStockAndWarrantIssuance_i01_d0_maCz5HK_zx4Xf6jbjndg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Proceeds from common stock and warrant issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ProceedsFromCommonStockAndWarrantIssuance" unitRef="USD">120,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="NCRA:ProceedsFromCommonStockAndWarrantIssuance" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants_i01_d0_maCz5HK_z4IXMnKN6cs8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left">Proceeds from preferred stock and warrant issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants" unitRef="USD">200,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--ProceedsFromIssuanceOfCommonStock_i01_d0_maCz5HK_zmxgKNpTSQe" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Proceeds from issuance of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="USD">2,090,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--RepaymentsOfSubordinatedShortTermDebt_i01N_di_msCz5HK_zwGZ70kHx7e1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Repayment of short-term bank loan</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSubordinatedShortTermDebt" unitRef="USD">487,826</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfSubordinatedShortTermDebt" unitRef="USD">44,444</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--NetCashProvidedByUsedInFinancingActivities_iT_mtCz5HK_maCCERCzujE_zDT7BESUDXhe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="USD">1,203,833</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="USD">217,479</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_maCCERCzujE_zZxmJXxoyzYk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt; text-align: left">Effect of exchange rate changes on cash and cash equivalents</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" sign="-" unitRef="USD">10,017</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="USD">136,394</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzujE_zvNlpbUsfXek" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Net increase in cash and cash equivalents</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="USD">1,420,478</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="USD">994,992</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iS_zsLUBLkjDrV3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Cash and cash equivalents at beginning of year</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="USD">1,023,531</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2019-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="USD">28,539</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iE_zfHRuB0hqkB4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Cash and cash equivalents at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="USD">2,444,009</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="USD">1,023,531</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--SupplementalCashFlowInformationAbstract_iB_zvdInBHzatLf" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Supplemental disclosures of cash flow information</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InterestPaidNet_i01_d0_zuiiEkfml3I7" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for interest expenses</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:InterestPaidNet" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:InterestPaidNet" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--IncomeTaxesPaidNet_i01_d0_zneuwsTYKEe7" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash paid for Income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:IncomeTaxesPaidNet" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:IncomeTaxesPaidNet" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">See notes to the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <!-- Field: Page; Sequence: 59; Value: 1 --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOCERA, INC.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="a30"/>NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_803_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zhUmCLTAp858" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_27" style="display:inline-block"/><b>Note 1     <span id="xdx_82C_zXIedRDNuFi4">PRINCIPAL ACTIVITIES AND ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements include the financial statements of Nocera, Inc. (“Nocera” or the “Company”) and its subsidiaries, Grand Smooth Inc. Limited (“GSI”) and Guizhou Grand Smooth Technology Ltd. (“GZ GST” or “WFOE”), and Xin Feng Construction Co., Ltd. (“XFC”) that is controlled through contractual arrangements. The Company, GSI, GZ GST and XFC are collectively referred to as the “Company”.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Nocera was incorporated in the State of Nevada on February 1, 2002 and is based in New Taipei City, Taiwan (R.O.C.). It did not engage in any operations and was dormant from its inception until its reverse merger of GSI on December 31, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Reverse merger</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 31, 2018, Nocera completed a reverse merger transaction (the “Transaction”) pursuant to an Agreement and Plan of Merger (the “Agreement”), with (i) GSI, (ii) GSI’s stockholders, Yin-Chieh Cheng and Zhang Bi, who together owned shares constituting 100% of the issued and outstanding ordinary shares of GSI (the “GSI Shares”) and (iii) GSI Acquisition Corp. Under the terms of the Agreement, the GSI Stockholders transferred to Nocera all of the GSI Shares in exchange for the issuance of 10,000,000 shares (the “Shares”) of Nocera’s common stock (the “Share Exchange”). As a result of the reverse merger, GSI became Nocera’s wholly-owned subsidiary and Yin-Chieh Cheng and Zhang Bi, the former stockholders of GSI, became Nocera’s controlling stockholders. The share exchange transaction with GSI was treated as a reverse merger, with GSI as the accounting acquirer and Nocera as the acquired party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GSI is a limited company established under the laws and regulations of Hong Kong on August 1, 2014, and is a holding company without any operation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GZ WFH was incorporated in Xingyi City, Guizhou Province, People’s Republic of China (PRC) on October 25, 2017, and is engaged in providing fish farming containers service, which integrates sales, installments, and maintenance of aquaculture equipment. The registered capital of GZ WFH is RMB$5,000,000 (equal to US$733,138).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 13, 2018, GSI incorporated GZ GST in PRC with registered capital of US$15,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Divestiture</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 21, 2020, the Company filed a Current Report on Form 8-K outlining the lack of communication that led to the termination by Nocera, Inc. of its relationship with Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited (“GZ WFH”) and its management, and termination of the Variable Interest Entity agreements between the parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subsequently on October 8, 2020, Zhang Bi and GZ WFH entered into a Settlement Agreement and Release with Nocera, Inc. wherein all claims as to GZ WFH’s debt (claim to shares in Nocera, Inc. or GZ GST) were compromised, settled, and otherwise resolved as to any and all claims or causes of action whatsoever against Nocera for any matter, action, or representation as to Nocera, and any debt to ownership of Nocera or GZ GST up to the date of the agreement. The consideration for the agreement was mutual waiver of any and all claims against each other and GZ GST, and GZ WFH (including Zhang Bi) waives any claims to Nocera stock, meaning the 4,750,000 shares of common stock of Nocera owned by Zhang Bi were cancelled as part of the agreement. The Settlement Agreement and Release is attached hereto as Exhibit 10.8.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">The VIE Agreements</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera and XFC, a domestic funded limited liability company registered in Taiwan (R.O.C), entered into a series of contractual agreements (“VIE Agreements”) whereby Nocera, Inc. agreed to provide technical consulting and related services to XFC. As a result, Nocera has been determined to be the primary beneficiary of XFC and XFC became a VIE (Variable Interest Entity) of Nocera.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_233_z5pIBwQp4Dh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_232_zd0cFKeFJ439" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_232_z62zOfuYvS1h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 60; Value: 1 --> <div id="xdx_233_z1Z7TRiT28Kf" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_233_zXPHvD5Zukl2" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_237_zkjPFEE54Wqi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, Nocera exchanged <span id="xdx_903_ecustom--SharesExchanged_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShareholdersMember_zotQNRbFXK4h" title="Shares exchanged"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_ShareholdersMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:SharesExchanged" unitRef="Shares">700,000</ix:nonFraction></span> shares of the Company’s restricted common stock to Shareholders of XFC in exchange for 100% controlling interest in XFC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The VIE structure was adopted mainly because we engage in business in an industry that prohibits foreign investment (e.g., construction) and of which requires special licenses in Taiwan. We are not currently planning to engage in business in mainland China or Hong Kong, and as a result, we are not currently required to obtain any special licenses in mainland China or Hong Kong. The Company has entered into the following contractual arrangements with a stockholders of XFC, that enable the Company to (1) have the power to direct the activities that most significantly affects the economic performance of XFC, and (2) receive the economic benefits of XFC that could be significant to XFC. The Company is fully and exclusively responsible for the management of XFC, assumes all of the risk of losses of XFC and has the exclusive right to exercise all voting rights of XFC’s stockholders. Therefore, in accordance with ASC 810 “Consolidation”, the Company is considered the primary beneficiary of XFC and has consolidated XFC’s assets, liabilities, results of operations, and cash flows in the accompanying consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(1) Voting Rights Proxy Agreement Power of Attorney.</i> Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao (Existing Stockholders) hereby irrevocably undertake that they authorize Nocera or the individual then designated by Nocera (“Attorney”) to exercise, on his behalf, the following rights available to them in their capacity as a stockholder of the XFC under the then effective articles of association of the XFC (collectively, “Powers”): (a) to propose the convening of, and attend, stockholders’ meetings in accordance with the articles of association of the XFC on behalf of the Existing Stockholder; (b) to exercise voting rights on behalf of the Existing Stockholder on all matters required to be deliberated and resolved by the stockholders’ meeting, including without limitation the appointment and election of the directors and other executives to be appointed and removed by the stockholders, of the XFC the sale or transfer of all or part of the equity held by stockholders in the XFC; (c) to exercise other stockholders’ voting rights under the articles of association of the XFC (including any other stockholders’ voting rights stipulated upon an amendment to such articles of association); (d) other voting rights that stockholders shall enjoy under the Taiwan (R.O.C.) laws, as amended, revised, supplemented and re-enacted, no matter whether they take effect before or after the conclusion of this Agreement. The Existing Stockholders shall not revoke the authorization and entrustment accorded to the Attorney other than in the case where Nocera gives the Existing Stockholders a written notice requesting the replacement of the Attorney, in which event the Existing Stockholders shall immediately appoint such other person as then designated by Nocera to exercise the foregoing Powers and such new authorization and entrustment shall supersede, immediately upon its grant, the original authorization, and entrustment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify; text-indent: -21pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(2) Exclusive Business Cooperation Agreement.</i> Nocera agrees to provide technical consulting and services including management consulting services, general and financial advisory service and various general and administrative service, for the specific content thereof (hereinafter referred to as the “Target Business”) to the XFC as the technical consulting and service provider of the XFC in accordance with the conditions set forth herein during the term of this Agreement. XFC agrees to accept the technical consulting and services provided by Nocera. XFC further agrees that, without the prior written consent of Nocera, during the term of this Agreement, it shall not accept any technical consulting and services identical or similar to Target Business that are provided by any third party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(3) Equity Pledge Agreement. </i>Under the Equity Interest Pledge Agreement between Nocera and Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao, the stockholder of XFC, stockholder pledged all of his equity interests in XFC to Nocera to guarantee the performance of XFC’s obligations under the Exclusive Business Cooperation Agreement. Under the terms of the agreement, in the event that XFC or stockholders breach their respective contractual obligations under the Exclusive Business Cooperation Agreement, Nocera, as pledge, will be entitled to certain rights, including, but not limited to, the right to collect dividends generated by the pledged equity interests. Zhang Bi also agreed that upon the occurrence of any event of default, as set forth in the Equity Interest Pledge Agreement, Nocera is entitled to claim indemnity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>(4) Exclusive Call Option Agreement. </i>XFC and its stockholders, Mr. Tsai, Wen-Chih, Ms. Tu, Hui-Min, Mr. Tsai, Chin-Yao, and Mr. Tsai, Chin-Chao, have entered into an Exclusive Call Option Agreement with Nocera. Under the Exclusive Call Option Agreement, the XFC stockholders irrevocably granted Nocera (or its designee) an exclusive option to purchase, to the extent permitted under Taiwan (R.O.C.) law, part or all of their equity interests in XFC. According to the Exclusive Call Option Agreement, the purchase price shall be the minimum price permitted by applicable Taiwan (R.O.C.) Law at the time when such share transfer occurs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SubstantialDoubtAboutGoingConcernTextBlock"><p id="xdx_80D_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zonIGsMjiAn" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span class="alphaminr_link" id="alphaminr_28" style="display:inline-block"/><b>Note 2      <span id="xdx_82D_zSqaRzKsQ0N6">GOING CONCERN</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company had net loss of $<span id="xdx_905_eus-gaap--IncomeLossFromContinuingOperations_pn3n3_dm_c20210101__20211231_zcgLum4edEdf" title="Net loss"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" unitRef="USD">9.6</ix:nonFraction></span> million for the year ended December 31, 2021, which raise substantial doubt as to the Company’s ability to continue as a going concern. Management believes that it has developed a liquidity plan, as summarized below, that, if executed successfully, would enable to meet presently anticipated cash needs for at least the next 12 months after the date that the financial statements are issued and it has prepared the consolidated financial statements on a going concern basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_23D_znuEe2xkx0Zj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_230_zWwtGMl8LScg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_236_zvIGt1lx1yVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 61; Value: 1 --> <div id="xdx_23C_zXFm1JEbSsfa" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_232_z5ZHZcrC3yR4" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23B_zI7xezeTIuZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company started its business operation in 2018 and is continuing to focus on its business development and ultimately to attain profitable operations. XFC, the Company’s VIE in Taiwan, continuously receives orders from its customers. The Company expects XFC to generate $5 million of revenue in the coming twelve months. Moreover, NTB, the Company’s Taiwan branch, will keep engaged in the fish brokerage business, which is expected to generate $5 million of revenue in the coming twelve months.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company obtained a financial support letter from Mr. Yin-Chieh Cheng, the chief executive officer, also the Chairman of the Board and a principal shareholder of the Company.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">However, the Company continues to have ongoing obligations and it expects that it will require additional capital in order to execute its longer-term business plan. If the Company encounters unforeseen circumstances that place constraints on its capital resources, management will be required to take various measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing the Company’s business development activities, suspending the pursuit of its business plan, controlling overhead expenses and seeking to further dispose of non-core assets. Management cannot provide any assurance that the Company will raise additional capital if needed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zn7ukpbCquOd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span class="alphaminr_link" id="alphaminr_29" style="display:inline-block"/><b>Note 3      <span id="xdx_823_zq2unI2CGTFa">SUMMARY OF SIGNIFICANT ACCOUNTING POLICY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84D_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_z7vgfAK4NHAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_861_zJK3InjiUxo">Change of Reporting Entity and Basis of Presentation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result of the Share Exchange on December 31, 2018, GSI became a wholly owned subsidiary of Nocera, Inc. The former GSI’s stockholders owned a majority of the common stock of the Company. The Transaction was regarded as a reverse merger whereby GSI was considered to be the accounting acquirer as its stockholders retained control of the Company after the Share Exchange, although Nocera, Inc. is the legal parent company. The Share Exchange was treated as a recapitalization of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a result, the assets and liabilities and the historical operations that will be reflected in the Nocera’s financial statements after consummation of the Transaction will be those of GSI and will be recorded at the historical cost basis of GSI. Nocera’s assets, liabilities and results of operations will be consolidated with the assets, liabilities and results of operations of GSI upon consummation of the Transaction. As such, GSI is the continuing entity for financial reporting purpose. In a reverse merger, the historical stockholder’s equity of the accounting acquirer prior to the merger is retroactively reclassified (a recapitalization) for the equivalent number of shares received in the merger after giving effect to any difference in par value of the registrant’s and the accounting acquirer’s stock by an offset in paid-in-capital. Therefore, the financial statements have been prepared as if GSI had always been the reporting company and then on the share exchange date, had changed its name and reorganized its capital stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The consolidated financial statements included the financial statements of all subsidiaries and the VIE of the Company. All transactions and balances between the Company and its subsidiary and VIE have been eliminated in consolidation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription"><p id="xdx_842_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zYxmLa6Y0VI8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_869_zY5CuFzUzRed">Reclassification</span> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior period amounts have been reclassified to conform with current year presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:UseOfEstimates"><p id="xdx_841_eus-gaap--UseOfEstimates_zFrmDsdyrqQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_867_zCgGL4qoNqV3">Use of Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, the allowance for doubtful receivables; the useful lives of property and equipment and intangible assets; impairment of long-lived assets; recoverability of the carrying amount of inventory; fair value of financial instruments; provisional amounts based on reasonable estimates for certain income tax effects of the Tax Act and the assessment of deferred tax assets or liabilities. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_23F_z30jsdOEdYlk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_232_zFEkY76J6Yf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23A_znlHuyKMTrbh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 62; Value: 1 --> <div id="xdx_23D_zcwdxAFKtkF2" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_236_zMYwfknbF1l5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23D_zfPhPTJfEbNc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zfJDHJ3Sn0y6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_864_zng1Hy5sQjXk">Concentrations of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of accounts receivable. The Company conducts credit evaluations of its customers and suppliers, and generally does not require collateral or other security from them. The Company evaluates its collection experience and long outstanding balances to determine the need for an allowance for doubtful accounts. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There was one customer who represented <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zenTm1S09Ip6" title="Concentration risk"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_OneCustomerMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">58.22</ix:nonFraction></span>% of the Company's total revenue during the years ended December 31, 2021. There were two customers who represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zJUVUsC4KZE4" title="Concentration risk"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember_custom_TwoCustomersMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">96.44</ix:nonFraction></span>% of the Company's total revenue during the years ended December 31, 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth a summary of single customers who represent 10% or more of the Company’s total accounts receivable, net:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_zuNfOiei4cm2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Concentrations)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B1_zZE5GZbS60bd" style="display: none">Concentrations of credit risk</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s accounts receivable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zLEt0PnvmSoi" title="Concentration percentage"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">16.37</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerAMember_zAiLxdeZWNYj" title="Concentration percentage"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerAMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">26.33</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_z9JxVXMmXEt9" title="Concentration percentage"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">59.53</ix:nonFraction></span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerBMember_zo5fkrtrYZUc" title="Concentration percentage"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerBMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">73.67</ix:nonFraction></span>%</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Customer C</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_zAercTJXXuxk" title="Concentration percentage"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">16.30</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp0_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerCMember_z3ebNQvDNuu1" title="Concentration percentage"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_CustomerCMember" decimals="INF" format="ixt:zerodash" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_zRAClf1l4zc2" title="Concentration percentage"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">92.20</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllCustomersMember_znTTTnBWCj7h" title="Concentration percentage"><ix:nonFraction contextRef="From2020-01-012020-12-31_us-gaap_AccountsReceivableMember_us-gaap_CustomerConcentrationRiskMember_custom_AllCustomersMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">100.00</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table sets forth a summary of single suppliers who represent 10% or more of the Company’s total purchase:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Percentage of the Company’s purchase</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify">Supplier A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zOhvlFfuIRb2" title="Concentration percentage"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierAMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">48.76</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierAMember_zjW3P9UbohRk"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierAMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Supplier B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zBbEuUheBzgk"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierBMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">15.14</ix:nonFraction></span>%</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp0_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierBMember_zU2CcAw2RD64"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierBMember" decimals="INF" format="ixt:zerodash" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Supplier C</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zYc3IDjTK4B4"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierCMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">14.26</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp0_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--SupplierCMember_zPrayZk2RLR5"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_SupplierCMember" decimals="INF" format="ixt:zerodash" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_zSWXTK631ktg"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_AllSuppliersMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">78.16</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchasesMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--ProductConcentrationRiskMember__srt--MajorCustomersAxis__custom--AllSuppliersMember_zlvPhPZnAaz8"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_PurchasesMember_us-gaap_ProductConcentrationRiskMember_custom_AllSuppliersMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A0_ztb2HZ99QMFe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock"><p id="xdx_84D_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zcsHxZcpsMs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_zhQJe0mzJ2k2">Fair Value Measurement</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company applies ASC Topic 820, Fair Value Measurements and Disclosures which defines fair value, establishes a framework for measuring fair value and expands financial statement disclosure requirements for fair value measurements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 defines fair value as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) on the measurement date in an orderly transaction between market participants in the principal or most advantageous market for the asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASC Topic 820 specifies a hierarchy of valuation techniques, which is based on whether the inputs into the valuation technique are observable or unobservable. The hierarchy is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value. Unobservable inputs are valuation technique inputs that reflect the Company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_23D_z5tdh3mVzH8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23F_zEbXfpyrgjO1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23B_zMPE0ubi6hej" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 63; Value: 1 --> <div id="xdx_230_zG5bVrEsfYh1" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_236_z9kDCZZW50ij" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_234_z9D07bHWlQS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management of the Company is responsible for determining the assets acquired, liabilities assumed and intangibles identified as of the acquisition date and considered a number of factors including valuations from an independent appraiser.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When available, the Company uses quoted market prices to determine the fair value of an asset or liability. If quoted market prices are not available, the Company measures fair value using valuation techniques that use, when possible, current market-based or independently sourced market parameters, such as interest rates and currency rates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, there are <span id="xdx_906_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_do_c20211231_zILo7DGOhm43" title="Assets at fair value"><span id="xdx_908_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_do_c20201231_z7StQOJ8AeK3" title="Assets at fair value"><span id="xdx_908_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_do_c20211231_znafLoyArJud" title="Liabilities at fair value"><span id="xdx_903_eus-gaap--LiabilitiesFairValueDisclosure_iI_pp0p0_do_c20201231_zjyLU0wOgz0b" title="Liabilities at fair value"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:AssetsFairValueDisclosure" scale="0" unitRef="USD"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:AssetsFairValueDisclosure" scale="0" unitRef="USD"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="USD"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> assets or liabilities that are measured and reported at fair value on a recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_840_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zeBqfqWn1Q6c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_868_zLqu7jqYLmmj">Cash and Cash Equivalents</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents include all cash on hand and cash in bank with no restrictions. The balance of cash as of December 31, 2021 and 2020 were $<span id="xdx_90A_eus-gaap--Cash_c20211231_pp0p0" title="Cash"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" unitRef="USD">2,444,009</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--Cash_c20201231_pp0p0" title="Cash"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="0" unitRef="USD">1,023,531</ix:nonFraction></span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ReceivablesPolicyTextBlock"><p id="xdx_84D_eus-gaap--ReceivablesPolicyTextBlock_zTsdjtjDAIt" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86C_zTkLhDCfZ777">Accounts Receivable, Net</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivable are stated at the original amount less an allowance for doubtful accounts, if any, based on a review of all outstanding amounts at period end. An allowance is also made when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. The Company analyzes the aging of the customer accounts, coverage of credit insurance, customer concentrations, customer credit-worthiness, historical and current economic trends and changes in its customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="NCRA:PrepaidExpensesAndOtherAssetsPolicyTextBlock"><p id="xdx_848_ecustom--PrepaidExpensesAndOtherAssetsPolicyTextBlock_z7tjAiNSSJrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_862_zSNQS6sF1gVk">Prepaid Expenses and Other Assets, Net</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prepaid expense and other assets, net consist of receivable from investment, prepaid rent and etc. Management reviews its receivable balance each reporting period to determine if an allowance for doubtful accounts is required. An allowance for doubtful account is recorded in the period in which loss is determined to be probable based on an assessment of specific evidence indicating doubtful collection, historical experience, account balance aging, and prevailing economic conditions. Bad debts are written off against the allowance after all collection efforts have ceased.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:InventoryPolicyTextBlock"><p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zrS1jyxHJVB9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86A_zI3Go6PgDa91">Inventories, net</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Inventories are stated at lower of cost or net realizable value. Cost is determined using the weighted average method. Inventories include raw materials, work in progress and finished goods. The variable production overhead is allocated to each unit of product on the basis of the actual use of the production facilities. The allocation of fixed production overhead to the costs of conversion is based on the normal capacity of the production facilities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Where there is evidence that the utility of inventories, in their disposal in the ordinary course of business, will be less than cost, whether due to physical deterioration, obsolescence, changes in price levels, or other causes, the inventories are written down to net realizable value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock"><p id="xdx_840_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zZI3Fb1axjda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_864_z7hGrsR8xQje">Property and Equipment, Net</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Property and equipment are stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Maintenance, repairs, and betterments, including replacement of minor items, are charged to expense; major additions to physical properties are capitalized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation of property and equipment is provided using the straight-line method over their estimated useful lives, which are shown as follows.</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="NCRA:PropertyAndEquipmentUsefulLivesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--PropertyAndEquipmentUsefulLivesTableTextBlock_zq5pIoOWUF13" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICY (Details - Property useful lives)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8BD_zLfF3WzBWZt4" style="display: none">Property and Equipment Useful Lives</span></td> <td> </td> <td style="text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful life</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 38%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td> <td style="width: 10%"> </td> <td style="width: 52%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Property useful lives"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_LeaseholdImprovementsMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">Shorter of the remaining lease terms and estimated useful lives</ix:nonNumeric></span></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and fixture</span></td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember" title="Property useful lives"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_FurnitureAndFixturesMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">5 years</ix:nonNumeric></span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equipment</span></td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember" title="Property useful lives"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_EquipmentMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">3 years</ix:nonNumeric></span></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vehicle</span></td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember" title="Property useful lives"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_VehiclesMember" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives">5 years</ix:nonNumeric></span></span></td></tr> </table> </ix:nonNumeric><p id="xdx_8A7_zoqtmQTx7ls" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_23E_zA0yPuVIb6zk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_237_zfP6K4M4LAOa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23C_zjoy1OBH7sc3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 64; Value: 1 --> <div id="xdx_230_z3rUo2Cvz6J" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_232_zggURZYM2g4c" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_238_z87QsO9Tgbzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon sale or disposal, the applicable amounts of asset cost and accumulated depreciation are removed from the accounts and the net amount less proceeds from disposal is charged or credited to income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy"><p id="xdx_849_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_z6ORzUxEZblg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86A_z5ZTYEK7Oc62">Goodwill and Intangible Assets</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize goodwill in accordance with ASC 350, <i>Intangibles—Goodwill and Other</i>. Goodwill is the excess of cost of an acquired entity over the amounts assigned to assets acquired and liabilities assumed in a business combination. Goodwill is not amortized. Goodwill is tested for impairment annually as of October 1st of each year, and is tested for impairment between annual tests if an event occurs or circumstances change that would indicate the carrying amount may be impaired. An impairment charge for goodwill is recognized only when the estimated fair value of a reporting unit, including goodwill, is less than its carrying amount.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We recognize intangibles assets in accordance with ASC 350, <i>Intangibles—Goodwill and Other</i>. Acquired intangible assets subject to amortization are stated at cost and are amortized using the straight-line method over the estimated useful lives of the assets. Intangible assets that are subject to amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable. Assets not subject to amortization are tested for impairment at least annually.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimates of fair value are based on the best information available as of the date of the assessment, which primarily incorporates management assumptions about expected future cash flows. Although these assets are not currently impaired, there can be <span id="xdx_901_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20210101__20211231_zIpZJzKEzp29" title="Goodwill impairment"><span id="xdx_900_eus-gaap--GoodwillImpairmentLoss_pp0p0_do_c20200101__20201231_zedKBwK3L6Q8" title="Goodwill impairment"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" unitRef="USD"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" unitRef="USD">no</ix:nonFraction></ix:nonFraction></span></span> assurance that future impairments will not occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock"><p id="xdx_848_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_z8ppabqXLjm" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86D_zwLyiZjEGvNb">Share-Based Compensation</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">We determine our share-based compensation in accordance with ASC 718, </span><i>Compensation—Stock Compensation </i><span style="background-color: white">(ASC 718), which requires the measurement and recognition of compensation expense for all share-based payment awards made to employees based on the grant date fair value of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Determining the appropriate fair value model and calculating the fair value of phantom award grants requires the input of subjective assumptions. We use the Black-Scholes pricing model to value our phantom awards. Share-based compensation expense is calculated using our best estimates, which involve inherent uncertainties and the application of management’s judgment. Significant estimates include our expected volatility. If different estimates and assumptions had been used, our phantom unit valuations could be significantly different and related share-based compensation expense may be materially impacted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Black-Scholes pricing model requires inputs such as the risk-free interest rate, expected term, expected volatility and expected dividend yield. We base the risk-free interest rate that we use in the Black-Scholes pricing model on zero coupon U.S. Treasury instruments with maturities similar to the expected term of the award being valued. The expected term of phantom awards is estimated from the vesting period of the award and represents the weighted average period that our phantom awards are expected to be outstanding. We estimated the volatility based on the historic volatility of our guideline companies, which we feel best represent our company. We have never paid and do not anticipate paying any cash dividends in the foreseeable future and, therefore, we use an expected dividend yield of zero in the pricing model. We account for forfeitures as they occur.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"><p id="xdx_840_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_z20u27mD9rag" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86F_zcJQ5NUP6Di">Impairment of Long-lived Assets</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may no longer be recoverable. When these events occur, the Company measures impairment by comparing the carrying value of the long-lived assets to the estimated undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the sum of the expected undiscounted cash flow is less than the carrying amount of the assets, the Company would recognize an impairment loss, which is the excess of carrying amount over the fair value of the assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock"><p id="xdx_841_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_ziis5z1PE3u7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_867_zJMlY9yFIhP3">Commitments and Contingencies</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the normal course of business, the Company is subject to contingencies, including legal proceedings and claims arising out of its business that relate to a wide range of matters, such as government investigations and tax matters. The Company recognizes a liability for such contingency if it determines it is probable that a loss has occurred and a reasonable estimate of the loss can be made. The Company may consider many factors in making these assessments including historical and the specific facts and circumstances of each matter.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <ix:exclude><p id="xdx_230_zLf3ByYmNrx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p></ix:exclude> <ix:exclude><p id="xdx_238_zpEpVS2Rr5cb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p></ix:exclude> <ix:exclude><p id="xdx_236_zjClRayAteti" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b/></p></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 65; Value: 1 --> <div id="xdx_23B_zhlHM83Ubtle" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_23C_zuV4lEvIEOAg" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23A_zvggYmofnGE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p></ix:exclude> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_843_eus-gaap--RevenueRecognitionPolicyTextBlock_zMob4PUvTRz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_zk2gVICPzj7i">Revenue Recognition</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has early adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606) and all subsequent ASUs that modified ASC 606 on January 1, 2017.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, the Company applies the following steps:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 28px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 1: Identify the contract (s) with a customer</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 28px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 2: Identify the performance obligations in the contract</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 28px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 3: Determine the transaction price</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 28px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 4: Allocate the transaction price to the performance obligation in the contract</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 28px"><span style="font-family: Symbol">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company considered revenue is recognized when (or as) the Company satisfies performance obligations by transferring a promised goods and provide maintenance service to a customer. Revenue is measured at the transaction price which is based on the amount of consideration that the Company expects to receive in exchange for transferring the promised goods and providing maintenance service to the customer. Contracts with customers are comprised of invoices and written contracts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have arrangements for returns from customers and does not have any future obligations directly or indirectly related to services resale by customers. The Company has no sales incentive programs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company provides goods, maintenance service warranties for the goods sold with a period varying from 18 months to 72 months, which majority are 18 months, and exclusive sales agency license to its customers. For performance obligation related to providing products, the Company expects to recognize the revenue according to the delivery of products. For performance obligation related to maintenance service warranties, the Company expects to recognize the revenue on a ratable basis using a time-based output method. The performance obligations are typically satisfied as services are rendered on a straight-line basis over the contract term, which is generally for 18 months as majority of the maintenance service warranties periods provided are 18 months. For performance obligation related to exclusive agency license, the Company recognizes the revenue ratably upon the satisfaction over the estimated economic life of the license.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have amounts of contract assets since revenue is recognized as control of goods is transferred. The contract liabilities consist of advance payments from customers and deferred revenue. Advance payments from customer are expected to be recognized as revenue within 12 months. Deferred revenue is expected to be recognized as revenue within 12 months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CostOfSalesPolicyTextBlock"><p id="xdx_842_eus-gaap--CostOfSalesPolicyTextBlock_zNjO7djih5Y1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_86E_zfxmt1I7blPi">Cost of Sales</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cost of sales consists primarily of material costs, labor costs, depreciation, and related expenses, which are directly attributable to the production of the product. Write-down of inventories to lower of cost or net realizable value is also recorded in cost of sales.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84C_eus-gaap--IncomeTaxPolicyTextBlock_zTYpY562gYEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_zblbX0wxJDbg">Income Taxes</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates, applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <ix:exclude><p id="xdx_233_zTqidqZr7yFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p></ix:exclude> <ix:exclude><p id="xdx_230_zxrzwsKm2pWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p></ix:exclude> <ix:exclude><p id="xdx_237_zThuzPOzZGMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p></ix:exclude> <ix:exclude><p id="xdx_23A_zzT9B0UoWf53" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i/></b></p></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 66; Value: 1 --> <div id="xdx_237_zygaYu4vRYJk" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_23B_zNUT4ftkAdGc" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LesseeLeasesPolicyTextBlock"><p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zbUqjfSzOv6g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_ztOppBawEfgd">Leases</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In February 2016, the FASB issued ASU 2016-12, Leases (ASC Topic 842), which amends the leases requirements in ASC Topic 840, Leases. Under the new lease accounting standard, a lessee will be required to recognize a right-of-use asset and lease liability for most leases on the balance sheet. The new standard also modifies the classification criteria and accounting for sales-type and direct financing leases, and enhances the disclosure requirements. Leases will continue to be classified as either finance or operating leases.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted ASC Topic 842 using the modified retrospective transition method effective January 1, 2019. There was no cumulative effect of initially applying ASC Topic 842 that required an adjustment to the opening retained earnings on the adoption date nor revision of the balances in comparative periods. As a result of the adoption, The Company recognized a lease liability and right-of-use asset for each of our existing lease arrangement. The adoption of the new lease standard does not have a material impact on our consolidated income statement or our consolidated statement of cash flow.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxUncertaintiesPolicy"><p id="xdx_845_eus-gaap--IncomeTaxUncertaintiesPolicy_zv4N5yXqoWyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_866_zud8hfsiCP6k">Uncertain Tax Positions</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Interest and penalties related to uncertain tax positions are recognized and recorded as necessary in the provision for income taxes. According to the PRC Tax Administration and Collection Law, the statute of limitations is three years if the underpayment of taxes is due to computational errors made by the taxpayer or the withholding agent. The statute of limitations is extended to five years under special circumstances, where the underpayment of taxes is more than RMB 100,000. In the case of transfer pricing issues, the statute of limitation is ten years. There is no statute of limitation in the case of tax evasion. The Company records interest and penalties on uncertain tax provisions as income tax expense. There are no uncertain tax positions as of December 31, 2021 and 2020, and the Company has no accrued interest or penalties related to uncertain tax positions. The company does not believe that the unrecognized tax benefits will change over the next twelve months.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock"><p id="xdx_84A_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z8cZL2qvNMEa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86F_zifGtFLOZia4">Comprehensive (Loss) Income</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Comprehensive income or loss is comprised of the Company’s net (loss) income and other comprehensive income or loss. The component of other comprehensive income or loss consists solely of foreign currency translation adjustments, net of the income tax effect.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"><p id="xdx_844_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zwGozg2iSZle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_86C_zn3acDV819zb">Foreign Currency Translation and Transactions</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s reporting currency is the U.S. dollar (“US$”). The functional currency of the Company’s subsidiary and the consolidated VIE is RMB. In the consolidated financial statements, the financial information of the Company’s subsidiary and the consolidated VIE has been translated into US$. Assets and liabilities are translated at the exchange rates on the balance sheet date, equity amounts are translated at historical exchange rates, except for changes in accumulated deficit during the year which is the result of income statement translation process, and revenue, expense, gains or losses are translated using the average exchange rate during the year. Translation adjustments are reported as foreign currency translation adjustments and are shown as a separate component of other comprehensive income or loss in the consolidated statements of changes in equity and comprehensive (loss) income. The exchange rates as of December 31, 2021 and 2020 are <span id="xdx_908_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_uPure_c20211231_zzsiw9ZPPGU1" title="Exchange rates at end of period"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyExchangeRateTranslation1" unitRef="Pure">6.4854</ix:nonFraction></span> and <span id="xdx_90E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_uPure_c20201231_zTA9AEM4Mzqa" title="Exchange rates at end of period"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyExchangeRateTranslation1" unitRef="Pure">6.5249</ix:nonFraction></span>, respectively. The annual average exchange rates for the year ended December 31, 2021 and 2020 are <span id="xdx_901_ecustom--ForeignCurrencyExchangeRateTranslation2_uPure_c20210101__20211231_zV3jkDjNDeFg" title="Annual average exchange rates"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="NCRA:ForeignCurrencyExchangeRateTranslation2" unitRef="Pure">6.3700</ix:nonFraction></span> and <span id="xdx_906_ecustom--ForeignCurrencyExchangeRateTranslation2_uPure_c20200101__20201231_zNLv4wRO5q1k" title="Annual average exchange rates"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="NCRA:ForeignCurrencyExchangeRateTranslation2" unitRef="Pure">6.8996</ix:nonFraction></span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84E_eus-gaap--EarningsPerSharePolicyTextBlock_ztz8ahT1WSlb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="xdx_863_zK3UAhTp204a">(Loss) Earnings per Share</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic (loss) earnings per share is computed by dividing net (loss) income attributable to holders of common stock by the weighted average number of common shares outstanding during the year. Diluted earnings per share reflect the potential dilution that could occur if securities or other contracts to issue common shares were exercised or converted into common shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <ix:exclude><p id="xdx_23C_zF9gHx3pnzS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p></ix:exclude> <ix:exclude><p id="xdx_23D_zkwpWY02vkze" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p></ix:exclude> <ix:exclude><p id="xdx_23D_zd1p7enRU1nd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 67; Value: 1 --> <div id="xdx_23F_z5EtTsZdRO3c" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_232_zuCi2KvxGsse" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_232_zDcjBxcsSF6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p></ix:exclude> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zzcspamv4HRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline"><span id="xdx_861_z4QQQQBNq2rc">Recent Accounting Pronouncements</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration: underline">Recently Adopted Accounting Standards</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Adoption of ASC Topic 606, “Revenue from Contracts with Customers</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASU 2018-13. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement”. The amendments in this update is to improve the effectiveness of disclosures in the notes to the financial statements by facilitating clear communication of the information required by GAAP that is most important to users of each entity’s financial statements. The amendments in this update apply to all entities that are required, under existing GAAP, to make disclosures about recurring or nonrecurring fair value measurements. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. There was no impact of the standard on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline">Accounting Pronouncements Issued But Not Yet Adopted</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ASU 2019-12. On December 18, 2019, the FASB issued ASU No. 2019-12, Income taxes (Topic 740), Simplifying the Accounting for Income Taxes. This guidance amends ASC Topic 740 and addresses several aspects including 1) evaluation of step-up tax basis of goodwill when there is not a business combination, 2) policy election to not allocate consolidated taxes on a separate entity basis to entities not subject to income tax, 3) accounting for tax law changes or rates during interim periods, 4) ownership changes from equity method investment to subsidiary or vice versa, 5) elimination of exception to intraperiod allocation when there is gain in discontinued operations and a loss from continuing operations, 6) treatment of franchise taxes that are partially based on income. The guidance is effective for calendar year-end public entities on January 1, 2021 and other entities on January 1, 2022. The Company is evaluating the impact of this guidance on its consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not believe other recently issued but not yet effective accounting standards, if currently adopted, would have a material effect on the consolidated financial position, statements of operations and cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> </ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:AccountsAndNontradeReceivableTextBlock"><p id="xdx_806_eus-gaap--AccountsAndNontradeReceivableTextBlock_z24m6hFv3Dab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_30" style="display:inline-block"/><b>Note 4     <span id="xdx_826_zmi72v9ks9u">ACCOUNTS RECEIVABLE, NET</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, accounts receivable consisted of the following:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zVoy3ILolCd5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, NET (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span id="xdx_8B4_zYAAyFlUAadb" style="display: none">Schedule of accounts receivable</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_499_20211231_z6yjSD7eqYr8" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_494_20201231_zrRQP27h25ji" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_pp0p0_maARNCzdLd_z36xZcKGO5Wg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Accounts receivable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGross" scale="0" unitRef="USD">699,555</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGross" scale="0" unitRef="USD">432,309</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_d0_msARNCzdLd_zZgBdkJ1G2Ca" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AccountsReceivableNetCurrent_iI_pp0p0_mtARNCzdLd_zww2tZG0FoE1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" unitRef="USD">699,555</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="0" unitRef="USD">432,309</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and 2020, the Company has recorded provision for doubtful accounts of <span id="xdx_903_eus-gaap--ProvisionForDoubtfulAccounts_c20210101__20211231_pp0p0" style="display: none" title="Provision for doubtful accounts"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="0" unitRef="USD">0</ix:nonFraction></span> nil and <span id="xdx_905_eus-gaap--ProvisionForDoubtfulAccounts_c20200101__20201231_pp0p0" style="display: none" title="Provision for doubtful accounts"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="0" unitRef="USD">0</ix:nonFraction></span> nil, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_zYzSEgGbSsXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_31" style="display:inline-block"/><b>Note 5     <span id="xdx_827_zc0HzX3oCQ5c">INVENTORIES, NET</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, inventories consisted of the following:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zgFQMXTy8FWk" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"><span id="xdx_8BA_zPwIhfiGf212" style="display: none">Schedule of inventory</span></td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49E_20211231_zdGMuUJQbgk2" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="text-align: left"> </td><td id="xdx_49D_20201231_z2zLdCDWlHIb" style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_401_eus-gaap--InventoryRawMaterialsNetOfReserves_iI_pp0p0_maINz9My_zTGiN0EdtSld" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Raw materials</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" unitRef="USD">97,163</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="0" unitRef="USD">115,373</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryWorkInProcessAndRawMaterialsNetOfReserves_iI_pp0p0_maINz9My_z2M21wtGmxZi" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Work in process</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves" scale="0" unitRef="USD">1,391,518</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessAndRawMaterialsNetOfReserves" scale="0" unitRef="USD">1,608,301</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--InventoryNet_iTI_pp0p0_mtINz9My_zYT7tQZN9wp5" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="0" unitRef="USD">1,488,681</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="0" unitRef="USD">1,723,674</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <ix:exclude><p id="xdx_235_z2uz1qa3qr73" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p></ix:exclude> <ix:exclude><p id="xdx_23E_zGpzyIm6lHj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p></ix:exclude> <ix:exclude><p id="xdx_238_zMziN3Ws5b79" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b/></p></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 68; Value: 1 --> <div id="xdx_23F_znKpZIUr4YU5" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_235_zOzDLTlpcLG2" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23A_zW4CFxihSO9f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The inventory write downs were $nil <span id="xdx_90B_eus-gaap--InventoryWriteDown_c20210101__20211231_pp0p0" style="display: none" title="Inventory write down"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="0" unitRef="USD">0</ix:nonFraction></span> and $nil <span id="xdx_905_eus-gaap--InventoryWriteDown_c20200101__20201231_pp0p0" style="display: none" title="Inventory write down"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="0" unitRef="USD">0</ix:nonFraction></span> for the years ended December 31, 2021 and December 31, 2020, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="NCRA:AdvanceToSuppliersTextBlock"><p id="xdx_80F_ecustom--AdvanceToSuppliersTextBlock_zZrWpCdmrII4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_32" style="display:inline-block"/><b>Note 6     <span id="xdx_827_zeXppLffQWNi">ADVANCE TO SUPPLIERS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Balances of advances to suppliers were $<span id="xdx_907_eus-gaap--AccountsAndOtherReceivablesNetCurrent_c20211231_pp0p0" title="Advances to suppliers"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="0" unitRef="USD">42,969</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--AccountsAndOtherReceivablesNetCurrent_c20201231_pp0p0" title="Advances to suppliers"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccountsAndOtherReceivablesNetCurrent" scale="0" unitRef="USD">1,732</ix:nonFraction></span> as of December 31, 2021 and 2020, respectively, which represented prepayments to suppliers for raw materials.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:OtherCurrentAssetsTextBlock"><p id="xdx_80A_eus-gaap--OtherCurrentAssetsTextBlock_zOu3s1lwTvx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_33" style="display:inline-block"/><b>Note 7     <span id="xdx_826_zVe1oulOnEub">PREPAID EXPENSES AND OTHER ASSETS, NET</span></b></p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_zgcDnCdcyNT3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PREPAID EXPENSES AND OTHER ASSETS, NET (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BE_zNTiHQfV3Jrg" style="display: none">Schedule of prepaid expenses and other assets</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Other receivables from third party</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--PrepaidExpenseAndOtherAssets_c20211231__us-gaap--BalanceSheetLocationAxis__custom--OtherReceivablesMember_pp0p0" style="width: 13%; text-align: right" title="Prepaid expenses, gross"><ix:nonFraction contextRef="AsOf2021-12-31_custom_OtherReceivablesMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">107,444</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--PrepaidExpenseAndOtherAssets_c20201231__us-gaap--BalanceSheetLocationAxis__custom--OtherReceivablesMember_pp0p0" style="width: 13%; text-align: right" title="Prepaid expenses, gross"><ix:nonFraction contextRef="AsOf2020-12-31_custom_OtherReceivablesMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">3,161</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--PrepaidExpenseAndOtherAssets_iI_pp0p0_d0_c20211231__us-gaap--BalanceSheetLocationAxis__custom--OtherPrepaidsMember_z4e5vHTYobV1" style="border-bottom: Black 1pt solid; text-align: right" title="Prepaid expenses, gross"><ix:nonFraction contextRef="AsOf2021-12-31_custom_OtherPrepaidsMember" decimals="0" format="ixt:zerodash" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--PrepaidExpenseAndOtherAssets_iI_pp0p0_d0_c20201231__us-gaap--BalanceSheetLocationAxis__custom--OtherPrepaidsMember_z0PM02i1S8Wf" style="border-bottom: Black 1pt solid; text-align: right" title="Prepaid expenses, gross"><ix:nonFraction contextRef="AsOf2020-12-31_custom_OtherPrepaidsMember" decimals="0" format="ixt:zerodash" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--PrepaidExpenseAndOtherAssets_c20211231_pp0p0" style="text-align: right" title="Prepaid expenses, gross"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">107,444</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--PrepaidExpenseAndOtherAssets_c20201231_pp0p0" style="text-align: right" title="Prepaid expenses, gross"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">3,161</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: Allowance for doubtful accounts</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--AllowanceForDoubtfulOtherReceivablesCurrent_iI_pp0p0_d0_c20211231_z6pVCRDeqWxj" style="border-bottom: Black 1pt solid; text-align: right" title="Allowance for doubtful accounts"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--AllowanceForDoubtfulOtherReceivablesCurrent_iI_pp0p0_d0_c20201231_zz1kHjRxr3v2" style="border-bottom: Black 1pt solid; text-align: right" title="Allowance for doubtful accounts"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:AllowanceForDoubtfulOtherReceivablesCurrent" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Prepaid expenses and other assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="USD">107,444</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Prepaid expenses"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="0" unitRef="USD">3,161</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock"><p id="xdx_809_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zvTTIFz6iqt6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_34" style="display:inline-block"/><b>Note 8     <span id="xdx_82F_zVz3j6URT5me">PROPERTY AND EQUIPMENT, NET</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and December 31, 2020, property and equipment consisted of the following:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--PropertyPlantAndEquipmentTextBlock_z98jNTrNtYwd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - PROPERTY AND EQUIPMENT, NET (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B6_zoDAHUIGmFch" style="display: none">Schedule of property and equipment</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Furniture and fixtures</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zZDr4zV65Pua" style="text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_FurnitureAndFixturesMember" decimals="0" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zLmBShkWqTdi" style="text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" decimals="0" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify">Equipment</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_EquipmentMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">78,802</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--EquipmentMember_pp0p0" style="width: 13%; text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_EquipmentMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">51,287</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Leasehold improvement</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zwH57G5Ojwr6" style="text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_LeaseholdImprovementsMember" decimals="0" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zr2QYlYAfNR6" style="text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" decimals="0" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Vehicle</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zVxn2XMrNLG9" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_VehiclesMember" decimals="0" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_d0_c20201231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zNvM9CZ2ljBg" style="border-bottom: Black 1pt solid; text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_VehiclesMember" decimals="0" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--PropertyPlantAndEquipmentGross_c20211231_pp0p0" style="text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">78,802</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_c20201231_pp0p0" style="text-align: right" title="Property and equipment, gross"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="0" unitRef="USD">51,287</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Less: Accumulated depreciation</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_zyim2e76CAE4" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(<ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="USD">7,557</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20201231_zZ3e0j96WNVj" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated depreciation">(<ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="0" unitRef="USD">361</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentNet_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="USD">71,245</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Property and equipment, net"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="0" unitRef="USD">50,926</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Depreciation expenses for the years ended December 31, 2021 and 2020 were $<span id="xdx_902_eus-gaap--Depreciation_c20210101__20211231_pp0p0" title="Depreciation expense"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="0" unitRef="USD">6,127</ix:nonFraction></span> and $<span id="xdx_900_eus-gaap--Depreciation_c20200101__20201231_pp0p0" title="Depreciation expense"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="0" unitRef="USD">74,958</ix:nonFraction></span>, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:GoodwillDisclosureTextBlock"><p id="xdx_80D_eus-gaap--GoodwillDisclosureTextBlock_zWXa1sOdJxSb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_35" style="display:inline-block"/><b>Note 9     <span id="xdx_828_zuihs4lBGwSg">Goodwill</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and December 31, 2020, goodwill consisted of the followings:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfGoodwillTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88E_eus-gaap--ScheduleOfGoodwillTextBlock_zlxoMglgxqaa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - GOODWILL (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B0_zq8STyQUc7H2" style="display: none"> Schedule of goodwill</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Goodwill - XFC</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--Goodwill_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill"><ix:nonFraction contextRef="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--Goodwill_c20201231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Goodwill"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20211231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zOYHUBDzerD1" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"><ix:nonFraction contextRef="AsOf2021-12-31_custom_XinFengConstructionCoLtdMember" decimals="0" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_d0_c20201231__dei--LegalEntityAxis__custom--XinFengConstructionCoLtdMember_zM1yc43s3U07" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember" decimals="0" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--Goodwill_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_985_eus-gaap--Goodwill_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Goodwill"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:GuaranteesTextBlock"><p id="xdx_80A_eus-gaap--GuaranteesTextBlock_zZZJ3TOZ5JM2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_36" style="display:inline-block"/><b>Note 10     <span id="xdx_82C_zcZVHxuLjKae">WARRANTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On April 1, 2021, the Company entered in a securities purchase agreement with certain investors for an aggregate of 80,000 shares of its preferred stock at a per share purchase price of $2.50. As part of the transaction, the investors received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the date of inception. The subscription was completed on August 10, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_23B_zOcXxs8E6uk7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_239_zBs3n87inNy" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23D_zPZxQxm5ZVGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 69; Value: 1 --> <div id="xdx_234_z9Rxhb187Ski" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_231_zI65DEdbQHS1" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23B_zSXlAbhaBhj9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">On September 27, 2021 the Company entered into another securities purchase agreement with the same investors, pursuant to which the Company issued in a registered direct offering, an aggregate of 48,000 shares of common stock of the Company at a per share purchase price of $2.50. In addition, the investors also received one Class C warrant and one Class D warrant for the subscription of each preferred share. The Class C warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $2.50 per share exercisable for 36 months from the date of inception. The Class D warrants consist of the right to purchase up to 80,000 shares of the Company’s common stock at an exercise price of $5.00 per share exercisable for 36 months from the </span>date of inception.</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_zVlD5HTJPXUj" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - WARRANT (Details - Assumptions used)"> <tr style="vertical-align: bottom; background-color: white"> <td colspan="6"><span id="xdx_8B7_zlf2vO7DKxve" style="display: none">Schedule Assumption used</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="6" style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Appraisal Date (Inception Date)</b></span></td> <td> </td> <td colspan="3" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>C Warrant<br/> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>D Warrant<br/> August 10, </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2021</b></p></td> <td> </td></tr> <tr> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>(Unaudited)</b></span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td colspan="4" style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>(Unaudited)</b></span></td> <td style="vertical-align: bottom"> </td> <td colspan="5"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="6"> </td> <td> </td> <td colspan="3" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td colspan="6"><span style="font-size: 10pt">Market price per share (USD/share)</span></td> <td> </td> <td> </td> <td colspan="2" id="xdx_983_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="text-align: right" title="Market price per share (USD/share)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-08-10_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharePrice" unitRef="USDPShares">1.47</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--SharePrice_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="text-align: right" title="Market price per share (USD/share)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-08-10_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharePrice" unitRef="USDPShares">0.66</ix:nonFraction></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="6"><span style="font-size: 10pt">Exercise price (USD/price)</span></td> <td> </td> <td> </td> <td colspan="2" id="xdx_98A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="text-align: right" title="Exercise price (USD/price)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-08-10_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">2.50</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98B_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="text-align: right" title="Exercise price (USD/price)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-08-10_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">5.00</ix:nonFraction></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td colspan="6"><span style="font-size: 10pt">Risk free rate</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><span style="font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_z2FPviF4hP15" title="Risk free rate"><ix:nonFraction contextRef="From2021-01-012021-08-10_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="Pure">0.14</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zhFuYmJ7NBE6" title="Risk free rate"><ix:nonFraction contextRef="From2021-01-012021-08-10_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="Pure">0.14</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="6"><span style="font-size: 10pt">Dividend yield</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><span style="font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zSTIFjXWRxrb" title="Dividend yield"><ix:nonFraction contextRef="From2021-01-012021-08-10_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zlSocMzA7e4e" title="Dividend yield"><ix:nonFraction contextRef="From2021-01-012021-08-10_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td colspan="6"><span style="font-size: 10pt">Expected term/ Contractual life (years)</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_zdz3Y5B4MNZ8" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-08-10_custom_CWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.39</ix:nonNumeric></span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_zNGJfNaOO6si" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-08-10_custom_DWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.39</ix:nonNumeric></span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="6"><span style="font-size: 10pt">Expected volatility</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--CWarrantMember_z8yONQIiFlNe" title="Expected volatility"><ix:nonFraction contextRef="From2021-01-012021-08-10_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="Pure">56.36</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210810__us-gaap--AwardTypeAxis__custom--DWarrantMember_z55Sv6A8dOYg" title="Expected volatility"><ix:nonFraction contextRef="From2021-01-012021-08-10_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="Pure">56.36</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 31%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 10%"> </td> <td style="width: 3%"> </td> <td style="width: 1%"> </td> <td style="width: 10%"> </td> <td style="width: 16%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 21%"> </td> <td style="width: 1%"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><b>Appraisal Date (Inception Date)</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>C Warrant<br/> September 27,<br/> 2021</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>D Warrant<br/> September 27,<br/> 2021</b></span></td> <td> </td></tr> <tr> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><b>(Unaudited)</b></span></td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom"> </td> <td colspan="2" style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td colspan="5"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="5"> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>$</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td colspan="5"><span style="font-size: 10pt">Market price per share (USD/share)</span></td> <td> </td> <td> </td> <td id="xdx_98A_eus-gaap--SharePrice_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="text-align: right" title="Market price per share (USD/share)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-09-27_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharePrice" unitRef="USDPShares">1.71</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_989_eus-gaap--SharePrice_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="text-align: right" title="Market price per share (USD/share)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-09-27_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharePrice" unitRef="USDPShares">0.73</ix:nonFraction></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="5"><span style="font-size: 10pt">Exercise price (USD/price)</span></td> <td> </td> <td> </td> <td id="xdx_982_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_pdd" style="text-align: right" title="Exercise price (USD/price)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-09-27_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">2.50</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_pdd" style="text-align: right" title="Exercise price (USD/price)"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-09-27_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">5.00</ix:nonFraction></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td colspan="5"><span style="font-size: 10pt">Risk free rate</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_z8iKDfzWcuN5" title="Risk free rate"><ix:nonFraction contextRef="From2021-01-012021-09-27_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="Pure">0.15</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zIEn0q36L1M8" title="Risk free rate"><ix:nonFraction contextRef="From2021-01-012021-09-27_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="Pure">0.15</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="5"><span style="font-size: 10pt">Dividend yield</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zlQTjvPsk4Ch" title="Dividend yield"><ix:nonFraction contextRef="From2021-01-012021-09-27_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_z7Q8Ab1vOGMj" title="Dividend yield"><ix:nonFraction contextRef="From2021-01-012021-09-27_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" unitRef="Pure">0.00</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td colspan="5"><span style="font-size: 10pt">Expected term/ Contractual life (years)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zyNDVTnU14z5" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-09-27_custom_CWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.26</ix:nonNumeric></span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zNUlwM81DTU9" title="Expected term/ Contractual life (years)"><ix:nonNumeric contextRef="From2021-01-012021-09-27_custom_DWarrantMember" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">1.26</ix:nonNumeric></span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="5"><span style="font-size: 10pt">Expected volatility</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--CWarrantMember_zxP2XptjQYK8" title="Expected volatility"><ix:nonFraction contextRef="From2021-01-012021-09-27_custom_CWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="Pure">52.93</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20210927__us-gaap--AwardTypeAxis__custom--DWarrantMember_zwueA11eMIad" title="Expected volatility"><ix:nonFraction contextRef="From2021-01-012021-09-27_custom_DWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="Pure">52.93</ix:nonFraction></span></span></td> <td><span style="font-size: 10pt">%</span></td></tr> <tr> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 34%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 4%"> </td> <td style="width: 2%"> </td> <td style="width: 25%"> </td> <td style="width: 2%"> </td> <td style="width: 2%"> </td> <td style="width: 2%"> </td> <td style="width: 23%"> </td> <td style="width: 2%"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8AA_zWPrpFgzFxU4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The following is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 3 inputs:</span></p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zLUS2L8qmqKh" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - WARRANT (Details - Warrant Liability)"> <tr style="vertical-align: bottom; background-color: white"> <td><span id="xdx_8B3_zpZvJsYwHqzf" style="display: none">Schedule of Warranty Liability</span></td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>December 31, <br/> 2021</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>December 31, <br/> 2020</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt">$</span></td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"><span style="font-size: 10pt">$</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Balance at the beginning of period</span></td> <td> </td> <td> </td> <td id="xdx_985_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_d0_c20210101__20211231_zuT7RrlqB8Uh" style="text-align: right" title="Balance at the beginning of period"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="0" unitRef="USD">–</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_983_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_d0_c20200101__20201231_zHRaMBbZfMC2" style="text-align: right" title="Balance at the beginning of period"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2019-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="0" unitRef="USD">–</ix:nonFraction></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 68%"><span style="font-size: 10pt">Warrants issued to investors</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_985_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_c20210101__20211231_pp0p0" style="width: 13%; text-align: right" title="Warrants issued to investors"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="0" unitRef="USD">287,520</ix:nonFraction></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_984_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_d0_c20200101__20201231_z6T3s1WzVEXi" style="width: 13%; text-align: right" title="Warrants issued to investors"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="0" unitRef="USD">–</ix:nonFraction></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Warrants redeemed</span></td> <td> </td> <td> </td> <td id="xdx_98B_ecustom--WarrantsRedeemed_pp0p0_d0_c20210101__20211231_zf0mmU0BCtoj" style="text-align: right" title="Warrants redeemed"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="NCRA:WarrantsRedeemed" scale="0" unitRef="USD">–</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_986_ecustom--WarrantsRedeemed_pp0p0_d0_c20200101__20201231_zjXH7GElKd6b" style="text-align: right" title="Warrants redeemed"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="NCRA:WarrantsRedeemed" scale="0" unitRef="USD">–</ix:nonFraction></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Fair value change of warrants included in earnings</span></td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_988_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_c20210101__20211231_pp0p0" style="border-bottom: black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease" scale="0" unitRef="USD">24,800</ix:nonFraction></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1pt solid"> </td> <td id="xdx_98B_eus-gaap--ProductWarrantyAccrualPeriodIncreaseDecrease_pp0p0_d0_c20200101__20201231_zgC5mANE768d" style="border-bottom: black 1pt solid; text-align: right" title="Fair value change of warrants included in earnings"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualPeriodIncreaseDecrease" scale="0" unitRef="USD">–</ix:nonFraction></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt"><b>Total</b></span></td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98E_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zOIIUepUXml1" style="border-bottom: black 2.25pt double; text-align: right" title="Balance at the end of period"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="0" unitRef="USD">312,320</ix:nonFraction></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_989_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_d0_c20200101__20201231_zefkarI8U5Da" style="border-bottom: black 2.25pt double; text-align: right" title="Balance at the end of period"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="0" unitRef="USD">–</ix:nonFraction></span></td> <td> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A7_zb7LgkqGvkAc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The following is a summary of the warrant activity:</span></p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfNoncashOrPartNoncashAcquisitionsTextBlock_zsMUvaPLmgma" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - WARRANT (Details - Warrant Activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BA_ziSVWvDw2aki" style="display: none"> Schedule of warrant activity</span></td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Warrants</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise Price</b></p></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Remaining</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Contractual</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Term in</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Years</b></p></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Outstanding at January 1, 2021</span></td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z9E35xgyr1U4" style="text-align: right" title="Warrants outstanding, beginning balance"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:zerodash" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="Shares">–</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zEluhFIJ2US" style="text-align: right" title="Average exercise price, outstanding beginning"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0967">–</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Exercisable at January 1, 2021</span></td> <td> </td> <td> </td> <td id="xdx_98A_ecustom--WarrantsExercisable_iS_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z5yc4lTwVew1" style="text-align: right" title="Warrants exercisable beginning"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2020-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:zerodash" name="NCRA:WarrantsExercisable" unitRef="Shares">–</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98E_ecustom--AverageExercisePriceExerciasable_iS_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zskQZGeFH7Fh" style="text-align: right" title="Average exercise price, exerciasable beginning"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0971">–</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 52%"><span style="font-size: 10pt">Granted</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd" style="width: 13%; text-align: right" title="Warrants Granted"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="Shares">256,000</ix:nonFraction></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td id="xdx_983_ecustom--AverageExercisePriceGranted_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd" style="width: 13%; text-align: right" title="Average exercise price, granted"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:AverageExercisePriceGranted" unitRef="USDPShares">3.75</ix:nonFraction></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: right"><span style="font-size: 10pt"><span id="xdx_909_ecustom--WeightedAverageRemainingContractualTermGranted_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zgqGKhHwgNH1" title="Weighted Average Remaining Contractual Term, granted"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="NCRA:WeightedAverageRemainingContractualTermGranted">3.00</ix:nonNumeric></span></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Exercised / surrendered</span></td> <td> </td> <td> </td> <td id="xdx_98A_ecustom--WarrantsExercisedSurrendered_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zuhBhpHN36jd" style="text-align: right" title="Warrants Exercised / surrendered"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:zerodash" name="NCRA:WarrantsExercisedSurrendered" unitRef="Shares">–</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_988_ecustom--AverageExercisePriceExercisedSurrendered_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Average exercise price, exercised / surrendered"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0981">–</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Expired</span></td> <td> </td> <td> </td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_d0_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zt3TQbL1U714" style="text-align: right" title="Warrants expired"><span style="font-size: 10pt"><ix:nonFraction contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations" unitRef="Shares">–</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98B_ecustom--WarrantWeightedAverageExercisePriceExpired_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_pdd" style="text-align: right" title="Average exercise price, expired"><span style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0985">–</span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">–</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><span style="font-size: 10pt">Outstanding at December 31, 2021</span></td> <td> </td> <td> </td> <td id="xdx_981_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z0CMVMvlkCFf" style="text-align: right" title="Warrants outstanding, ending balance"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="Shares">256,000</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zmSWzn36ELt4" style="text-align: right" title="Average exercise price, outstanding ending"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">3.75</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_903_ecustom--WeightedAverageRemainingContractualTermOutsanding_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zjb6UuGLy57i" title="Weighted Average Remaining Contractual Term, outsanding"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="NCRA:WeightedAverageRemainingContractualTermOutsanding">2.66</ix:nonNumeric></span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><span style="font-size: 10pt">Exercisable at December 31, 2021</span></td> <td> </td> <td> </td> <td id="xdx_98E_ecustom--WarrantsExercisable_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_zZ36m38zumU8" style="text-align: right" title="Warrants exercisable at ending"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsExercisable" unitRef="Shares">256,000</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td id="xdx_981_ecustom--AverageExercisePriceExerciasable_iE_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_z2j1rnreMRF8" style="text-align: right" title="Average exercise price, exerciasable ending"><span style="font-size: 10pt"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_WarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:AverageExercisePriceExerciasable" unitRef="USDPShares">3.75</ix:nonFraction></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt"><span id="xdx_908_ecustom--WeightedAverageRemainingContractualTermExercisable_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--WarrantMember_znODF4mnqcLj" title="Weighted Average Remaining Contractual Term, exercisable"><ix:nonNumeric contextRef="From2021-01-012021-12-31_us-gaap_WarrantMember" format="ixt-sec:duryear" name="NCRA:WeightedAverageRemainingContractualTermExercisable">2.66</ix:nonNumeric></span></span></td> <td> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A5_zAApw6KdtGUe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_239_zwGpVKhdUQcf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23F_zljVwdWgDNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_239_zYs2s5zhLoS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 70; Value: 1 --> <div id="xdx_23F_zqvIT5bOHeTa" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_235_ztftRaE0D3A2" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23D_zJoVqVfLhF05" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LeasesOfLesseeDisclosureTextBlock"><p id="xdx_80C_eus-gaap--LeasesOfLesseeDisclosureTextBlock_zfUUMj5Uhnj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_37" style="display:inline-block"/><b>Note 11     <span id="xdx_825_zqsXaqNubDRk">LEASES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has two non-cancelable lease agreements for certain office and accommodation as well as fish farming containers for research and develop advanced technology for water circulation applying in fishery with original lease periods expiring between 2022 and 2023. The lease terms may include options to extend or terminate the lease when it is reasonably certain the Company will exercise that option. The Company recognizes rental expense on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The components of lease expenses for the year ended December 31, 2021 and December 31, 2020 were as follows:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:LeaseCostTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--LeaseCostTableTextBlock_zCt4gIy9al78" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - LEASES (Details - Lease costs)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8BC_zye9SsmS8ZN7" style="display: none">Components of lease expenses</span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Statement of Income Location</b></span></td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended December 31, 2021</b></span></td> <td> </td> <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For the year ended December 31, 2020</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td colspan="3"> </td> <td> </td> <td colspan="3"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td> </td> <td colspan="3" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Costs</b></span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 37%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating lease expense</span></td> <td style="width: 2%"> </td> <td style="width: 29%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General and administrative expenses</span></td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td> <td id="xdx_988_eus-gaap--OperatingLeaseExpense_c20210101__20211231_pp0p0" style="border-bottom: black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="0" unitRef="USD">4,424</ix:nonFraction></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="border-bottom: black 1pt solid; width: 1%"> </td> <td id="xdx_98D_eus-gaap--OperatingLeaseExpense_pp0p0_c20200101__20201231_zQD48WHSFHn1" style="border-bottom: black 1pt solid; width: 13%; text-align: right" title="Operating lease expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseExpense" scale="0" unitRef="USD">26,224</ix:nonFraction></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total net lease costs</span></td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_98B_eus-gaap--LeaseCost_c20210101__20211231_pp0p0" style="border-bottom: black 2.25pt double; text-align: right" title="Total net lease costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="0" unitRef="USD">4,424</ix:nonFraction></span></td> <td> </td> <td> </td> <td style="border-bottom: black 2.25pt double"> </td> <td id="xdx_980_eus-gaap--LeaseCost_pp0p0_c20200101__20201231_z2scel3p42ed" style="border-bottom: black 2.25pt double; text-align: right" title="Total net lease costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="0" unitRef="USD">26,224</ix:nonFraction></span></td> <td> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Maturity of lease liabilities under our non-cancelable operating leases as of December 31, 2021 and December 31, 2020 are US$ nil.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_80D_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z9YakujMcCR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_38" style="display:inline-block"/><b>Note 12     <span id="xdx_824_zaHlDghotLVj">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zWZsZ9byRA3i" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8BD_zYokgpG698V8" style="display: none">Schedule of payables</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20211231_zyvswY37iyf4" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20201231_zSnNOs7VyIC" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_40F_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pp0p0_maOAPAAznIt_zuakSywVoHud" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">VAT payable</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="USD">40,023</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:SalesAndExciseTaxPayableCurrent" scale="0" unitRef="USD">12,235</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--AccruedSalariesCurrent_iI_pp0p0_maOAPAAznIt_zVPEB1hCmjeg" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Salary payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="0" unitRef="USD">89,775</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="0" unitRef="USD">920</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maOAPAAznIt_zCOO52BNGuF8" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Others</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" unitRef="USD">12,628</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="0" unitRef="USD">43,681</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAznIt_zDGswG8hal5j" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="USD">142,426</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OtherAccountsPayableAndAccruedLiabilities" scale="0" unitRef="USD">56,836</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_808_eus-gaap--IncomeTaxDisclosureTextBlock_ztymaIm2SIt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_39" style="display:inline-block"/><b>Note 13     <span id="xdx_822_zpE5G9fd7oSd">TAXATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its subsidiary, and the consolidated VIE file tax returns separately.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1) Value-added tax (“VAT”)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Provisional Regulation of the PRC on VAT and the related implementing rules, all entities and individuals (“taxpayers”) that are engaged in the sale of products in the PRC are generally required to pay VAT, at a rate of which was changed from <span id="xdx_909_ecustom--ValueAddedTaxRate_iI_dp_c20201231_z46EhiDm9VPa" title="Value added tax rate"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="NCRA:ValueAddedTaxRate" scale="-2" unitRef="Pure">16</ix:nonFraction></span>% to <span id="xdx_901_ecustom--ValueAddedTaxRate_iI_dp_c20211231_zq8eVf9O18sd" title="Value added tax rate"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="NCRA:ValueAddedTaxRate" scale="-2" unitRef="Pure">13</ix:nonFraction></span>% on April 1, 2019 of the gross sales proceeds received, less any deductible VAT already paid or borne by the taxpayers. GZ WFH also subjected to 10% for the installment service provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Taiwan</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Value-added and Non-value-added Business Tax Act and the related implementing rules, all entities and individuals ("taxpayers") that are engaged in the sale of products in the Taiwan are generally required to pay VAT, at a rate of 5%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2) Income tax</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <ix:exclude><p id="xdx_235_zZJsv5kHPv4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p></ix:exclude> <ix:exclude><p id="xdx_235_zVyUROr22yh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p></ix:exclude> <ix:exclude><p id="xdx_231_zdiZ5wjtRMA5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 71; Value: 1 --> <div id="xdx_235_zcfFOd7GYjj7" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_239_zvUzmTkUuBIb" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23C_zmnFoUBsMZMa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">United States</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the Tax Cuts and Jobs Act (the “Tax Act”) was signed into legislation. The 2017 Tax Act significantly revises the U.S. corporate income tax by, among other things, lowering the statutory corporate tax rate from 34% to 21%, imposing a mandatory one-time tax on accumulated earnings of foreign subsidiaries, introducing new tax regimes, and changing how foreign earnings are subject to U.S. tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, Staff Accounting Bulletin No. 118 (“SAB 118”) was issued to provide guidance on accounting for the tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. The Company has completed the assessment of the income tax effect of the Tax Act and there were no adjustments recorded to the provisional amounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Coronavirus Aid, Relief and Economy Security (CARES) Act (the “CARES Act, H.R. 748”) was signed into law on 27 March 2020. The CARES Act temporarily eliminates the 80% taxable income limitation (as enacted under the Tax Cuts and Jobs Act of 2017) for NOL deductions for 2018-2020 tax years and reinstated NOL carrybacks for the 2018-2020 tax years. Moreover, the CARES Act also temporarily increases the business interest deduction limitations from 30% to 50% of adjusted taxable income for the 2019 and 2020 taxable year. Lastly, the Tax Act technical correction classifies qualified improvement property as 15-year recovery period, allowing the bonus depreciation deduction to be claimed for such property retroactively as if it was included in the Tax Act at the time of enactment. The Company does not anticipate a significant tax impact on its financial statements and will continue to examine the impact the CARES Act may have on its business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company evaluated the Global Intangible Low Taxed Income (“GILTI”) inclusion on current earnings and profits of greater than 10% owned foreign controlled corporations. The Company has evaluated whether it has additional provision amount resulted by the GILTI inclusion on current earnings and profits of its foreign controlled corporations. The law also provides that corporate taxpayers may benefit from a 50% reduction in the GILTI inclusion, which effectively reduces the <span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__country--US_zmwB0oVmQjvd" title="Effective income tax rate"><ix:nonFraction contextRef="From2021-01-012021-12-31_country_US" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="Pure">21</ix:nonFraction></span>% U.S. corporate tax rate on the foreign income to an effective rate of <span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20200101__20201231__us-gaap--IncomeTaxAuthorityAxis__country--US_zHT5IcHREQDc" title="Effective income tax rate"><ix:nonFraction contextRef="From2020-01-012020-12-31_country_US" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="Pure">10.5</ix:nonFraction></span>%. The GILTI inclusion further provides for a foreign tax credit in connection with the foreign taxes paid. In 2019, the Company recorded a GILTI inclusion of $<span id="xdx_903_ecustom--GlobalIntangibleLowTaxedIncome_c20210101__20211231_pp0p0" title="Global Intangible Low Taxed Income"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:GlobalIntangibleLowTaxedIncome" scale="0" unitRef="USD">152,829</ix:nonFraction></span>. The Company has elected to treat the financial statement impact of GILTI as current period expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reverse merger was completed on December 31, 2018 and the tax losses of US subsidiary was not in the scope as of December 31, 2018. As of December 31, 2019, net operating loss carried forward which was available to offset future taxable income for the Company in the United States was $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20181231__us-gaap--IncomeTaxAuthorityAxis__country--US_zMLF0FBFmAh" title="Net operating loss carryforwards"><ix:nonFraction contextRef="AsOf2018-12-31_country_US" decimals="0" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="0" unitRef="USD">99,817</ix:nonFraction></span>. There is a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Taiwan</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Company’s loss before income taxes is primarily derived from the operations in Taiwan and income tax expense is primarily incurred in Taiwan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">As a result of amendments to the “Taiwan Income Tax Act” enacted by the Office of the President of Taiwan on February 7, 2018, the statutory income tax rate increased from 17% to 20% and the undistributed earning tax, or a surtax, decreased from 10% to 5% effective from January 1, 2018. As a result, the statutory income tax rate in Taiwan is 20% for the years ended August 31, 2021 and 2020. An additional surtax, of which rate was reduced from 10% to 5% being applied to the Company starting from September 1, 2018, is assessed on undistributed income for the entities in Taiwan, but only to the extent such income is not distributed or set aside as a legal reserve before the end of the following year. The 5% surtax is recorded in the period the income is earned, and the reduction in the surtax liability is recognized in the period the distribution to stockholders or the setting aside of legal reserve is finalized in the following year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">Hong Kong</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The HK tax reform has introduced two-tiered profits tax rates for corporations. Under the two-tiered profits tax rates regime, the profits tax rate for the first HK$2 million (approximately $257,931) of assessable profits will be lowered to <span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__country--HK_z9D6SZEDc4bj" title="Effective income tax rate"><ix:nonFraction contextRef="From2021-01-012021-12-31_country_HK" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="Pure">8.25</ix:nonFraction></span>% (half of the rate specified in Schedule 8 to the Inland Revenue Ordinance (IRO)) for corporations. Assessable profits above HK$2 million (approximately $257,931) will continue to be subject to the rate of 16.5% for corporations. The Company assessed that the HK entity will not earn a profit greater than HK$2 million (approximately $257,931), it is subject to a corporate income tax rate of 8.25%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_231_zzpWOiVKMNM3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23B_z6evwmibqqHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_236_zXgXXVMX3oP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 72; Value: 1 --> <div id="xdx_23F_z3iPZb9rnpkc" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_235_zYLwGeUvj1Sg" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_23A_zFl6PrS8XkCc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, The Company’s subsidiary in Hong Kong had net operating loss carry forwards available to offset future taxable income. The net operating losses will be carryforward indefinitely under Hong Kong Profits Tax regulation. There is a full valuation allowance applied against these loss carry forward as management determined it was not more likely than not that these net operating losses would be utilized in the foreseeable future.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration: underline">PRC </span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WFOE and the consolidated VIE established in the PRC are subject to the PRC statutory income tax rate of <span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20210101__20211231__us-gaap--IncomeTaxAuthorityAxis__custom--PrcMember_zX7IAQH7Jnwh" title="Effective income tax rate"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_PrcMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" unitRef="Pure">25</ix:nonFraction></span>%, according to the PRC Enterprise Income Tax (“EIT”) law.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with the relevant tax laws and regulations of the PRC, a company registered in the PRC is subject to income taxes within the PRC at the applicable tax rate on taxable income. All the PRC subsidiaries were subject to income tax at a rate of 25% for the year ended December 31, 2021 and 2020. According to PRC tax regulations, the PRC net operating loss can generally carry forward for no longer than five years starting from the year subsequent to the year in which the loss was incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The components of the income tax (benefit) expense are:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z71iXE2meCg3" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Income tax expense)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B6_zhpZdZiKl3T9" style="display: none">Income tax components</span></td><td> </td> <td colspan="2" id="xdx_49A_20210101__20211231_z5H7RWWLkUd4" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" id="xdx_49B_20200101__20201231_zzWTKozeuVk" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_400_eus-gaap--CurrentIncomeTaxExpenseBenefit_d0_maITEBzes5_zM7MUFFd56c2" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Current</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="USD">139,932</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="USD">–</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredIncomeTaxExpenseBenefit_d0_maITEBzes5_zf1WWZtG1na4" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Deferred</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" sign="-" unitRef="USD">42,777</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzes5_zDwmAV7ztY36" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total income tax expense (benefit)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" unitRef="USD">139,932</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="0" sign="-" unitRef="USD">42,777</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> </ix:nonNumeric><p id="xdx_8AB_z10gZaqrQOSl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reconciliation of income taxes expenses computed at the TW statutory tax rate (2020: at PRC statutory tax rate) applicable to income tax expense is as follows:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zzAUyYPR0Y6a" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Reconcilation of income tax)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8BA_zGls2reKgdl6" style="display: none">Reconciliation of income tax expense</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Taiwan (2020 - PRC) income tax statutory rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20210101__20211231_zSj4p7VWLRvd" title="PRC income tax statutory rate"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" unitRef="Pure">20.00</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_dp_c20200101__20201231_zgol5G08oNb6" title="PRC income tax statutory rate"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" scale="-2" unitRef="Pure">25.00</ix:nonFraction></span>%</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of non-deductible expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp_c20210101__20211231_zpw5rq6nMrai" title="Tax effect of non-deductible expense"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" unitRef="Pure">6.78</ix:nonFraction></span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_dp0_c20200101__20201231_zsfo2foIEuR6" title="Tax effect of non-deductible expense"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Tax effect of stock-based compensation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<span id="xdx_909_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp_c20210101__20211231_zZf6qxDv9WSh" title="Tax effect of stock-based compensation"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" unitRef="Pure">14.71</ix:nonFraction></span></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_dp0_c20200101__20201231_z9GlSviSAM8d" title="Tax effect of stock-based compensation"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Tax effect of non-taxable income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCredits_dp0_c20210101__20211231_zAoGZz5ibU5l" title="Tax effect of non-deductible income"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationTaxCredits_dp0_c20200101__20201231_zHlNFMXhSqg8" title="Tax effect of non-deductible income"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Tax effect of different tax rates in other jurisdictions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp_c20210101__20211231_zrk92aaexVH4" title="Tax effect of different tax rates in other jurisdictions"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="Pure">1.07</ix:nonFraction></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_dp0_c20200101__20201231_zrEts9ygCUE8" title="Tax effect of different tax rates in other jurisdictions"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">GILTI Tax impact</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp0_c20210101__20211231_z5qw3xy2NHxj" title="GILTI Tax Impact"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_dp0_c20200101__20201231_zGidyzAErYR4" title="GILTI Tax Impact"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:zerodash" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" unitRef="Pure">–</ix:nonFraction></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Changes in valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20210101__20211231_zF4kEz6Nkxt9" title="Changes in valuation allowance"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="Pure">1.01</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20200101__20201231_ziIpiRAUpg8d" title="Changes in valuation allowance"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" unitRef="Pure">18.73</ix:nonFraction></span>%</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Effective tax rate</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<span id="xdx_906_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_zKPA2I2wCgEf" title="Effective tax rate"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="Pure">1.43</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20200101__20201231_zpbTkB9vPzv3" title="Effective tax rate"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" unitRef="Pure">6.27</ix:nonFraction></span>%</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A7_zVSjbscCmPE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3) Deferred tax assets (liabilities), net</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The tax effects of temporary differences representing deferred income tax assets and liabilities result principally from the following:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_891_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_z6vTbUWp6w45" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Deferred taxes)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B0_z0C5o9iZOkH1" style="display: none">Schedule of deferred income taxes</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20211231_zhDP1tKfzzpg" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_492_20201231_z2m0vyYEemT7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsGrossAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify">Deferred tax assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_i01I_pp0p0_d0_maDTAGzVGK_z0J4MpxhXBn3" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify">Tax loss carried forward</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 13%; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="0" unitRef="USD">2,300</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances_i01I_pp0p0_d0_maDTAGzVGK_zXAQ2OgydEc9" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Allowance for doubtful receivables</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetsGross_i01TI_pp0p0_d0_mtDTAGzVGK_maDTANz7Ul_zqkK0V9grICf" style="vertical-align: bottom; background-color: White"> <td style="color: White; text-align: justify">Total deferred tax assets </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="0" unitRef="USD">2,300</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DeferredTaxAssetsValuationAllowanceCurrents_i01NI_pp0p0_di0_msDTANz7Ul_zQpUBBiJPucb" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="NCRA:DeferredTaxAssetsValuationAllowanceCurrents" scale="0" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="NCRA:DeferredTaxAssetsValuationAllowanceCurrents" scale="0" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--DeferredTaxAssetsNet_i01TI_pp0p0_d0_mtDTANz7Ul_zv174ZFOcNFg" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total deferred tax assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsNet" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsNet" scale="0" unitRef="USD">2,300</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxLiabilitiesAbstract_iB" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify">Deferred tax liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_i01NI_pp0p0_di0_maDITLz2Zl_zzgcQoebrOBk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Property and equipment, difference in depreciation</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="0" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredIncomeTaxLiabilities_i01NTI_pp0p0_di0_mtDITLz2Zl_zm2VfojIBVBg" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Deferred tax liabilities, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredIncomeTaxLiabilities" scale="0" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A3_zAO13lkutSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b> </p> <ix:exclude><p id="xdx_233_zM3mk9U27fmi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23F_zC7w2F0n4gOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_230_zNdOsZ9Dh6th" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 73; Value: 1 --> <div id="xdx_233_znwqxHlQyAPb" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_232_zxpgGtnjAfm7" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_234_zAwyLmmJgmN3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation allowance as of December 31, 2021 and 2020 was primarily provided for the deferred income tax assets if it is more likely than not that these items will expire before the Company is able to realize its benefits, or that the future deductibility is uncertain. The ultimate realization of deferred income tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible or utilizable. Management considers projected future taxable income and tax planning strategies in making this assessment. The movement for the valuation allowance is as following.</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SummaryOfValuationAllowanceTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_894_eus-gaap--SummaryOfValuationAllowanceTextBlock_zaVk7Yivsxk8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - TAXATION (Details - Valuation Allowance)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B6_zHPJ7n1YyYO8" style="display: none">Movement in valuation allowance</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; font-weight: bold; text-align: justify">Balance at beginning of the year</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pp0p0_di0_c20210101__20211231_zLa43PWKLHFg" style="width: 13%; text-align: right" title="Valuation allowance, beginning"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" sign="-" unitRef="USD">–</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNS_pp0p0_di_c20200101__20201231_zJOaTkMFzMw9" style="width: 13%; text-align: right" title="Valuation allowance, beginning">(<ix:nonFraction contextRef="AsOf2019-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="USD">304,418</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Additions of valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20210101__20211231_pp0p0" style="text-align: right" title="Additions to valuation allowance"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" unitRef="USD">95,844</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_pp0p0_d0_c20200101__20201231_zbUeuJEMiLL6" style="text-align: right" title="Additions to valuation allowance"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">Reductions of valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_pp0p0_d0_c20210101__20211231_zoQTt10g5YCe" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:zerodash" name="NCRA:ValuationAllowanceDeferredTaxAssetChangeInAmount1" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ValuationAllowanceDeferredTaxAssetChangeInAmount1_c20200101__20201231_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Reductions in valuation allowance"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ValuationAllowanceDeferredTaxAssetChangeInAmount1" scale="0" unitRef="USD">304,418</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Balance at the end of the year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_c20210101__20211231_zD32qZVGywi2" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="USD">95,844</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowance_iE_pp0p0_d0_c20200101__20201231_zArchrNvMVX3" style="border-bottom: Black 2.5pt double; text-align: right" title="Valuation allowance, ending balance"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:zerodash" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A5_zkYypbP7NH6a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>PRC Withholding Tax on Dividends</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The current PRC Enterprise Income Tax Law imposes a 10% withholding income tax for dividends distributed by foreign-invested enterprises to their immediate holding companies outside the PRC. A lower withholding tax rate will be applied if there is a tax treaty arrangement between the PRC and the jurisdiction of the foreign holding company. Distributions to holding companies in Hong Kong that satisfy certain requirements specified by PRC tax authorities, for example, will be subject to a 5% withholding tax rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the Company had not recorded any withholding tax on the retained earnings of its foreign-invested enterprises in the PRC, since the Company intends to reinvest its earnings to potentially continue its business in mainland China, namely the manufacturing of the RASs through GZ GST, and its foreign-invested enterprises do not intend to declare dividends to their immediate foreign holding companies. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zb2XXaJyiRvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_40" style="display:inline-block"/><b>Note 14     <span id="xdx_82C_zR40MsiSBwfd">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due to related parties</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due to related parties was as following:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_897_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zGXoTd6tnHic" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Details - Due to related parties)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"><span id="xdx_8B8_z2gYN0LMI9Od" style="display: none">Schedule of related party transactions</span></td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Mountain Share Transfer, LLC (2)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_zOCzndHbmPW2" style="width: 13%; text-align: right" title="Due to related parties"><ix:nonFraction contextRef="AsOf2021-12-31_custom_MountainShareTransferMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="0" unitRef="USD">39,341</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98E_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDIp_zBsuRTMv7tJ6" style="width: 13%; text-align: right" title="Due to related parties"><ix:nonFraction contextRef="AsOf2020-12-31_custom_MountainShareTransferMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesCurrent" scale="0" unitRef="USD">7,681</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Due from a related party</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The balance due from a related party was as following:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31, <br/> 2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify">Mr. Yin-Chieh Cheng (1)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_d0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zolbXB6Kfxh9" style="width: 13%; text-align: right" title="Due from related parties"><ix:nonFraction contextRef="AsOf2021-12-31_custom_YinChiehChengMember" decimals="0" format="ixt:zerodash" id="Fact001161" name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zQ4Kd2nXC3a2" style="width: 13%; text-align: right" title="Due from related parties"><ix:nonFraction contextRef="AsOf2020-12-31_custom_YinChiehChengMember" decimals="0" format="ixt:numdotdecimal" id="Fact001163" name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" scale="0" unitRef="USD">19,067</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Taisi Electrical Plumbing Co. Pte Ltd. (3)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zygpNx7sVUSf" style="border-bottom: Black 1pt solid; text-align: right" title="Due from related parties"><ix:nonFraction contextRef="AsOf2021-12-31_custom_TaisiElectricMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" scale="0" unitRef="USD">1,615,217</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_iI_pp0p0_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TaisiElectricMember_fKDMp_zse3CREvFWTc" style="border-bottom: Black 1pt solid; text-align: right" title="Due from related parties"><ix:nonFraction contextRef="AsOf2020-12-31_custom_TaisiElectricMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" scale="0" unitRef="USD">877,809</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20211231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Due from related parties"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" scale="0" unitRef="USD">1,615,217</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--DueToOtherRelatedPartiesCurrentAndNoncurrent_c20201231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Due from related parties"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:DueToOtherRelatedPartiesCurrentAndNoncurrent" scale="0" unitRef="USD">896,876</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span id="xdx_F02_zWEvjF9aSQ3a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F12_zXkv5es7vkwh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001172" xml:lang="en-US">Mr. Yin-Chieh Cheng (“Mr. Cheng”) is the chairman the Company, and he holds 42.5% shares of the Company. The balance due to Mr. Cheng as of December 31, 2020 mainly represented the amount paid by Mr. Cheng on behalf of the Company. In September 2019, Mr. Cheng took over the receivable amount of the concert the Company invested in November 2018, and assumed the liability of $551,457 related to such receivable to the Company. In September 2019, Mr. Cheng collected the payment of $1,000,000 from JCD, our exclusive sales agent in Asia Pacific, on behalf of the Company. As agreed between Mr. Cheng and the Company, the due from balance was netted off by due to balances.</ix:footnote></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p> <ix:exclude><p id="xdx_233_zR9ETLI2mZnk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_236_zTnwoqpVTXH4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 74; Value: 1 --> <div id="xdx_23B_zaVyjdSYM5wi" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_237_zpKcdk0YckK5" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_237_zuZGDpLCaiIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21pt; text-align: justify"> </p></ix:exclude> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span id="xdx_F0F_zUZ2p7X53mXi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td> <td style="text-align: justify"><span id="xdx_F1C_z6moZzXBnVU" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001176" xml:lang="en-US">Mountain Share Transfer, LLC is company 100% controlled by Erik S. Nelson, the corporate secretary and director of the Company. The balances represented the amount paid on behalf of the Company for its daily operation purpose.</ix:footnote></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span id="xdx_F07_z8ryZy2DqrR4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td> <td style="text-align: justify"><span id="xdx_F13_z3BqZTVZlZ8c" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001177" xml:lang="en-US">Mr. Tsai Wen-Chih is the director of XFC and has control power over Taisi Electrical Plumbing Co. Pte Ltd. The Company took over the receivable amount of $877,809 from acquisition of XFC in December 2020. None of the receivables have been impaired and it is expected that the full contractual amounts can be collected.</ix:footnote></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Related party transactions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i> </i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The details of the related party transactions were as follows:</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="font-weight: bold; text-align: justify">Paid on behalf of the Company</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify">Mr. Zhang Bi (1)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_d0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ZhangBiMember_fKDEp_z8U37EBYx5Rc" style="width: 13%; text-align: right" title="Proceeds from related party"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_ZhangBiMember" decimals="0" format="ixt:zerodash" id="Fact001179" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ZhangBiMember_fKDEp_zyAtbGoN2pQd" style="width: 13%; text-align: right" title="Proceeds from related party"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_ZhangBiMember" decimals="0" format="ixt:numdotdecimal" id="Fact001181" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="USD">3,455</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Mr. Yin-Chieh Cheng (1)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_d0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zwpbVIE6aRf6" style="text-align: right" title="Proceeds from related party"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_YinChiehChengMember" decimals="0" format="ixt:zerodash" id="Fact001183" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_fKDEp_zKyVh3q9ipU5" style="text-align: right" title="Proceeds from related party"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_YinChiehChengMember" decimals="0" format="ixt:numdotdecimal" id="Fact001185" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="USD">86,320</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Mountain Share Transfer, LLC (1)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_d0_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDEp_z3kMDnNvCuu" style="text-align: right" title="Proceeds from related party"><ix:nonFraction contextRef="From2021-01-012021-12-31_custom_MountainShareTransferMember" decimals="0" format="ixt:zerodash" id="Fact001187" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="USD">–</ix:nonFraction></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromRelatedPartyDebt_pp0p0_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MountainShareTransferMember_fKDEp_zzwTNCXOpOcj" style="text-align: right" title="Proceeds from related party"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_MountainShareTransferMember" decimals="0" format="ixt:numdotdecimal" id="Fact001189" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="0" unitRef="USD">7,000</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: justify">Repayment to related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Mr. Yin-Chieh Cheng</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--RepaymentsOfRelatedPartyDebt_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_pp0p0" style="text-align: right" title="Repayment to related party"><span style="-sec-ix-hidden: xdx2ixbrl1191">–</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--RepaymentsOfRelatedPartyDebt_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember_pp0p0" style="text-align: right" title="Repayment to related party"><ix:nonFraction contextRef="From2020-01-012020-12-31_custom_YinChiehChengMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="0" unitRef="USD">665,000</ix:nonFraction></td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 27px"><span id="xdx_F04_z1e9I4XK5j6d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td> <td style="text-align: justify"><span id="xdx_F1E_ztwecF1VrYub" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote001194" xml:lang="en-US">The transactions represent the amount paid by Mr. Zhang Bi, Mr. Yin-Chieh Cheng, and Mountain Share Transfer, LLC on behalf of the Company for its daily operation.</ix:footnote></span></td></tr> </table> </ix:nonNumeric><p id="xdx_8A3_zRpDp8OEBc8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8pCyds7nPT1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_41" style="display:inline-block"/><b>Note 15     <span id="xdx_827_zHWj7RhXKR19">COMMON STOCK</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s authorized number of common stock is <span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zgLnHZkGNdr4" title="Common stock, shares authorized"><span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_c20201231_z5i4cBCmSN5g" title="Common stock, shares authorized"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" unitRef="Shares">200,000,000</ix:nonFraction></ix:nonFraction></span></span> shares with par value of $<span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231_zkMyITEtHtS6" title="Common stock par value"><span id="xdx_901_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20201231_zcFzGrIi9Mg8" title="Common stock par value"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="USDPShares">0.001</ix:nonFraction></ix:nonFraction></span></span> each, and issued ordinary shares were <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20211231_zZ8L2ClaWiAh" title="Common stock, shares issued"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" unitRef="Shares">10,607,150</ix:nonFraction></span> and <span id="xdx_90F_eus-gaap--CommonStockSharesIssued_iI_c20201231_zJEGRKipgHFc" title="Common stock, shares issued"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" unitRef="Shares">9,131,786</ix:nonFraction></span> as of December 31, 2021 and 2020, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All number of shares, share amounts and per share data presented in the accompanying consolidated financial statements and related notes have been retroactively restated to reflect the reverse merger transaction and subsequent issuance of shares stated above, except for authorized common shares, which were not affected.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"><p id="xdx_803_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zcty8w3nn3x9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_42" style="display:inline-block"/><b>Note 16     <span id="xdx_822_zLWXKZtDqOCg">SHARE-BASED COMPENSATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 27, 2018, Nocera granted Mr. Yin-Chieh Cheng quarterly option awards of <span id="xdx_906_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--YinChiehChengMember__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_zIEOlbBL2nW6"><ix:nonFraction contextRef="From2018-12-012018-12-27_custom_YinChiehChengMember_custom_SeriesAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">250,000</ix:nonFraction></span> Series “A” Warrants for 20 quarters (5 years) for a total of <span id="xdx_90F_ecustom--WarrantsGranted_c20181201__20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_zRRVxpIoaEC7"><ix:nonFraction contextRef="From2018-12-012018-12-27_custom_SeriesAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">5,000,000</ix:nonFraction></span> Series “A” Warrants with exercise price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20181227__us-gaap--AwardTypeAxis__custom--SeriesAWarrantMember_zNEKYUauR2Jj"><ix:nonFraction contextRef="AsOf2018-12-27_custom_SeriesAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">0.50</ix:nonFraction></span> per share, subject to continued employment for services as Chairman of the Board and a Director.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2020, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_905_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zW6x8LKoa3g8" title="Warrants granted"><ix:nonFraction contextRef="From2020-05-292020-06-01_custom_ShunChihChuangMember_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">50,000</ix:nonFraction></span> shares of Class A warrants and <span id="xdx_90A_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zy613U00xgL8"><ix:nonFraction contextRef="From2020-05-292020-06-01_custom_HsienWenYuMember_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">60,000</ix:nonFraction></span> shares of Class A warrants separately, each with exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601_zNqYAMtsob92" title="Warrants exercise price"><ix:nonFraction contextRef="AsOf2020-06-01" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">0.50</ix:nonFraction></span> per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees <span id="xdx_90B_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zc8IjyV9qI61"><ix:nonFraction contextRef="From2020-05-292020-06-01_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">50,000</ix:nonFraction></span> shares of Class A warrants with exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zpXfX7rj8rgl"><ix:nonFraction contextRef="AsOf2020-06-01_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">0.50</ix:nonFraction></span> per share. The Class A warrants consist of the right to purchase one share for $0.50 per share from the date of issuance until April 23, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 1, 2020, Nocera granted Mr. Michael A. Littman <span id="xdx_908_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zewNkjEWg33b"><ix:nonFraction contextRef="From2020-05-292020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">50,000</ix:nonFraction></span> shares of Class A warrants with exercise price of $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zZo5IzHBzup8"><ix:nonFraction contextRef="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">0.50</ix:nonFraction></span> per share and <span id="xdx_90A_ecustom--WarrantsGranted_c20200529__20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_z6bKGtPNor7j"><ix:nonFraction contextRef="From2020-05-292020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">50,000</ix:nonFraction></span> shares of Class B warrants with exercise price of $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20200601__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_zoJ8H7taqTP6"><ix:nonFraction contextRef="AsOf2020-06-01_custom_MichaelALittmanMember_custom_ClassBWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">1.00</ix:nonFraction></span> per share. Mr. Littman exercised <span id="xdx_90F_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zSxzibltFPY3"><ix:nonFraction contextRef="From2021-08-022021-08-11_custom_MichaelALittmanMember_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">50,000</ix:nonFraction></span> shares of Class A warrants and <span id="xdx_903_ecustom--WarrantsGranted_c20210802__20210811__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MichaelALittmanMember__us-gaap--AwardTypeAxis__custom--ClassBWarrantMember_zHJTRdSAFlQ5"><ix:nonFraction contextRef="From2021-08-022021-08-11_custom_MichaelALittmanMember_custom_ClassBWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">50,000</ix:nonFraction></span> shares of Class B warrants on August 11, 2021. The Class B warrants consist of the right to purchase one share for $1.00 per share separately from the date of issuance until April 23, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_23E_zFkocv5rQEd1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_23C_z0tkrrTjHpB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_230_zXn9wDXCjWw8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 75; Value: 1 --> <div id="xdx_239_zsjS4EsSRVj" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_231_z488MJtLsuqa" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 1, 2021, Nocera granted Mr. Shun-Chih Chuang and Mr. Hsien-Wen Yu <span id="xdx_900_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zCpzDQ15cHhc"><ix:nonFraction contextRef="From2021-11-292021-12-02_custom_ShunChihChuangMember_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">75,000</ix:nonFraction></span> shares of Class A warrants and <span id="xdx_90D_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HsienWenYuMember__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zqEEjahFnTe5"><ix:nonFraction contextRef="From2021-11-292021-12-02_custom_HsienWenYuMember_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">60,000</ix:nonFraction></span> shares of Class A warrants separately, each with exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211202_ztWfGrh2dSTg"><ix:nonFraction contextRef="AsOf2021-12-02" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">0.50</ix:nonFraction></span> per share, for serving as the Company’s Chief Financial Officer and Chief Operating Officer. The Company also granted 2 employees <span id="xdx_900_ecustom--WarrantsGranted_c20211129__20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zD0eZ7ur1dHb"><ix:nonFraction contextRef="From2021-11-292021-12-02_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="NCRA:WarrantsGranted" unitRef="Shares">70,000</ix:nonFraction></span> shares of Class A warrant with exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20211202__us-gaap--AwardTypeAxis__custom--ClassAWarrantMember_zMz5ktNnoMs2"><ix:nonFraction contextRef="AsOf2021-12-02_custom_ClassAWarrantMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="USDPShares">0.50</ix:nonFraction></span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2021, the Company issued an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20211201__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ShunChihChuangMember_zs650KokMEjg" title="Issued for services"><ix:nonFraction contextRef="From2021-12-012021-12-31_custom_ShunChihChuangMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" unitRef="Shares">505,000</ix:nonFraction></span> shares of common stock to Mr. Shun-Chih Chuang and a total of five consultants in consideration for services rendered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated fair value of share-based compensation for employees is recognized as a charge against income on a ratable basis over the requisite service period, which is generally the vesting period of the award. The fair value of stock option grant was estimated on the date of grant using the Black-Scholes option pricing model under the following assumptions:</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zGeov4Zgdzid" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED COMPENSATION (Details - assumptions)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B2_zRuP49StNE5d" style="display: none">Assumptions used</span></td> <td> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2021</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, <br/> 2020</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 68%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 13%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20210101__20211231_zsnQzL9VrBR4" title="Risk-free interest rate"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="Pure">1.16</ix:nonFraction></span>%</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20200101__20201231_zcVvyIzHOmlh" title="Risk-free interest rate"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" unitRef="Pure">0.20</ix:nonFraction></span>%</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected term (in years)</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20210101__20211231_zEgvYXVcNkTh" title="Expected term (in years)"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">4.31</ix:nonNumeric></span></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231_zs9y0RcpTcya" title="Expected term (in years)"><ix:nonNumeric contextRef="From2020-01-012020-12-31" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">2.88</ix:nonNumeric></span></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20210101__20211231_zkCcwonehNpi" title="Volatility"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="Pure">48.15</ix:nonFraction></span>%</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20200101__20201231_zL4V12pCECGl" title="Volatility"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" unitRef="Pure">407.00</ix:nonFraction></span>%</span></td> <td> </td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company estimated the grant date fair value of time-based stock option awards using the Black-Scholes option valuation model, which requires assumptions involving an estimate of the fair value of the underlying common stock on the date of grant, the expected term of the options, volatility, discount rate and dividend yield. The Company calculated expected option terms based on the “simplified” method for “plain vanilla” options due to the limited exercise information. The “simplified method” calculates the expected term as the average of the vesting term and the original contractual term of the options. The Company calculated volatility using the average adjusted volatility of quick companies feature of Capital IQ for a period of time reflective of the expected option term, while the discount rate was estimated using the interest rate for a treasury note with the same contractual term as the options granted. Dividend yield is estimated at our current dividend rate, which adjustments for any known future changes in the rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the years ended December 31, 2021 and December 31, 2020, $<span id="xdx_903_ecustom--ReverseMergerRecapitalization_c20210101__20211231_pp0p0" title="Reverse merger recapitalization"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ReverseMergerRecapitalization" scale="0" unitRef="USD">6,638,371</ix:nonFraction></span> and $<span id="xdx_901_ecustom--ReverseMergerRecapitalization_c20200101__20201231_pp0p0" title="Reverse merger recapitalization"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="NCRA:ReverseMergerRecapitalization" scale="0" unitRef="USD">266,586</ix:nonFraction></span> share-based compensation expenses was recognized into additional paid-in capital of the Company, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, total unrecognized compensation cost related to unvested share-based compensation awards was $<span id="xdx_90E_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c20211231_pp0p0" title="Unrecognized compensation costs"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="0" unitRef="USD">11,114,097</ix:nonFraction></span>. This amount is expected to be recognized as stock-based compensation expense in the Company’s consolidated statements of operations and comprehensive income over the remaining vesting period of <span id="xdx_903_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_dtY_c20210101__20211231_zITgcvI3UbPf" title="Unrecognized compensation cost amortization period"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">1.99</ix:nonNumeric></span> years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:PreferredStockTextBlock"><p id="xdx_806_eus-gaap--PreferredStockTextBlock_zXfSfXfJoac3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_43" style="display:inline-block"/><b>Note 17     <span id="xdx_82F_zLYnrUlG7Fei">PREFERRED STOCK</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In August 2021, the Company issued <span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_c20211231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z9OaaFZcT1h" title="Preferred Stock, Shares Issued"><ix:nonFraction contextRef="AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesIssued" unitRef="Shares">80,000</ix:nonFraction></span> shares of preferred shares of $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20210801_zJG6VC5UPoMc" title="Sale of stock, price"><ix:nonFraction contextRef="AsOf2021-08-01" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockPricePerShare" unitRef="USDPShares">1.00</ix:nonFraction></span> each at an issue price of $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_c20210801_zyjgN7yEqa62" title="Shares issued, price"><ix:nonFraction contextRef="AsOf2021-08-01" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssuedPricePerShare" unitRef="USDPShares">2.50</ix:nonFraction></span> per share to certain investors credited as fully paid. The preferred shares are non-voting and non-redeemable. The holder of the preferred shares will have priority over the holders of ordinary shares of the Company on the assets and funds of the Company available for distribution in a distribution of assets on liquidation, winding up or dissolution of the Company. The holder of the preferred shares shall not have the right to attend or vote at any general meeting of the Company (except a general meeting for winding up of the Company or a resolution is to be proposed which if passed would vary or abrogate the rights or privileges of such holder).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:EarningsPerShareTextBlock"><p id="xdx_80A_eus-gaap--EarningsPerShareTextBlock_zkIhynksbgc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_44" style="display:inline-block"/><b>Note 18     <span id="xdx_824_zXmDx0ztwZbc">(LOSS) EARNINGS PER SHARE</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the computation of basic and diluted (loss) earnings per common share for the years ended December 31, 2021 and 2020.</p> <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zQi9yQp7yJB8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - (LOSS) EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"><span id="xdx_8B7_ztXs5OnZwop4" style="display: none">Schedule of earnings (loss) per share</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20210101__20211231_ztXWYtOOQcNi" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20200101__20201231_z3HAmDp6dgJ7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">For the years ended December 31,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td><td> </td> <td colspan="2" style="text-align: center">$</td><td> </td></tr> <tr id="xdx_403_ecustom--NumeratorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_i01_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="width: 68%; text-align: justify; padding-bottom: 2.5pt">Net loss attributable to the Company</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" sign="-" unitRef="USD">9,619,079</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="0" sign="-" unitRef="USD">632,365</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_403_ecustom--DenominatorAbstract_iB" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfSharesOutstandingAbstract_i01B" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Weighted-average shares outstanding</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 1pt">- Basic</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="Shares">9,160,862</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="Shares">11,752,447</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="Shares">9,160,862</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="Shares">11,752,447</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasicAndDilutedAbstract_i01B" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify">Earnings (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--EarningsPerShareBasic_i01_pdd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">- Basic</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" unitRef="USDPShares">1.0500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:EarningsPerShareBasic" sign="-" unitRef="USDPShares">0.0538</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_404_eus-gaap--IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_i01_pdd" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: justify; padding-bottom: 2.5pt">- Diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" sign="-" unitRef="USDPShares">1.0500</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction contextRef="From2020-01-012020-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" sign="-" unitRef="USDPShares">0.0538</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_234_zcrEv3tAIgd5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_239_zzjezrECXR8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_232_zU20mA1rpXR7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 76; Value: 1 --> <div id="xdx_237_zyS0W5tkZe29" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_238_zXjHCIqddYn7" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_234_zdoxtztmDpj7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic net (loss) income per common share is computed using the weighted average number of the common shares outstanding during the period. Diluted (loss) income per share is computed using the weighted average number of ordinary shares and ordinary equivalent shares outstanding which include <span id="xdx_90C_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_pdd" title="Antidilutive shares"><ix:nonFraction contextRef="From2021-01-01to2021-12-31" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="Shares">5,473,636</ix:nonFraction></span> warrants outstanding as of December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z0MwjZOgH6vf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_45" style="display:inline-block"/><b>Note 19     <span id="xdx_827_zfcyfGkD70x1">COMMITMENTS AND CONTINGENCIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Capital commitments</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021 and 2020, the Company’s capital commitments contracted but not yet reflected in the consolidated financial statements amounted to $nil. <span id="xdx_90D_eus-gaap--ContractualObligation_c20211231_pp0p0" title="Commitments"><span id="xdx_90C_eus-gaap--ContractualObligation_c20201231_pp0p0" style="display: none" title="Commitments"><ix:nonFraction contextRef="AsOf2021-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" unitRef="USD"><ix:nonFraction contextRef="AsOf2020-12-31" decimals="0" format="ixt:numdotdecimal" name="us-gaap:ContractualObligation" scale="0" unitRef="USD">0</ix:nonFraction></ix:nonFraction></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Contingencies</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the ordinary course of business, the Company may be subject to legal proceeding regarding contractual and employment relationships and a variety of other matters. The Company records contingent liabilities resulting from such claims when a loss is assessed to be probable and the amount of the loss is reasonably estimable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has no significant pending litigation for the year ended December 31, 2021 and 2020.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">  </p> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:BusinessCombinationDisclosureTextBlock"><p id="xdx_800_eus-gaap--BusinessCombinationDisclosureTextBlock_zHu3wBu8Cb24" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span class="alphaminr_link" id="alphaminr_46" style="display:inline-block"/><b>NOTE 20 <span id="xdx_82D_zjlD3w4feUAl">BUSINESS COMBINATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Xin Feng Construction Co., Ltd.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 31, 2020, the Company acquired substantially all of the assets of XFC. The fair values of assets acquired and liabilities assumed were as follows:</p> <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_XinFengConstructionCoLtdMember" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_z4BpQFylTR1c" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS COMBINATION (Details - XFC)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B2_zENLZfOVcOId" style="display: none">Schedule of assets acquired and liabilities assumed</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%; text-align: left">Cash and bank balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="width: 13%; text-align: right" title="Cash and bank balance"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="0" unitRef="USD">857,555</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade receivables</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="text-align: right" title="Trade receivables"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="0" unitRef="USD">318,487</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="text-align: right" title="Inventory"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="0" unitRef="USD">1,608,301</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses and other current assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="text-align: right" title="Prepaid expenses and other current assets"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">877,809</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Plant and equipment, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="text-align: right" title="Plant and equipment, net"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="0" unitRef="USD">50,567</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other non-current assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="text-align: right" title="Other non-current assets"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="0" unitRef="USD">458,392</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Notes payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_zEd6r9rk0Tah" style="text-align: right" title="Notes payable">(<ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="0" unitRef="USD">187,447</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Bank borrowing</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBankBorrowing_iNI_pp0p0_di_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_z9lxooaNAc81" style="text-align: right" title="Bank borrowing">(<ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBankBorrowing" scale="0" unitRef="USD">532,824</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other payables and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_iNI_pp0p0_di_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_zofmiHRRPkS3" style="text-align: right" title="Other payables and accrued liabilities">(<ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" scale="0" unitRef="USD">55,917</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Income tax payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIncomeTaxPayable_iNI_pp0p0_di_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_zREopXB8xdMc" style="text-align: right" title="Income tax payable">(<ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIncomeTaxPayable" scale="0" unitRef="USD">285,186</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Advance receipts</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvanceReceipts_iNI_pp0p0_di_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_ziqCQH6TASTk" style="text-align: right" title="Advance receipts">(<ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvanceReceipts" scale="0" unitRef="USD">1,285,777</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Goodwill</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_zkEO7d8jOQ7e" style="border-bottom: Black 1pt solid; text-align: right" title="Goodwill"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="0" unitRef="USD">332,040</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20201231__us-gaap--BusinessAcquisitionAxis__custom--XinFengConstructionCoLtdMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net assets acquired"><ix:nonFraction contextRef="AsOf2020-12-31_custom_XinFengConstructionCoLtdMember1173991656" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="0" unitRef="USD">2,156,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A4_zAtBdBB2FQq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Guizhou Wan Feng Hu Intelligent Aquatic Technology Co. Limited.</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 8, 2020, the Company terminated the VIE agreements with and settled all debt claims as to GZ WFH. The fair values of assets and liabilities of GZ WFH were as follows:</p> <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" escape="true" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_893_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_hus-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_zbUNBPemFkyh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - BUSINESS COMBINATION Business Combination (Details - GZ WFH)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8BB_znWb1JZjpME1" style="display: none">Schedule of assets acquired and liabilities assumed</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 84%; text-align: left">Cash and bank balance</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="width: 13%; text-align: right" title="Cash and bank balance"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="0" unitRef="USD">3,974</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Trade receivables</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Trade receivables"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="0" unitRef="USD">1,534,961</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Inventory</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Inventory"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="0" unitRef="USD">295,960</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses and other current assets</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Prepaid expenses and other current assets"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" scale="0" unitRef="USD">143,819</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Plant and equipment, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Plant and equipment, net"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="0" unitRef="USD">703,412</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Advance to suppliers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvanceToSupplier_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Advance to suppliers"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvanceToSupplier" scale="0" unitRef="USD">3,996</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Deferred tax assets, net</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Deferred tax assets, net"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="0" unitRef="USD">121,675</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_zkVMTUyIzz35" style="text-align: right" title="Accounts payable">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="0" unitRef="USD">264,622</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Other payables and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iNI_pp0p0_di_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_z7lHa1QfIqmj" style="text-align: right" title="Other payables and accrued liabilities">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" scale="0" unitRef="USD">312,562</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Advance from customers</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvanceFromCustomer_iNI_pp0p0_di_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_z3fePWIiuFy1" style="text-align: right" title="Advance from customers">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAdvanceFromCustomer" scale="0" unitRef="USD">637,455</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Income tax payable</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIncomeTaxPayables_iNI_pp0p0_di_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_zoMtNi5CLNx4" style="text-align: right" title="Income tax payable">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIncomeTaxPayables" scale="0" unitRef="USD">629,666</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Due to related parties</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98E_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDueToRelatedParties_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Due to related parties">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDueToRelatedParties" scale="0" sign="-" unitRef="USD">414,583</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Net assets acquired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Net assets acquired"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="0" unitRef="USD">548,909</ix:nonFraction></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Consideration received</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitieAssumedConsiderationReceived_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Consideration received">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitieAssumedConsiderationReceived" scale="0" sign="-" unitRef="USD">4,750</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Non-controlling interest</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="text-align: right" title="Non-controlling interest">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" scale="0" sign="-" unitRef="USD">21,868</ix:nonFraction></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Cumulative exchange difference from translation of foreign operations</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTranslationOfForeignOperation_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="border-bottom: Black 1pt solid; text-align: right" title="Cumulative exchange difference from translation of foreign operations">(<ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedTranslationOfForeignOperation" scale="0" sign="-" unitRef="USD">62,174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss on disposal of subsidiary</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLossOnDisposalOfSubsidiary_c20201008__us-gaap--BusinessAcquisitionAxis__custom--GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss on disposal of subsidiary"><ix:nonFraction contextRef="AsOf2020-10-08_custom_GuizhouWanFengHuIntelligentAquaticTechnologyCoLimitedMember" decimals="0" format="ixt:numdotdecimal" name="NCRA:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLossOnDisposalOfSubsidiary" scale="0" unitRef="USD">460,117</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </ix:nonNumeric><p id="xdx_8A5_zrKFviWNVHvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <ix:exclude><p id="xdx_236_zhiW1yob9ZXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_232_za40NgDDQzmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> <ix:exclude><p id="xdx_235_zscXTInrkrYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/></ix:exclude> <ix:exclude><!-- Field: Page; Sequence: 77; Value: 1 --> <div id="xdx_23E_zRe82uM6b9lh" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <div id="xdx_237_ztPb4rXbiR01" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt"> </p></div> <!-- Field: /Page --></ix:exclude> <ix:exclude><p id="xdx_238_zZq2UXXHlO4g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p></ix:exclude> </ix:nonNumeric><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_804_eus-gaap--SubsequentEventsTextBlock_zVhw2DCbrT4f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span class="alphaminr_link" id="alphaminr_47" style="display:inline-block"/><b>Note 21     <span id="xdx_828_z4s04SDUExf4">SUBSEQUENT EVENT</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Consulting Agreements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">On January 3, 2022, the Company entered into a consulting agreement with a consultant. The term the consulting agreement is from January 3, 2022 to January 2, 2025. In consideration for services rendered under the consulting agreement, the Company agreed to issue the consultant 60,000 Class A warrants, vesting in three equal installments commencing on the first anniversary date of the consulting agreement. Each Class A warrant is exercisable to purchase one share of common stock for $0.50 per share from the date of vesting until April 23, 2026.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">On January 3, 2022, the Company entered into two consulting agreements with two consultants. The term of each consulting agreement is from January 3, 2022 to January 2, 2025. In consideration for services rendered under the consulting agreements, the Company agreed to issue the consultants an aggregate of 90,000 Class C Warrants, vesting in three equal installments commencing on the first anniversary date of the consulting agreements. Each Class C Warrant is exercisable to purchase one share of common stock for $2.50 per share from the date of vesting in each installment until the third anniversary date of the date of vesting.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The foregoing securities were issued in reliance on the exclusion from registration provided by Rule 903 of Regulation S under the Securities Act due to the fact that such persons was a non-U.S. Person (as defined under Rule 902 Section (k)(2)(i) of Regulation S).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Gerald H. Lindberg’s Employment Agreement</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">On January 3, 2022, the Company agreed to issue 60,000 Class C warrants to Gerald H. Lindberg in connection with the Employment Agreement, dated January 3, 2022, between the Company and Mr. Lindberg, as more fully described under Item 5.02 of the Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission (the “SEC”) on January 5, 2022. The Class C warrants issued to Mr. Lindberg vest in three equal installments over a three-year period, commencing on the first-year anniversary date of Mr. Lindberg’s employment agreement. Each Class C warrant will be exercisable to purchase one share of common stock for $2.50 per share from the vesting date until the third anniversary of such vesting date. The Company agreed to issue the foregoing Class C warrants to Mr. Lindberg pursuant to the exemption from the registration requirements of the Securities Act of 1933 available under Section 4(a)(2) promulgated thereunder due to the fact that the issuance did not involve a public offering of securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b><i>Issuance of Common Stock to CARMEL, MILAZZO FEIL LLP</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">On January 28, 2022, the Company issued 100,000 common shares as consideration to CARMEL, MILAZZO FEIL LLP, which has served as the Company’s legal counsel since November 2021, according to the engagement letter signed by mutual parties.</p> </ix:nonNumeric><p id="xdx_817_zx0siD6U50ac" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <!-- Field: Page; Sequence: 78; Options: Last --> <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%"> </td><td style="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right"> </td></tr></table></div> <!-- Field: /Page --> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <noscript><img src="https://www.sec.gov/akam/13/pixel_58da3e7a?a=dD1mMjE3ZWIzYTAxNGRmYzI3ZDRmMGZiY2FlMTI2ZTljMDk2YTczYTQ1JmpzPW9mZg==" style="visibility: hidden; position: absolute; left: -999px; top: -999px;"/></noscript></body> </html><!-- Field: Set; Name: xdx; ID: xdx_08B_extensions --><!-- eJy9Wety2jgUfoK+gya/Oy3QZmc2/4xD0sySwABt2u30h7CPQVNbYnUhIW+0b7lHsuwYYsDulnQ6Q6nO+c79InF29vbsWlyxFCT52p8MyQyyVUo1kAkkIIFHgBThzV8XBD8nsGBKS8q1+1owhgJ5AHnO33V7FA8c6ZopiC9I58P77p/vez3S7V2cd8j49uyNPQ8FT1gMXDOaEspjMpZiJRloKjc5wow+Ci6yjRP1BaRigl+Q7rtOfvwv6XW6PXIn1vRByJ+KDIfh2Zu37s+bs2spzMqKMUqLjAxSyFCWylmf/zpVIkdzEcRriubOxNSsVilDgXjW7XZRTOfjXq4J2o1GCD6BCNiazlNoxOelOa6VU6zbO8Iy1VQbLeQm4PFIL0FOQIFcQyPmISh1JSSwBQ+NtIHdzDCQCmONyg+FUoHWks2NtibMxJ3gkeBaijRlfHHDNSaD0k5S77Ckm2xFmbTuHiXXTw/J0rnjCFO4pHwB6oZfIe8XmhoYJfdU2lTbDBmds5Rp5j17DEpwZVKN3t1M0T0sAjUFrVOI+5vBP6Yxzg2PJFAFl5B/3vB9sT7qkRdIPvpXUmR5hvps+2Ukn0dNMLDQIoBYOeEiywSfahH9xKTyDr9RytC88I86aW9O3kI2B2khOhYi6OyFmAlN0zvUSVKnyFKkMbrDhWrTAgZkxrjL5lHyhUGwkJAX/T3TyzIRj3rYGz9K7uBhuqSY9Z9Xgo8lxlvDOKWRA20C1UCjXEBpXuf8/+rVHLBJmTRHe9k8Z/Co+ynGs2QP97OPJWDTiAePK+AKVJFMgVKg1VikDLtVG7y8nfyObjLAgtebII7REcp/DBmHj6UavfbM502Y7UAEqW1l2XisbHg/K0hMOmRYYDPXp9s45SvjV8AXNvBamsjmZSiGOm5eY9eGPS2FuacO6JOxYwHnwwI1C/4xmOnRDKIlF6lYbBCaZUxDC/g83QaPkYte/CLv8nMCFYJaCN9B9giuktSlju/HQXO9C5Z+e5awOUuQpuWsaM41NhK9pfY25PKcfM8pftR51Rf1Pp8U5yRogrLPTSVKvwnKPs+VKOEhlNmD+AVnjjj8AtfO2lXk9wT7dmUF6z2n+x/4T89UJjuRdik3uFITLYj2fEBoJgxOFIKrtHDTBgkYJ4nhrsBxuY68XMuHbVZIjQvd8//GRtrv2G4Jthsm4ncoPeDc2L18jUMZZW8pUVc0fvSXW9Ee5zgyUqE7FCJH7AfDYcCC6BBa6Pt/87BdtubwDGoCsR30roEdWxIKnsEjyIgp6xUnqnt43u6wQTx18cSeVtM365pJHtmCHdeIyH+h2zr0w1YY11arigot2Q+acwDLu+MeS2aJ4uuhV+wFWsFQyfSchawsz1v8XnDVSd0WN4GMMs7chMUCjTSWkN0Bd33S7e+3oxniyGiFd2Y8+I2guxl4BNWuVa5x4VwSD3b5u7QvBugsvLi7xa1YwgLXorpnW9sW1ki+gijbrtYFGKEFWkOaOrUAVy2nhm2xz5lsbXHHhNpzoumja2j19l2nYk5T3HDQCIY+GYoHRIQYr2DY/7dLO6clz8QEqYkjJyV9I6JdLcYy2je4JyEZ2Gs5Zirma45g4Q51wd0QqZdRzMdUsxeJWxtYTCa3UrlZhvDN++U3xsMlg2W4xG2yxU2PMsUGKUQaa7Q52982HfusOcOdwTlP8XIbzJUrlJzpA5aFbazl8QX5XlD8qEe6LIbzPqwKwXG0CWAhK7gFuXBDl64Y3qDZk4vjdmJ6UpI5Whz/L4iPU+yKny6NDRtGDS+kLcIWphQvQa2H6ifFgN8D/2aa89wy3FcgDYZM64zyljr2W+vYNwpvdUqFIpv7Gz/GRSw4e8KG4V45E2Yba150QYT3OaxCvNlVbqN4hhkV9yn/2RdSigff3rdeEk8p6ZRW5e0J286YbooJ0zuVYTXCTmnbsafc08p6BcueX3VOmo910l7Buuoj7GvEbkfea1bdaXOzTtoprbs0mCsTsNfgeExl8aJ3Mvvq5Z3CQi/QvtSx2C4Z5W8O/lJZNXGLyg7wguyUvq88XIwS/1YxWnklXqpoMmOJ15WnhJgl/gdGkmBFlE8a1giRkMS/f4gC9NTZZH8CG/FLplZC0XSUTM0c3crynyO3zbGkBNWMPbHVV1XJd/Usbuu7N8EDF/QpSKtb61UE9/jyCb7Fwy4u8VUHsDyw10/3zX41qTyMHRH6H9PhoPQ= --> </div> </div> <!---------------------------------------> <!----------- 3rd column ----------------> <!----------- RIGHT MENU ----------------> <section class="col-md-3 col-sm-3 col-lg-3 section toc" id="3rd"> <div id="report_table_cont">TABLE OF CONTENTS</div> <div id="table_filing"> <a href="#alphaminr_1" class="part-link link-button">Part I</a><a href="#alphaminr_2" class="item-link link-button">Item 1. Business</a><a href="#alphaminr_3" class="item-link link-button">Item 1A. Risk Factors</a><a href="#alphaminr_4" class="item-link link-button">Item 1B. Unresolved Staff Comments</a><a href="#alphaminr_5" class="item-link link-button">Item 2. Properties</a><a href="#alphaminr_6" class="item-link link-button">Item 3. Legal Proceedings</a><a href="#alphaminr_7" class="item-link link-button">Item 4. Mine Safety Disclosures</a><a href="#alphaminr_8" class="part-link link-button">Part II</a><a href="#alphaminr_9" class="item-link link-button">Item 5. Market For Registrant S Common Stock, Related Stockholder Matters and Issuer Purchases Of Equity Securities</a><a href="#alphaminr_10" class="item-link link-button">Item 6. [reserved]</a><a href="#alphaminr_11" class="item-link link-button">Item 7. Management S Discussion and Analysis Of Financial Condition and Results Of Operations</a><a href="#alphaminr_12" class="item-link link-button">Item 7A. Quantitative and Qualitative Disclosures About Market Risk</a><a href="#alphaminr_13" class="item-link link-button">Item 8. Financial Statements and Supplementary Data</a><a href="#alphaminr_14" class="item-link link-button">Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a><a href="#alphaminr_15" class="item-link link-button">Item 9A. Controls and Procedures</a><a href="#alphaminr_16" class="item-link link-button">Item 9B. Other Information</a><a href="#alphaminr_17" class="item-link link-button">Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</a><a href="#alphaminr_18" class="part-link link-button">Part III</a><a href="#alphaminr_19" class="item-link link-button">Item 10. Directors, Executive Officers, and Corporate Governance</a><a href="#alphaminr_20" class="item-link link-button">Item 11. Executive Compensation</a><a href="#alphaminr_21" class="item-link link-button">Item 12. Security Ownership Of Certain Beneficial Owners and Management and Related Stockholder Matters</a><a href="#alphaminr_22" class="item-link link-button">Item 13. Certain Relationships and Related Transactions and Director Independence</a><a href="#alphaminr_23" class="item-link link-button">Item 14. Principal Accounting Fees and Services</a><a href="#alphaminr_24" class="part-link link-button">Part IV</a><a href="#alphaminr_25" class="item-link link-button">Item 15. Exhibits and Financial Statement Schedules</a><a href="#alphaminr_26" class="item-link link-button">Item 16. Form 10-k Summary</a><a href="#alphaminr_27" class="note-link link-button">Note 1 Principal Activities and Organization</a><a href="#alphaminr_28" class="note-link link-button">Note 2 Going Concern</a><a href="#alphaminr_29" class="note-link link-button">Note 3 Summary Of Significant Accounting Policy</a><a href="#alphaminr_30" class="note-link link-button">Note 4 Accounts Receivable, Net</a><a href="#alphaminr_31" class="note-link link-button">Note 5 Inventories, Net</a><a href="#alphaminr_32" class="note-link link-button">Note 6 Advance To Suppliers</a><a href="#alphaminr_33" class="note-link link-button">Note 7 Prepaid Expenses and Other Assets, Net</a><a href="#alphaminr_34" class="note-link link-button">Note 8 Property and Equipment, Net</a><a href="#alphaminr_35" class="note-link link-button">Note 9 Goodwill</a><a href="#alphaminr_36" class="note-link link-button">Note 10 Warrants</a><a href="#alphaminr_37" class="note-link link-button">Note 11 Leases</a><a href="#alphaminr_38" class="note-link link-button">Note 12 Other Payables and Accrued Liabilities</a><a href="#alphaminr_39" class="note-link link-button">Note 13 Taxation</a><a href="#alphaminr_40" class="note-link link-button">Note 14 Related Party Balances and Transactions</a><a href="#alphaminr_41" class="note-link link-button">Note 15 Common Stock</a><a href="#alphaminr_42" class="note-link link-button">Note 16 Share-based Compensation</a><a href="#alphaminr_43" class="note-link link-button">Note 17 Preferred Stock</a><a href="#alphaminr_44" class="note-link link-button">Note 18 (loss) Earnings Per Share</a><a href="#alphaminr_45" class="note-link link-button">Note 19 Commitments and Contingencies</a><a href="#alphaminr_46" class="note-link link-button">Note 20 Business Combination</a><a href="#alphaminr_47" class="note-link link-button">Note 21 Subsequent Event</a><h3 class="exhibit-header">Exhibits</h3><a href="nocera_ex1015.htm" class="exhibit-link" target="_blank">10.15 Consulting Agreement dated as of November 15, 2021, by and between Nocera, Inc. and Shih-Chung Lin * </a><a href="nocera_ex1016.htm" class="exhibit-link" target="_blank">10.16 Consulting Agreement dated as of November 15, 2021, by and between Nocera, Inc. and Han-Chieh Shih * </a><a href="nocera_ex1017.htm" class="exhibit-link" target="_blank">10.17 Employment Agreement dated as of August 16, 2019, by and between Nocera, Inc. and Hsien-Wen Yu * </a><a href="nocera_ex1018.htm" class="exhibit-link" target="_blank">10.18 Employment Agreement dated as of August 16, 2019, by and between Nocera, Inc. and Shun-Chih Chuang * </a><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1001.htm" class="exhibit-link" target="_blank">10.19 Employment Agreement dated as of January 3, 2022, by and between Nocera, Inc. and Gerald H. Lindberg Filed as Exhibit 10.1 to Form 8-K filed on January 6, 2022. </a><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1002.htm" class="exhibit-link" target="_blank">10.20 Addendum, dated December 31, 2021, to that certain Employment Agreement, dated August 16, 2019, between Nocera, Inc. and Shun-Chih Chuang Filed as Exhibit 10.2 to Form 8-K filed on January 6, 2022. </a><a href="http://www.sec.gov/Archives/edgar/data/1756180/000168316822000131/nocera_ex1003.htm" class="exhibit-link" target="_blank">10.21 Addendum, dated December 31, 2021, to that certain Employment Agreement, dated August 16, 2019, between Nocera, Inc. and Hsien-Wen Yu Filed as Exhibit 10.3 to Form 8-K filed on January 6, 2022. </a><a href="nocera_ex2101.htm" class="exhibit-link" target="_blank">21.1 List of Subsidiaries of Nocera, Inc. * </a><a href="nocera_ex3101.htm" class="exhibit-link" target="_blank">31.1 Rule 13a-14(a)/15d-14(a) Certification of the President and Chief Executive Officer of Nocera, Inc. * </a><a href="nocera_ex3102.htm" class="exhibit-link" target="_blank">31.2 Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer of Nocera, Inc. * </a><a href="nocera_ex3201.htm" class="exhibit-link" target="_blank">32.1 Section 1350 Certification of the President and Chief Executive Officer of Nocera, Inc. ** </a><a href="nocera_ex3202.htm" class="exhibit-link" target="_blank">32.2 Section 1350 Certification of the Chief Financial Officer of Nocera, Inc. ** </a> </div> </section> </div> </div> <style> .ended { font-size: 8pt; display: block; } #financeModal { padding: 0 !important; } .reload { font-family: Lucida Sans Unicode; cursor: pointer; } .modal-blur { -webkit-filter: blur(5px); -moz-filter: blur(5px); -o-filter: blur(5px); -ms-filter: blur(5px); filter: blur(5px); } #financeModal .modal-dialog { width: 80%; max-width: none; margin: 0; left: 10%; top: 5%; } #financeModal .modal-content { border: 0; border-radius: 0; } #financeModal .modal-body { overflow-y: auto; } .date { font-size: 9pt; } .active-finance { background-color: #2196f3 !important; color : ffffff !important; } .active-fin-type { background-color: #2196f3 !important; color : ffffff !important; } .finance_type:hover, .finance_type:active, .finance_type:focus { background-color: #ffffff; text-decoration: none; } .finance:hover, .finance:active, .finance:focus { background-color: #ffffff; text-decoration: none; } #finance-div table tbody tr td:not(:first-child) { text-align: right; } .blur { box-shadow: 0px 0px 20px 20px rgba(255, 255, 255, 1); text-shadow: 0px 0px 10px rgba(51, 51, 51, 0.9); transform: scale(0.9); opacity: 0.6; } </style> <style> .gemini-response { font-family: Arial, sans-serif; line-height: 1; } .gemini-response h2, .gemini-response h3 { margin-top: 20px; margin-bottom: 10px; } .gemini-response ul { padding-left: 20px; } .gemini-response ul li { margin-bottom: 10px; } .gemini-response p { margin-bottom: 15px; } .modal-lg { max-width: 50%; } </style> <div aria-hidden="true" aria-labelledby="shareholderModalLabel" class="modal fade " id="shareholderModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="shareholderModalTitle"></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <h2 class="fund-header" id='dynamic-header' style="text-decoration:underline"></h2> <p id="p-fund" style="display: none;">No information found </p> <div id="fund_div"> <p class="small-note ">* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.</p> <div class="table-responsive x-overflow-hide"> <table class="fl-table table" id="fund-table"> <thead> <th onclick="sortTable(0)">FUND</th> <th onclick="sortTable(1)">NUMBER OF SHARES</th> <th onclick="sortTable(2)">VALUE ($)</th> <th>PUT OR CALL</th> </thead> <tbody class="tbody"> </tbody> </table> </div> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="directorModalLabel" class="modal fade" id="directorModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="dynamicDirector-header">Directors of NOCERA, INC. - as per the latest proxy <sup><small>Beta</small></sup></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="table-wrapper-director" id="dircter-table-div"> <table class="fl-table table" id="director-table"> <thead> <th class="directorCol">DIRECTORS</th> <th class="directorCol ageCol">AGE</th> <th class="directorCol">BIO</th> <th class="directorCol">OTHER DIRECTOR MEMBERSHIPS</th> </thead> <tbody class="tbody"> </tbody> </table> </div> </div> </div> </div> </div> <div aria-labelledby="registerModalLabel" class="modal fade " data-backdrop="static" data-keyboard="false" id="registerModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div> <button class="close pr-2 pt-2" type="button"> <a class="text-dark text-decoration-none" href="/NCRA/"> <span aria-hidden="true">×</span></a> </button> </div> <div class="text-center pb-3"><a href="/pricing/">Subscribe</a> to view this or get a <a href="/token/">free 24 hour token </a> or take a free test drive with ticker <a href="/snapshot/AAPL">AAPL</a>. View our demo <a href="/demo/">video</a>. </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="executiveModalLabel" class="modal fade" id="executiveModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id='executiveModalLabelTitle'></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <h2 class="fund-header" style="text-decoration:underline"></h2> <div class="table-responsive"> <div class="table-wrapper-execs" id='executive-button'> <p>No information found </p> </div> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="customerModalLabel" class="modal fade" id="customerModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="cust-header"> Customers and Suppliers of NOCERA, INC. <sup><small>Beta</small></sup></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="container"> <div class="row"> <div class="col-md-6 col-12"> <div class=" table-responsive x-overflow-hide" id="Customer_table"> <p>No Customers Found </p> </tbody> </table> </div> </div> <div class="col-md-6 col-12"> <div class=" table-responsive x-overflow-hide" id="Supplier_table"> <p>No Suppliers Found</p> </tbody> </table> </div> </div> </div> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="bondModalLabel" class="modal fade " id="bondModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="bondModalTitle">Bonds of NOCERA, INC.</h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="table-responsive " id="bond_table"> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="bondpricegraphModalLabel" class="modal fade " id="bondpricegraphModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document" style=" height: 100%;"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="bondpricegraphModalTitle">Price Graph </h5> <button aria-label="Close" class="close" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body" id="price_graph"> <img id="bond_graph" src=""> </div> <div class="row mt-5"> <div class="col-1 mt-2 pr-0"> <h6 style="position: relative;float: right;"><em class="dot red"></em> </h6> </div> <div class="col-11 pl-0"> <p class="text-muted">Price</p> </div> <div class="col-1 mt-2 pr-0"> <h6 style="position: relative;float: right;"><em class="dot"></em> </h6> </div> <div class="col-11 pl-0"> <p class="text-muted">Yield</p> </div> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="InsiderOwnershipModalLabel" class="modal fade " id="InsiderOwnershipModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="insider_ownershipModalTitle">Insider Ownership of NOCERA, INC. company <sup><small>Beta</small></sup></h5> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div class="table-wrapper-director" id="insider_ownership_table-div"> <table class="fl-table table" id="insider_ownership_table"> <thead> <th class="insideOwnershipCol">Owner</th> <th class="insideOwnershipCol">Position</th> <th class="insideOwnershipCol">Direct Shares</th> <th class="insideOwnershipCol">Indirect Shares</th> </thead> <tbody class="tbody"> </tbody> </table> </div> </div> </div> </div> </div> <div class="modal fade" id="aiInsights" tabindex="-1" role="dialog" aria-labelledby="aiInsightsLabel" aria-hidden="true"> <div class="modal-dialog modal-lg" role="document"> <div class="modal-content"> <div class="modal-header"> <h5 class="modal-title" id="aiInsightsLabel">AI Insights</h5> <button type="button" class="close" data-dismiss="modal" aria-label="Close"> <span aria-hidden="true">×</span> </button> </div> <div class="modal-body"> <div id="geminiResponseContainer" class="gemini-response"> <!-- Response content will be loaded here --> </div> </div> <div class="modal-footer"> <button type="button" class="btn btn-secondary" data-dismiss="modal">Close</button> </div> </div> </div> </div> <div aria-hidden="true" aria-labelledby="financeModalLabel" class="modal fade " id="financeModal" role="dialog" tabindex="-1"> <div class="modal-dialog modal-xl modal-dialog-scrollable" role="document"> <div class="modal-content"> <div class="modal-header"> <div> <span> <h5 class="modal-title" id="financeModalTitle">Summary Financials of NOCERA, INC. <sup><small>Beta</small></sup></h5> </span> <span style="font-size:80%"> <small>(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)</small> </span> </div> <button aria-label="Close" class="close pr-2 pt-2 pb-1" data-dismiss="modal" type="button"> <span aria-hidden="true">×</span> </button> </div> <input id="ftitle" type="hidden" value=""> <input id="displayed_finance" type="hidden" value="balance"> <input id="displayed_ftype" type="hidden" value="10-Q"> <input id="company_name_hidden" type="hidden" value="NOCERA, INC."> <div class="modal-body"> <div class="row"> <div class="col-10"> <div aria-label="Basic example" class="btn-group" role="group"> <button class="btn model_button border border-primary finance p-1 active-finance" id="balance" type="button">Balance Sheet </button> <button class="btn model_button finance p-1" id="income" type="button"> Income Statement </button> <button class="btn model_button finance p-1" id="cash_flow" type="button">Cash Flow </button> </div> </div> <div class="col-2 pull-right"> <div aria-label="Basic example" class="btn-group" role="group" style="float: right;"> <button class="btn model_button finance_type p-1 active-fin-type" id="10-Q" type="button">Quarterly </button> <button class="btn model_button finance_type p-1" id="10-K" type="button">Annual </button> </div> </div> </div> <div class="table-responsive pt-2" id="finance-div"> No information found </div> </div> </div> </div> </div> </div> <script> </script> <script src="/static/js/threeButtonScroll.js?v=9"></script> <script src="/static/js/scroll_js.js?v=7"></script> <script> var ticker = "NCRA"; $(document).ready(function() { $('#aiInsights').on('show.bs.modal', function (event) { var companyName = "NOCERA, INC."; var csrftoken = $('input[name="csrfmiddlewaretoken"]').val(); // Show loading spinner $('#geminiResponseContainer').html('<div class="text-center"><span class="spinner-border text-primary" role="status"><span class="sr-only">Loading...</span></span></div>'); // Logging the data sent in the AJAX request console.log('Preparing AJAX request with data:', { company_Name: companyName, csrfmiddlewaretoken: csrftoken }); $.ajax({ url: '/api/get_gemini_response/', type: 'POST', data: { 'company_Name': companyName, 'company_Ticker': ticker, 'csrfmiddlewaretoken': csrftoken }, success: function(data) { console.log('AJAX request successful. Data received:', data); if (data.error) { $('#geminiResponseContainer').html(`<div class='alert alert-danger'>Error: ${data.error}</div>`); } else { $('#geminiResponseContainer').html(formatResponse(data.response)); } }, error: function(xhr, status, error) { console.error("AJAX Error:", error); console.error("Detailed response:", xhr.responseText); $('#geminiResponseContainer').html(`<div class='alert alert-danger'>AJAX Error: ${error}</div>`); } }); }); }); function formatResponse(response) { let formattedResponse = response.replace(/\*\*(.*?)\*\*/g, '<strong>$1</strong>'); // Convert **text** to <strong>text</strong> formattedResponse = formattedResponse.replace(/\* (.*?)(\n|$)/g, '<li>$1</li>'); // Convert * text to <li>text</li> formattedResponse = formattedResponse.replace(/<\/li><li>/g, '</li><li>').replace(/<li>/g, '<ul><li>').replace(/<\/li>/g, '</li></ul>'); // Wrap <li> in <ul> formattedResponse = formattedResponse.replace(/## (.*?)(\n|$)/g, '<h2>$1</h2>'); // Convert ## text to <h2>text</h2> formattedResponse = formattedResponse.replace(/### (.*?)(\n|$)/g, '<h3>$1</h3>'); // Convert ### text to <h3>text</h3> formattedResponse = formattedResponse.replace(/\n/g, '<br>'); // Convert newlines to <br> return `<div>${formattedResponse}</div>`; } </script> <script src="/static/js/filing.js?v=1"></script> <script> $("#second").contents().find("body").css({'padding': '1px 4px', 'overflow-x': 'hidden'}) var fid = '1756180', printerLink = "/printer/" + "469141" + "/" + "False" + '/' //Append the print button to TOC function addPrintButton(items, type) { items.forEach((itm) => { itm.innerHTML = itm.innerHTML + '<span class="print">print</span>' itm.addEventListener('mouseover', function () { this.querySelector('span.print').style.display = 'inline-block' }) itm.addEventListener('mouseout', function () { this.querySelector('span.print').style.display = 'none' }) }) $('.' + type + '-link span.print').on('click', function (e) { let part = this.parentElement.hash.replace('#', '') openPrintPortion(part) }) } document.addEventListener('DOMContentLoaded', function () { I_frame = document.querySelector('#second') if (window.innerWidth > '700') { // I_frame.setAttribute('style','border:none;position:absolute;left:0vw;min-width:100%;max-width:100%;top:0vh;height:100%;min-height:100%;') } else { // I_frame.setAttribute('style','border:none;position:absolute;left:0vw;min-width:100vw;max-width:100vw!important;top:0vh;height:100%;min-height:100%;') } let partsInTOC = document.querySelectorAll('.part-link') let itemsInToc = document.querySelectorAll('.item-link') let notesInTOC = document.querySelectorAll('.note-link') addPrintButton(partsInTOC, 'part'); addPrintButton(itemsInToc, 'item'); addPrintButton(notesInTOC, 'note'); /* Toogle between the sections*/ let fillinglist = document.querySelectorAll('.firstsec')[0] let doc_preview = document.querySelectorAll('.document-view-section')[0] let toc = document.querySelectorAll('.toc')[0] let mobile_view = document.querySelectorAll('.mobile_view')[0] /* buttons for toggling */ let showfilings_btn = document.querySelectorAll('.show_filings_btn')[0] let showdoc_btn = document.querySelectorAll('.show_doc_btn')[0] let showtoc_btn = document.querySelectorAll('.show_toc_btn')[0] showfilings_btn.addEventListener('click', function () { let shortcutsmobile = document.querySelector('#shortcuts-mobile') fillinglist.style.display = 'block' doc_preview.style.display = 'none' toc.style.display = 'none' mobile_view.style.display = 'block' shortcutsmobile.style.display = 'none' }) showdoc_btn.addEventListener('click', function () { let shortcutsmobile = document.querySelector('#shortcuts-mobile') fillinglist.style.display = 'none' doc_preview.style.display = 'block' toc.style.display = 'none' mobile_view.style.display = 'none' shortcutsmobile.style.display = 'block' }) showtoc_btn.addEventListener('click', function () { let shortcutsmobile = document.querySelector('#shortcuts-mobile') fillinglist.style.display = 'none' doc_preview.style.display = 'none' toc.style.display = 'block' mobile_view.style.display = 'none' shortcutsmobile.style.display = 'none' }) $(".section document-view-section div").eq(1).after('<div id="doc-head"></div>') }) //track which filing has been clicked on let filingslinks = document.querySelectorAll('.filedate') /* let filingvalue = window.location.href.split('&'); console.log(filingvalue,'filingvaluefilingvalue') if (filingvalue.length===1){ let row =document.querySelector('#filings-section-list').querySelector('tbody').querySelectorAll('tr')[0] row.style.backgroundColor='#d8ecf3'; } else { filingvalue = window.location.href.split('&')[1].split('=')[1]; console.log(filingvalue,'filingvalue') filingslinks.forEach((filing)=>{ if (filing.outerHTML.search(filingvalue) > -1) { filing.setAttribute('style','background-color:#d8ecf3') } }) }*/ function openPrintPortion(portion) { var a = window.open(printerLink + portion, '_blank'); } </script> <script> function numberWithCommasNoDecimal(x) { // If null or undefined, just return dash if (x === null || x === undefined) return '-'; // Convert to float let val = parseFloat(String(x).replace(/,/g, '').trim()); if (isNaN(val)) return '-'; // Track negativity const negative = val < 0; // Work with absolute value for splitting val = Math.abs(val); // Now split at the decimal let [intPart, decimalPart] = val.toString().split('.'); // Insert commas in integer portion only intPart = intPart.replace(/\B(?=(\d{3})+(?!\d))/g, ','); // Reattach sign and decimal let result = negative ? '-' + intPart : intPart; if (decimalPart !== undefined) { result += '.' + decimalPart; } return result; } function fetch_bond_price_graph(bond_symbol) { $("#bond_graph").attr("src","/image/price_graph/"+bond_symbol+".png"); } function clear_div(element) { $('#' + element).html(''); } $(document).ready(function () { var ticker = "NCRA"; /***************************************************** * 1) OLD FUNCTION: create_table_new2 (flat structure) *****************************************************/ function create_table_new2( finance_data_section, finance_data_value, finance_data_label, ended_lst, f_data, dates, finance_title ) { if (!f_data || f_data.length === 0) { $('#finance-div').html('<div class="alert alert-info">No financial data available.</div>'); return; } // A quick helper to strip commas and parse float function parseValue(val) { if (val === null || val === undefined) return null; // Already a number if (typeof val === 'number') return val; // If it's a string, remove commas, extra spaces, etc. if (typeof val === 'string') { let cleaned = val.replace(/,/g, '').trim(); let parsed = parseFloat(cleaned); return isNaN(parsed) ? null : parsed; } return null; } var table = ` <div class="text-center"><strong>${finance_title}</strong></div> <table class="fl-table table table-hover" id="finance-table"> <thead> <tr> <th>Field</th>`; // Add headers for each date (same order as ended_lst) ended_lst.forEach(function(date) { table += `<th>${date}</th>`; }); table += `</tr></thead><tbody>`; // Track the last section and sub-section for grouping var lastSection = null; var lastSubSection = null; // f_data = [section, sub_section, label, [values per date]] f_data.forEach(function(item) { var section = item[0]; var sub_section = item[1]; var label = item[2]; var values = item[3]; // If we've hit a new section, print a row if (section && section !== lastSection) { table += ` <tr style="background-color: #000; color: #fff; text-transform: uppercase;"> <td colspan="${ended_lst.length + 1}"> <strong>${section}</strong> </td> </tr>`; lastSection = section; lastSubSection = null; } // If we've hit a new sub-section if (sub_section && sub_section !== lastSubSection) { table += ` <tr style="background-color: #f0f0f0;"> <td colspan="${ended_lst.length + 1}"> <strong>${sub_section}</strong> </td> </tr>`; lastSubSection = sub_section; } // Now the actual row for this label table += `<tr> <td style="padding-left: 20px;">${label}</td>`; // For each value in this row’s array (aligned with ended_lst) values.forEach(function(value) { // Convert to a real float if possible let numericVal = parseValue(value); if (numericVal === null) { // Not a valid float => dash table += `<td>-</td>`; } else { // Format as thousands with commas (keeping negatives and decimals) let formatted = numberWithCommasNoDecimal(numericVal); table += `<td>${formatted}</td>`; } }); table += `</tr>`; }); table += `</tbody></table>`; $('#finance-div').html(table); } /******************************************************* * 2) NEW FUNCTION: createNestedTable (hierarchical) *******************************************************/ function createNestedTable(nested_sections, ended_lst, finance_title) { // 1) Declare "table" in this scope let table = ` <div class="text-center"><strong>${finance_title}</strong></div> <table class="fl-table table table-hover" id="finance-table"> <thead> <tr> <th>Field</th>`; ended_lst.forEach(function(date) { table += `<th>${date}</th>`; }); table += `</tr></thead><tbody>`; // 2) Define processNode *inside* so it can reference "table" function processNode(node, indentLevel) { const leftPadding = indentLevel * 20; table += `<tr> <td style="padding-left:${leftPadding}px; font-weight:${indentLevel === 0 ? 'bold' : 'normal'};"> ${node.label || node.sectionName} </td>`; node.valueByPeriod.forEach(function(val) { if (val === null || val === undefined) { val = '-'; } else { // Attempt to parse even if it's a string if (typeof val === 'string') { let cleaned = val.replace(/,/g, '').trim(); let parsed = parseFloat(cleaned); if (!isNaN(parsed)) { val = numberWithCommasNoDecimal(parsed); } else { val = '-'; } } else if (typeof val === 'number') { val = numberWithCommasNoDecimal(val); } } table += `<td>${val}</td>`; }); table += `</tr>`; // Recurse if (node.children && node.children.length > 0) { node.children.forEach(child => processNode(child, indentLevel + 1)); } } // 3) Loop through top-level nodes nested_sections.forEach(node => { processNode(node, 0); }); table += `</tbody></table>`; $('#finance-div').html(table); } /************************************************ * 3) Show the modal -> call get_ajax_data ************************************************/ $('#financeModal').on('shown.bs.modal', function (e) { get_ajax_data(); }); /************************************************ * 4) get_ajax_data: calls Django endpoint ************************************************/ function get_ajax_data() { console.log($('#company_name_hidden').val()); var company_name = $('#company_name_hidden').val().replace('/', ' ').replace('\\', ' '); console.log(company_name); var cik = "1756180"; // e.g. '123456' var finance_type = $('#displayed_finance').val(); // e.g. 'balance', 'income', 'cash_flow' var data_type = $('#displayed_ftype').val(); // e.g. '10-K', '10-Q' var url = `/get/finance/data/${cik}/${finance_type}/${data_type}/${encodeURIComponent(ticker)}/`; $.ajax({ url: url, method: 'GET', success: function (resp) { $('#finance-div').html(''); if (resp.error) { $('#finance-div').html(`<div class="alert alert-danger">${resp.error}</div>`); } else { console.log(resp); // If server returns nested_sections, show them if (resp.nested_sections && resp.nested_sections.length > 0) { createNestedTable(resp.nested_sections, resp.date, resp.finance_title); } else { // Otherwise, fallback to the old flat approach create_table_new2( resp.finance_data_section, resp.finance_data_value, resp.finance_data_label, resp.ended_lst, resp.f_data, resp.date, resp.finance_title ); } } }, error: function (xhr, status, error) { $('#finance-div').html(`<div class="alert alert-danger">An error occurred: ${error}</div>`); console.error(error); } }); } /************************************************ * 5) On-click handlers for toggling (unchanged) ************************************************/ $(document).on('click', '.finance', function () { $('.finance').removeClass('active-finance'); $(this).addClass('active-finance'); // the button's ID (like "balance" or "income") is stored: $('#displayed_finance').val($(this).attr('id')); get_ajax_data(); // calls the /get/finance/data endpoint }); $(document).on('click', '.finance_type', function () { $('.finance_type').removeClass('active-fin-type'); $(this).addClass('active-fin-type'); // the button's ID ("10-Q" or "10-K") is stored: $('#displayed_ftype').val($(this).attr('id')); get_ajax_data(); }); $("#registerModal").on('shown', function () { console.log(7899809) alert("I want this to appear after the modal has opened!"); }); /* close popover */ $('body').on('click', function (e) { $('[data-toggle="popover"]').each(function () { //the 'is' for buttons that trigger popups //the 'has' for icons within a button that triggers a popup if (!$(this).is(e.target) && $(this).has(e.target).length === 0 && $('.popover').has(e.target).length === 0) { $(this).popover('hide'); } }); }); $('[data-toggle="tooltip"]').tooltip(); $('.exhibit-link').each(function () { href = $(this).attr('href') if (href.search('/www.sec.gov/Archives/edgar/data/') == -1) $(this).attr('href', "https://www.sec.gov/Archives/edgar/data/1756180/000168316822001860/" + href) }); $('.info-btn-circle').on('click', function (e) { $('.info-btn-circle').not(this).popover('hide'); }); if ($('#fixed-content-filing').length > 0) { fetch("/fetch_fixed_content_filing", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": "NCRA", "current_filing_name": "NOCERA, INC.", "current_filing_filingtype": "10-K", "current_filing_filingdate": "2021-12-31" }) }) .then(response => response.json()) .then(function (data) { bonds = data.data.bonds directors = data.data.director executives = data.data.executive funds = data.data.funds insider_ownership = data.data.insider_ownership bond_html = '' director_html = '' funds_html = '' executive_html = '' insider_ownership_html = '' if (bonds.length > 0) { bond_html += '<table class="fl-table table" id="bond-table"> <thead> <tr> <th rowspan="2">ISSUER NAME</th> <th rowspan="2">SYMBOL</th> <th rowspan="2">CALLABLE</th> <th rowspan="2">SUB-PRODUCT TYPE</th> <th rowspan="2"> COUPON</th> <th rowspan="2">MATURITY</th> <th class="text-center" colspan="2">RATINGS</th> <th class="text-center" colspan="2">LAST SALE</th><th rowspan="2">GRAPH</th> </tr> <tr> <th>MOODY\'S® </th> <th>S&P</th > <th> PRICE </th> <th>YIELD</th> </tr> </thead> <tbody class = "tbody" > ' for (let i = 0; i < bonds.length; i++) { bond_html += '<tr> <td>' + bonds[i].issuer_name + '</td> <td> '+ bonds[i].symbol + ' </td> <td>' + bonds[i].callable + '</td> <td>' + bonds[i].sub_product_type + '</td> <td>' + bonds[i].coupon + '</td> <td>' + bonds[i].matuarity + '</td> <td>' + bonds[i].moody_rating + '</td> <td>' + bonds[i].s_and_p_rating + '</td> <td>' + bonds[i].last_sale_price + '</td> <td>' + bonds[i].last_sale_yield + '</td> <td> <div class="row justify-content-center"> <button class="btn col" style="font-size: inherit; margin-top: 0px; padding-top: 0px;" data-target="#bondpricegraphModal" onclick="fetch_bond_price_graph(\''+bonds[i].symbol+'\')" data-toggle="modal">Price Graph</button><div></td> </tr>' } bond_html += '</tbody> </table>' } else { bond_html = 'No information found' } $("#bond_table").empty(); $('#bond_table').append(bond_html); if (executives.length > 0) { executive_html = executives } else { executive_html = 'No information found' } $("#executive-button").empty(); $('#executive-button').append(executive_html); document.getElementById("dynamicDirector-header").innerHTML = "Directors of NOCERA, INC. - as per the latest proxy " + '<sup><small>Beta</small></sup>'; if (directors.length == 0) { $('#director-table').hide(); $('#dircter-table-div').html('<p>No information found</p>') } else { $('#director-table').show(); for (var i = 0; i < directors.length; i++) { tr = ' <tr >' tr += '<td ><center>' + directors[i][0] + '</center></td>' if (directors[i][1] == null) tr += '<td class=" ageCol" ><center></center></td>' else tr += '<td class=" ageCol" ><center>' + directors[i][1] + '</center></td>' tr += '<td id = "bioCol" ><p>' + directors[i][2] + '</p></td>' other = '' for (k = 0; k < directors[i][3].length; k++) { if (k == directors[i][3].length - 1) { other = other + directors[i][3][k] } else { other = other + directors[i][3][k] + ', ' } } tr += ' <td ><center>' + other + '</center></td>' tr += '</tr>' $('#director-table tbody').append(tr) } } if (funds.length != 0) { date = new Date(data.data.fund_report_date) day = date.getDate(); month = date.toLocaleString('default', { month: 'short' }); year = date.getFullYear(); $("#shareholderModalTitle").text("Top 100 Shareholders of NOCERA, INC. as of " + month + ' ' + day + ', ' + year) } else { $("#shareholderModalTitle").text("Top 100 Shareholders of NOCERA, INC.") } //$('#cust-header').text( "Customers and Suppliers of NOCERA, INC.") for (var i = 0; i < funds.length; i++) { tr = '<tr id="tr_doc">' tr += '<td class="success fund text-uppercase">' + funds[i].fund + '<button type="button" id="' + i + '" class="btn btn-secondary btn-small info-btn-circle" data-container="body" data-title="×" data-toggle="popover" data-placement="top" data-html="true" >i</button></td>' tr += '<td class = "fund-shares" >' + numberWithCommasNoDecimal(funds[i].share_prn_amount) + '</td>' tr += '<td class="fund-value">' + numberWithCommasNoDecimal(funds[i].value) + '</td>' tr += '<td class="success"><center>' + funds[i].put_call + '</center></td>' tr += '</tr>' $('#fund-table tbody').append(tr) } $('[data-toggle="popover"]').popover({sanitize:false, content: function() { var i = $(this).attr('id') text_tooltip = '<div class="container"><div class="row">'+ '<div class="col-4 p-0 font-weight-bold " >Filed By: </div><div class="col-8 p-0 hover-shareholder tooltip-custom copy-details"><div class="copy-text">'+funds[i].filed_by_name+'</div><span class="tooltiptext">Click To Copy</span></div>'+ '<div class="col-4 p-0 font-weight-bold" >Address: </div><div class="col-8 p-0 hover-shareholder tooltip-custom copy-details"><div class="copy-text">'+funds[i].address+'</div><span class="tooltiptext">Click To Copy</span></div>'+ '<div class="col-4 p-0 font-weight-bold" >Phone: </div><div class="col-8 p-0 hover-shareholder tooltip-custom copy-details"><div class="copy-text">'+funds[i].phone+'</div><span class="tooltiptext">Click To Copy</span></div>'+ '</div></div>' return text_tooltip; //return $('#po' + id).html(); } }); if (insider_ownership.length != 0) { for (var i = 0; i < insider_ownership.length; i++) { tr = '<tr id="tr_doc">' tr += '<td class="success fund text-uppercase">' + insider_ownership[i].owner + '</td>' tr += '<td class = "fund-shares" >' + numberWithCommasNoDecimal(insider_ownership[i].position) + '</td>' tr += '<td class="fund-value">' + numberWithCommasNoDecimal(insider_ownership[i].current_direct_shares) + '</td>' tr += '<td class="fund-value">' + numberWithCommasNoDecimal(insider_ownership[i].current_indirect_shares) + '</td>' tr += '</tr>' $('#insider_ownership_table tbody').append(tr) } } else { $('#insider_ownership_table tbody').append('No Data Found') } $("#executiveModalLabelTitle").text("Executives of NOCERA, INC. - as per the latest proxy") $('#executive-button table').addClass('table') $('#executive-button table tr:first-child').css('background-color', '#4FC3A1') $('#executive-button table tr td').css('border-right', 'none') $('#executive-button table').addClass('fl-table') $('#executive-button table').attr('border', '0') color = '#4FC3A1'; no = 0; $('#executive-button table tr:first-child td').each(function () { text = $(this).text(); text = text.replace(/\u200B/g, ''); text = text.replace(/[\u200B-\u200D\uFEFF]/g, ''); if (text.trim() == '') { $(this).css('background-color', color) if (no == 0) color = '#324960' } else { if (color == '#4FC3A1') color = '#324960' else color = '#4FC3A1' $(this).css('background-color', color) } no++; }) const table = document.querySelector('#executive-button table'); dates = data.data.yearly_years; ended_lst = data.data.ended_lst; finance_data_section = data.data.finance_data_section; finance_data_value = data.data.finance_data_value; finance_data_label = data.data.finance_data_label; f_data = data.data.f_data; }) } }) </script> </div> </div> </div> </body> <script crossorigin="anonymous" defer integrity="sha384-9/reFTGAW83EW2RDu2S0VKaIzap3H66lZH81PoYlFhbGU+6BZp6G7niu735Sk7lN" src="/static/bootstrap/js/popper.min.js"></script> <script defer src="/static/bootstrap/js/bootstrap.min.js"></script> <script defer src="/static/bootstrap/js/custom.min.js"></script> <script> var today_date = new Date(); today_date.setHours(0); today_date.setMinutes(0); today_date.setSeconds(0); $(document).ready(function() { $('#load-div-graph').show() finance_table_div = $('#finance_table_div') if (finance_table_div.length > 0) { fetch_live_stock_data(initial_call = 'true') setInterval(function() { fetch_live_stock_data() }, 30000) } serverStartTime = new Date("") moment_current_time = moment().tz("America/New_York"); moment_server_time = moment(serverStartTime).tz("America/New_York") var server_difference = (moment_current_time.diff(moment_server_time) / 1000).toFixed(2); var endTime = new Date(); var difference = ((endTime - startTime) / 1000).toFixed(2); //var serverdiff = ((endTime - serverStartTime)/1000).toFixed(2); $('#load_time').text(server_difference + ' s/' + difference + ' s') //MOBILE ONE AND MOBILE THREE var menu = "close"; $(".mobile-one .menu-toggle, .mobile-three .menu-toggle").click(function() { if (menu === "close") { $(this).parent().next(".mobile-nav").css("transform", "translate(0, 0)"); menu = "open"; } else { $(this).parent().next(".mobile-nav").css("transform", "translate(-100%, 0)"); menu = "close"; } }); }) function openNav() { document.getElementById("mySidebar").style.width = "250px"; // document.getElementById("main").style.marginLeft = "250px"; } function closeNav() { document.getElementById("mySidebar").style.width = "0"; // document.getElementById("main").style.marginLeft= "0"; } function change_selected_view(element) { site_view = element.value; if (document.getElementById('site_view').length == 3) { if (site_view === 'filing') { href = window.location.href href = href.split('/') href = href.slice(0, 3).join('/') + '/' + href.slice(-1) window.location.href = href } else { href = window.location.href href = href.split('/') href = href.slice(0, 3).join('/') + '/snapshot/' + href.slice(-1) window.location.href = href } } else if (site_view === 'filing') { href = window.location.href href = href.split('/') href = href.slice(0, 3).join('/') + '/' + href.slice(-1)[0].split('#')[0] window.location.href = href } else { href = window.location.href href = href.split('/') if (href.slice(-1) !== '') { ticker = href.slice(-2, -1) if (ticker[0].length == 1 && /^[1-9]+$/.test(ticker)) { ticker = href.slice(-1) } else if (!/^[a-zA-Z]+$/.test(ticker)) { ticker = href.slice(-3, -2) } } else { ticker = href.slice(-1) } href = href.slice(0, 3).join('/') + '/snapshot/' + ticker window.location.href = href } } function load_document(filedata) { // read text from URL location var request = new XMLHttpRequest(); request.open('GET', filedata.path, true); request.send(null); $('#second #load-div').show(); request.onreadystatechange = function() { if (request.readyState === 4 && request.status === 200) { var type = request.getResponseHeader('Content-Type'); if (type.indexOf("text") !== 1) { $('#load-div').hide(); $("#second").empty(); second = document.getElementById('second') second.insertAdjacentHTML('beforeend', request.responseText) second.scrollTop = 00; $("#filing-title").empty(); $('#filing-title').append(filedata.file_title); return true } } } } function fetch_history_graph_data(element) { ticker = window.location.href.split('/').slice(-1)[0] graph = localStorage.getItem('graph_' + ticker + today_date); if (graph) { $('#graph_div')[0].innerHTML = ''; $('#graph_div').append(graph); } else { localStorage.clear(); fetch("/fetch_history_graph_data", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": ticker, "years": '1y' }) }) .then(response => response.json()) .then(function(data) { $('#load-div-graph').hide() $('#graph_div').append(data.graph); fetch("/fetch_history_graph_data", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": ticker, "years": '10y' }) }) .then(response => response.json()) .then(function(data) { $('#load-div-graph').hide() $('#finance_table_div').append(data.table); $('#graph_div')[0].innerHTML = ''; $('#graph_div').append(data.graph); localStorage.setItem('graph_' + ticker + today_date, data.graph); }) }) } } function fetch_history_table_data(element) { table = localStorage.getItem('table_' + ticker + today_date); if (table) { $('#finance_table_div').append(table); } else { fetch("/fetch_history_table_data", { headers: { "X-CSRFToken": document.getElementById("csrf") .querySelector("input") .value, 'Content-type': 'application/json' }, method: "POST", body: JSON.stringify({ "ticker": window.location.href.split('/').slice(-1)[0], }) }) .then(response => response.json()) .then(function(data) { $('#finance_table_div').append(data.table); localStorage.setItem('table_' + ticker + today_date, data.table); }) } } function fetch_live_stock_data(initial_call = '') { let options = { timeZone: 'America/New_York', hour: 'numeric', minute: 'numeric', second: 'numeric', }; let formatter = new Intl.DateTimeFormat([], options); // "09:00:00" < currentTime < "16:00:00" or forced initial_call const currentTime = String(formatter.format(new Date())); if ((currentTime > '09:00:00' && currentTime < '16:00:00') || initial_call) { fetch("/fetch_live_stock_data", { headers: { "X-CSRFToken": document.getElementById("csrf").querySelector("input").value, "Content-type": "application/json" }, method: "POST", body: JSON.stringify({ // e.g. ticker is last part of the URL "ticker": window.location.href.split('/').slice(-1)[0] }) }) .then(response => response.json()) .then(function(data) { // Sanitize/format the incoming data so no double minus signs, etc. const cleanPrice = sanitizePrice(data.price); const cleanChange = sanitizeChange(data.change, data.change_type); // Update DOM $("#stock_price").empty().append(cleanPrice); $("#stock_price_difference").empty().append( `<div class="stock_${data.change_type}">${cleanChange}</div>` ); // Exchange name if (data.exchange) { $('#exchange_name').text(`(${data.exchange})`); } }) .catch(err => console.error("Error fetching stock data:", err)); } } /** * e.g. turns "$236.8500" into "$236.85" */ function sanitizePrice(rawPrice) { // Remove everything except digits, minus, plus, decimal let numeric = parseFloat(rawPrice.replace(/[^\d.-]/g, '')) || 0; return `$${numeric.toFixed(2)}`; } /** * Normalizes the change string. * Example: raw = "- $-5.8500 (-2.4104%)", changeType="loss" => "-5.85 (-2.41%)" * If changeType="gain", we might do "+5.85 (+2.41%)" instead. */ function sanitizeChange(rawChange, changeType) { // Regex tries to capture something like: "- $-5.8500 (-2.4104%)" // Group 1: optional sign before dollar // Group 2: optional sign + digits for the numeric difference // Group 3: optional sign + digits + % for the parenthetical part // // We'll parse them out, strip extra signs, and reapply a single sign // based on "changeType" (e.g. "loss" => "-"). // const re = /^(-?)\s*\$?(-?[\d.]+)\s*\((-?[\d.]+%)\)\s*$/; const match = rawChange.trim().match(re); if (!match) { // If it doesn't match, fallback: just strip out extra non-digit // and reapply sign from changeType return fallbackClean(rawChange, changeType); } // e.g. match[1] = "-" // match[2] = "-5.8500" // match[3] = "-2.4104%" let diffVal = parseFloat(match[2].replace(/[^\d.-]/g, '')) || 0; let pctVal = parseFloat(match[3].replace(/[^\d.-]/g, '')) || 0; // Decide sign from "changeType" const sign = (changeType === "loss") ? "-" : "+"; // Build final difference & percentage const finalDiff = `${sign}${Math.abs(diffVal).toFixed(2)}`; // e.g. "-5.85" const finalPct = `${sign}${Math.abs(pctVal).toFixed(2)}%`; // e.g. "(-2.41%)" return `${finalDiff} (${finalPct})`; } /** * If the data doesn't match our regex, do a simpler approach: * - strip all non-numerics except sign * - parse & reapply sign from changeType */ function fallbackClean(rawStr, changeType) { let numericVal = parseFloat(rawStr.replace(/[^\d.-]/g, '')) || 0; let sign = (changeType === "loss") ? "-" : "+"; return `${sign}${Math.abs(numericVal).toFixed(2)}`; } </script> </html>